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Abstract
Inorganic carbon is fundamental to the physiology of all organisms, however elevated CO2 is generally
detrimental. Numerous class III adenylyl cyclases (AC) from both prokaryotic and mammalian
organisms have been shown to respond to inorganic carbon in vitro, however, at present there is
limited evidence in vivo. This thesis demonstrates in cellulo evidence that hypercapnia CO2 blunts
agonist induced cAMP signalling. The effect of CO2 is independent of changes in intracellular and
extracellular pH, independent of the mechanism used to activate the cAMP signalling pathway, and
is independent of the cell line employed. Through a combination of pharmacological and genetic
tools this effect of elevated CO2 on cAMP signalling is demonstrated to require Ca
2+ ion release
from IP3 receptors in the endoplasmic reticulum. Consistent with these findings, CO2 caused an
increase in cytoplasmic Ca2+ concentrations which require the presence of active IP3 receptors
and is absent under comparable acidotic conditions. Physiological relevance for this signalling
mechanism is demonstrated through activity of the sodium dependant proton exchanger NHE3.
This transporter exhibits well-characterised inhibition by cAMP dependant protein kinase PKA
to increase bicarbonaturia in vivo. Overall these results provide conclusive evidence of potentially
profound effects of inorganic carbon on intracellular cell signalling, which could lead to significant
insight into the pathophysiology and treatment of numerous disorders including metabolic acidosis,
reperfusion injuries, acute lung injury and obesity.
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BCECF(-AM) 2′,7′-bis(carboxyethyl)-5(6)-carboxyfluorescein (- acetoxymethyl)
BSA Bovine Serum Albumin
CaM Calmodulin
cAMP 3′-5′-cyclic Adenosine Monophosphate
CaMKK Ca2+/Calmodulin-dependent Protein Kinase Kinase
CA Carbonic Anhydrase
CFTR Cystic Fibrosis Trans-membrane conductance Regulator
cGMP 3′-5′-cyclic Guanosine Monophosphate
Ci Inorganic Carbon
cNMP cyclic Nucleoside Monophosphate
CRE cAMP Response Element
CREB CRE Binding protein
DAG Diacylglycerol
DMEM Dulbecco’s Modified Eagle Medium
DMSO Dimethyl Sulfoxide
DTT Dithiothreitol
DT40 Chicken B Lymphocytes
DT40-IP3 R1 DT40-K/O with gene for IP3R1 re-introduced
DT40-K/O DT40 cell line with all IP3R genes disrupted
EGTA Ethylene Glycol Tetra-acetic Acid
EIA Enzyme Immunoassay
ELISA Enzyme-linked Immunosorbent Assay
Epac Exchange proteins activated by cAMP
ER Endoplasmic Reticulum
FSK Forskolin (adenylylyl cyclase activator)
GC Guanylyl Cyclase
HBS HEPES Buffered Saline
HEK293t Human Embryonic Kidney cells
HEKPR1 HEK cells stably expressing human Parathyroid Hormone Receptor 1
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HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
IP3 Inositol triphosphate
IP3R Inositol triphosphate receptor
IBMX Isobutylmethylxanthine
IPTG Isopropyl β-D-thiogalactoside
KO or K/O Knock-out
LC Liquid Chromatography
MAPK Mitogen Activated Protein Kinase
MS Mass Spectrometry
MS/MS Tandem Mass Spectrometry
NAD(P)H Nicotinamide Adenine Dinucleotide (Phosphate)
NAADP Nicotinic Acid-Adenine Dinucleotide Phosphate
NEAA Non-Essential Amino Acids
NHE Na+/H+ Exchanger
Pi Inorganic Phosphate
pHe Extracellular pH
pHi Intracellular pH
OK Opossum Kidney cell line
PA Propionic Acid
PBS Phosphate Buffered Saline
RyR Ryanodine Receptors
SDS Sodium Dodecyl Sulphate
SERCA Sarcoplasmic/Endoplasmic Reticulum Ca2+-ATPases
Sto-609 1,8-napthoylene benzimidazole-3-carboxylic acid
TBST Tris-Buffered Saline Tween-20
TCA Tricholoacetic acid
TEMED Tetramethylethylenediamine
tmAC Transmembrane Adenylyl Cyclase
PDE Phosphodiesterase
PIP2 Phosphatidylinositol 4,5-bisphosphate
PI3(K) Phospho-tri-inositol (Kinase)
PKA/C Phospho-Kinase A/C
PLC Phospho-Lipase C
PPi Inorganic Pyrophosphate
PT Proximal Tubule
PTH Parathyroid Hormone
sAC soluble Adenylyl Cyclase
SDS Sodium Dodecyl Sulphate
TEMED N,N,N′,N′-tetramethyl-ethylenediamine
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UMR-106 Rat osteosarcoma cell line
7TM Seven Transmembrane Receptors
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1 Chapter 1: Background Information
1.1 Overview
This thesis provides evidence that CO2 can alter physiological processes through IP3 mediated
Ca2+ release and an associated decrease in intracellular cAMP levels. This chapter is aimed at
providing the reader with a review of the topics required to greater appreciate the research findings.
A review of both the cAMP and calcium signalling pathways will be provided, with particular focus
on how inorganic carbon affects adenylyl cyclase isoforms and IP3 mediated calcium release from
the endoplasmic reticulum. Examples of the interactions between these two signalling pathways will
also be provided. Following on from this signalling information, inorganic carbon will be considered
and its role in the environment, as well as in vivo. The final section focuses on how systemic
inorganic carbon levels are regulated, in addition to how disruption of these mechanisms can lead to
pathophysiological acid-base disorders and their clinical implications. Particular focus in the final
section will lie on the effects of hypercapnia in a clinical setting, as well as the renal control of HCO−3
reabsorption, as it is this system that is most relevant for the experimental chapters to follow.
1.2 Cell Signalling
Cell signalling is part of a complex system of communication that governs basic cellular activities
and coordinates cell actions. No cells live in complete isolation; in order for organisms to survive,
cells need to be able to monitor their extra-cellular environments and adjust accordingly in order to
promote survival. Commonly, the perception of both abiotic and biotic elements of the environment
is provided through the use of protein receptors, which transduce a stimulus to an intracellular
signalling network. Within this network, information is commonly conveyed either through protein-
protein interactions, or is transmitted by diffusible elements, usually referred to as second messengers.
Cells often employ a number of these signalling pathways and cross-talk between them is an important
feature of their regulation. Responses to stimuli vary, but notably involve transcription, translation
and post-translational effects. Errors in cellular information processing can lead to diseases such as
cancer, autoimmune disorders and diabetes, as well as ultimately resulting in death.
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1.3 Adenylyl Cyclase and cAMP
1.3.1 Introduction
Once an abiotic or biotic stimulus has been perceived at the plasma membrane of a cell, intracellular
cascades of molecular responses usually ensue. One common method of signal propagation is
through the accumulation of an intracellular second messenger, which acts as an intermediary
between the receptor and target molecule. This section focuses on the generation of one such
second messenger, 3′,5′-cyclic adenosine monophosphate (cAMP). Cyclic-AMP (Sutherland & Rall,
1958) is an important signalling molecule involved in a host of processes as diverse as controlling
cellular shape in Bordetella pertussis infected cells (Ohnishi et al., 2008), osmoregulation, chemotaxis,
phototaxis, pH regulation (Linder & Schultz, 2003), memory formation (Gerstner et al., 2009),
olfaction (Kamenetsky et al., 2006) and cardiac contraction (Pignatti et al., 1993).
Figure 1: Reaction catalysed by adenylyl cyclase
Cyclic-AMP is generated by the enzyme adenylyl cyclase (AC) which catalyses the cyclisation of its
substrate ATP to produce cAMP, in addition to an inorganic pyrophosphate by-product (Figure 1).
This enzyme is present in all kingdoms of life, although its presence in plants is controversial
(Kamenetsky et al., 2006; Gehring, 2010; Fenyk et al., 2012). Genes encoding AC are divided into six
phylogenetically defined classes by primary amino acid sequence (Baˆrzu & Danchin, 1994). Briefly,
class I ACs are found in the Enterobacteria such as Escherichia coli where they mediate catabolic
repression; class II in exclusive toxin-producing bacteria such as Bacillus anthracis and Bordetella
pertussis; class III in higher eukaryotes in addition to certain prokaryotic members; class IV in certain
prokaryotic thermophiles such as Aeromonas hydrophila. Class V consists of a single member from
the obligate anaerobe Prevotella ruminicola; and class VI ACs are found in the genomes of the
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Rhizobiaceae (Cann et al., 2003). Class III is of most interest here as it encompasses the isoforms
found in mammalian cells and the class on which most work on AC stimulation by inorganic carbon
has been carried out (Section 1.3.6). From this point forth where ACs are mentioned they will
thus be isoforms in this class. Mammalian ACs are further divided into ten isoforms with isoforms
I-IX transmembranal across the plasma membrane and responsive to G-proteins (Section 1.3.2). In
contrast group X, discovered in 1975 (Braun & Dods, 1975), is intracellular and deceivingly has
been named soluble adenylyl cyclase (sAC) despite being located at specific organelles including
the centrioles, mitotic spindle, mitochondria and within the nucleus (Zippin et al., 2003; Acin-Perez
et al., 2011); and therefore is not typically ‘soluble’ (Section 1.3.3).
1.3.2 Transmembrane Adenylyl Cyclases
Transmembrane ACs (tmACs) consist of two sets of six transmembrane domains, each followed by
an intracellular catalytic domain (Figure 1.3.2). The two catalytic domains are called C1a and C2a
and contain similar (more than 50% similarity), but non-identical, sequences of around 230 amino
acids and are responsible for ATP binding and catalysis (Tang & Hurley, 1998). C1a and C2a
are then followed by two hyper-variable sequence regions, C1b and C2b respectively, which contain
several regulatory sites (Hurley, 1999) and are not related between isoforms. As expected with such
high sequence homology, the tertiary structure of C1a and C2a is almost identical, consisting of
a three-layer α/β sandwich enabling hetero-dimerisation. The two domains orientate head-to-tail
forming two potential ATP binding sites at their interface (Tang & Hurley, 1998). Only one of these
sites is involved in substrate binding and catalysis, whilst the other acts as a binding site for the AC
activator forskolin (Tesmer et al., 1997; Zhang et al., 1997), a plant diterpene from Coleus forskolhii.
Forskolin activates all AC isoforms bar type IX from several species (Hatley et al., 2002; Cumbay
& Watts, 2004; Yan et al., 1998; Hacker et al., 1998) and sAC (Forte et al., 1983) and works by
promoting the affinity of the C1 and C2 domains (Dessauer et al., 1997). This domain interaction
is particularly important as neither catalytic domain can function independently, as proven by
experiments in E.coli using recombinant forms of the cytosolic domains of the mammalian type I
and type II isoforms (Tang & Gilman, 1995).
In addition to forskolin, all tmACs are regulated by G-proteins, GTP activated proteins released
from the intracellular domain of an upstream seven trans-membrane (7TM) receptor (Section 1.3.5).
The AC activating G-protein Gαs has a binding site which is ∼30 A˚ away from the AC catalytic
site (Yan et al., 1997) and binding facilitates a 7 degree rotation of C1 with respect to C2, which
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Figure 2: Structure of transmembrane adenylyl cyclase.
A. Diagrammatic representation of AC showing the NH2 terminus, the first transmembrane region
(TM1, cyan cylinders), the first cytoplasmic loop comprising C1a (red) and C1b (black), the second
transmembrane cluster (TM2, cyan cylinders) the second cytoplasmic loop comprising C2a (orange)
and C2b (black) and the C terminus. C1a and C2a are highly conserved catalytic ATP-binding
regions, which dimerise to form the catalytic site. Figure adapted from Willoughby et al. (Willoughby
& Cooper, 2007).
B. Ribbon diagram of the AC catalytic domains with α-helices shown as cylinders and β-strands
as ribbons. The C2 domains of two AC molecules are superimposed with the open inactive enzyme
crystallised in the absence of an ATP analogue in grey (PDB ID: 1AZS) and the closed active state
crystallised with ATP bound to the AC catalytic site in cyan (PDB ID: 1CJT). Location of forskolin
and Gαs switch II domain (red) binding is also included. With substrate ATP in the active site the
two catalytic domains are held closer together which allows catalysis to proceed. Figure adapted
from Sprang et al. (Sprang et al., 2007).
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causes the AC active site to close around its ATP substrate (Tesmer et al., 1999). Binding of Gαi
to ACs I, V and VI (Kamenetsky et al., 2006), however, inhibits these isoforms by hindering this
active site collapse and stabilising anlinactive conformation of the enzymed(Tesmer et al., 1999).
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Certain AC isoforms can also be regulated by other G-protein subunits including: Gαo and Gβγ
(Section 1.3.5 and Table 2) and tissue specific subunits such as Gαolf which activates ACs in
the olfactory systemP(Milligan et al., 1990). TmACs are further regulated by adenosine analogs,
Ca2+/calmodulin (Section 1.5), CO2 (Section 1.3.6), protein kinases and via feedback inhibition
from downstream protein kinase A (PKA). Each AC isoform responds to these factors differentially
(Tang & Hurley, 1998) and a summary table of these interactions is provided as Table 2.
1.3.3 Soluble Adenylyl Cyclase
Compared to AC isoforms I-IX, sAC is structurally, molecularly and biochemically distinct (Buck
et al., 1999) being neither transmembranal nor regulated by G-proteins (Braun & Dods, 1975).
Although the enzyme still contains two catalytic domains (C1 and C2) these two domains exhibit
low sequence homology compared to those of the tmACs and are more similar to bacterial ACs
than other mammalian tmACs. This has led to the theory that sAC originated from the fusion of
two distinct bacterial proteins rather than a duplication event (Buck et al., 1999; Kobayashi et al.,
2004). As mentioned, sAC is not located at the plasma membrane but found within the cytoplasm,
mitochondria and nucleus (Xie & Conti, 2004; Zippin et al., 2003; Acin-Perez et al., 2011). sAC thus
provides an intracellular source of cAMP, closer to its downstream targets. For example, PKA is often
found at similar intracellular locations to sAC (Zippin et al., 2003), anchored by AKAPs; A-kinase
anchoring proteins (Alberts, 2002). This proximity is particularly advantageous as it reduces the
possibility of loss of signal via the breakdown of cAMP by endogenous phosphodiesterases (PDEs),
which restrict cAMP diffusion to less than 1 µm from its source (Zippin et al., 2003). sAC has been
shown to respond directly to Ca2+ (not via calmodulin) and bicarbonate, synergistically when both
are present (Garbers et al., 1982). As HCO−3 is in a pH dependent equilibrium with CO2 (Section
1.6) it is possible that sAC is regulated by either or both of these species and furthermore that other
AC types could be similarly activated (Townsend et al., 2009). Discussion of this AC regulatory
mechanism is provided in Section 1.3.6.
1.3.4 Catalysis Mechanism and Requirement for Divalent Metal Co-factors
Despite the differences in AC regulation and structure across the mammalian isoforms (Sections
1.3.2 and 1.3.3) the reaction mechanism of ATP cyclisation remains relatively constant (Figure 3).
Catalysis requires the interaction of two divalent metal ion co-factors. For tmACs these ions are
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Figure 3: Adenylyl cyclase reaction mechanism and divalent ion co-factor requirement.
A. Active site of the sAC-like cyclase CyaC in complex with the ATP. AC catalytic domain C1
presented as red ribbons with C2 in blue and magnesium ions A and B as yellow spheres. ATP
substrate coloured with the adenine base in grey and blue, the ribose sugar in grey and red and
the three phosphates in orange and red. The ion-coordinating aspartate residues 1017 and 1061,
the residues recognising the adenine ring (Thr1139* and Lys1057*), the phosphate binding arginine
(1150*), and the alanine conserved in sACs and replaced by serine in tmACs (1149*) are labeled.
B. Catalytic mechanism of class III AC enzymes. Schematic view of the two-ion catalysed reaction,
which starts with the substrate ATP and yields the products cAMP and pyrophosphate. The
reaction proceeds through a magnesium stabilised penta-covalent transition state.
Figures adapted from Kamenetsky et al. (Kamenetsky et al., 2006)
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usually both Mg2+, although Mn2+ at one site is able to enhance the catalytic activity of most
isoforms (Hatley et al., 2002). For sAC the co-factors are both normally Mn2+ (Braun & Dods,
1975), although other divalent cations can substitute, predominantly Mg2+ and Ca2+ (Geng et al.,
2005). The ion co-factors are co-ordinated by two conserved aspartate residues located within the
enzyme active site and are required to increase enzyme activity by both enabling the formation of
complexes with the substrate ATP (de Haen, 1974) and chelating free inhibitory ATP molecules
(Alvarez & Bruno, 1977; Hammes & Rodbell, 1976). ATP hydrolysis proceeds via a pseudo-
bimolecular nucleophilic substitution (SN2) mechanism (Kamenetsky et al., 2006). Metal ion A
acts to acidify the ATP ribose 3′-hydroxyl and stabilise the transition state between the 3′-hydroxyl
and the α-phosphoryl group, whilst ion B anchors the ATP’s β- and γ-phosphates (Tesmer et al.,
1999) and enables production of the pyrophosphate product (PPi). The shape of the cAMP product
is incompatible with the AC active site, whilst PPi fits by the metal ion A and thus cAMP is
preferentially released from the active site before PPi (Tesmer et al., 1999).
Divalent cations are not only vital for reaction progression, they also impart an element of regulation.
For example, as age increases in rats so does the need for a Mg2+ co-factor (Pignatti et al., 1993),
potentially altering signalling dynamics over time. Furthermore, increases in Mg2+ concentration
favour different signalling pathways through the AC, particularly through activation of the GTP
regulatory site of the AC activating G-protein Gαs (Alvarez & Bruno, 1977) and by promoting the
formation of functional complexes between Gαs and AC (Pignatti et al., 1993). Hormones increase
the affinity of tmACs to Mg2+ (Alvarez & Bruno, 1977), whilst the cation also improves tmAC
affinity for forskolin by favouring activation of Gαs, as mentioned (Pignatti et al., 1993).
1.3.5 AC and cAMP Signalling Pathway
Generally mammalian tmACs work as part of a signalling pathway in response to a hormonal
stimulus. The classic example of this is activation of the β-adrenergic receptor by adrenaline or, as
relevant to this work, parathyroid hormone (PTH) activation of the PTH receptor (Section 1.7.3).
Hormones bind to hepta-helical seven-transmembrane receptors (7-TM) at the plasma-membrane
which transduce the signal into the cell. With receptor activation, hetero-trimeric G-proteins
attached to the receptor intracellular domain are activated (Figure 4). Hetero-trimeric G-proteins
consist of distinct α, β and γ subunits, the α-subunit of which is activated when bound to GTP.
When stimulated by a ligand the 7-TM receptor acts as a guanine nucleotide exchange factor (GEF)
exchanging GDP for GTP on the Gα subunit, thus activating it (Kimata et al., 2012). This α subunit
28
Figure 4: G-protein coupled receptor activation cycle. When a ligand activates the G-protein-
coupled receptor (1-2), it induces a conformational change in the receptor that allows the receptor
to function as a guanine nucleotide exchange factor (GEF) that exchanges GDP for GTP on the
Gα subunit (3-4). This exchange triggers the dissociation of the active GTP-bound Gα subunit
from the Gβγ dimer and the receptor (5). Following GTP hydrolysis Gα reassociates with Gβγ,
terminating the signal (6). Figure adapted from Ja¨hnichen et al. (Ja¨hnichen, 2006).
Figure 5: Adenylyl cyclase activated pathway. Abbreviations used: CRE, cAMP Response
Element; CREB, CRE Binding protein; Epac, Exchange proteins activated by cAMP; GC, Guanylyl
Cyclase; MAPK, Mitogen Activated Protein Kinase; NO, Nitric Oxide; PI3K, Phospho-tri-inositol
Kinase; PKA, Phospho-Kinase A; PKC, Phospho-Kinase C; sAC, soluble Adenylyl Cyclase; tmAC,
transmembrane Adenylyl Cyclase.
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is then released from the receptor and the β-γ dimer complex, allowing it to diffuse within the cell
and influence downstream ACs accordingly, binding directly with the AC catalytic core (Sunahara
et al., 1997; Dessauer et al., 1997). The Gα subunit also contains an intrinsic GTPase activity which
hydrolyses the bound GTP to GDP and inorganic phosphate. Following GTP hydrolysis Gα then
reassociates with Gβγ and the receptor, terminating the signal.
There are numerous Gα moieties, although particularly relevant to AC signalling are the stimulatory
Gαs and inhibitory Gαi forms (Nowak & Zawilska, 1999; Cooper, 2003), as mentioned in Section
1.3.2. Although the α subunit appears to be most important to AC regulation, the β-γ dimer can
also have a regulatory effect on AC. This can either occur directly, with AC1 inhibited and both
ACs 2 and 7 activated by the β-γ dimer, or indirecty through β-γ chelation of G-protein α-subunits
(Cooper, 2003). Both the activation of the G-proteins and their interaction with the allosteric site
on the AC catalytic moiety is dependent on the availability of Mg2+ ions (Pignatti et al., 1993),
which is also the co-factor required for tmAC catalysis, as mentioned. As Gαs has lower affinity
for Mg2+ compared to Gαi, increased Mg
2+ concentration leads to a higher proportion of active
Gαs and therefore AC, increasing basal cAMP production (Pignatti et al., 1993). Of course, this
G-protein activation is not the case for sAC, which instead is activated by HCO−3 and Ca
2+ ions
(Sections 1.3.3 and 1.3.6).
The AC product, cAMP, is an important signalling molecule and second messenger, providing a
diffusible signal able to activate effector proteins. In the case of cAMP these effector proteins
are: protein kinase A (PKA), whose catalytic domains separate from the regulatory domains and
move to the nucleus (Meinkoth et al., 1993) to activate transcirption factor CREB (cAMP response
element-binding protien); exchange proteins activated by cAMP (Epacs); phopsho-diesterase GAF
domains; and cyclic nucleotide-gated ion channels CNGs and HCNs (Kamenetsky et al., 2006). A
diagrammatic representation of this pathway is presented in Figure 5.
As with all signalling molecules, the degradation and removal of the signal is as important as
its generation. For cAMP this is achieved through hydrolysis of its 3′-phosphate bond, yielding
5′-AMP (Johnson et al., 1994). Although this reaction is exergonic, a high activation energy
prevents spontaneous degradation which makes cAMP relatively stable in the cell (Hancock, 2005).
To overcome this, cAMP breakdown is catalysed by phosphodiesterases (PDEs). These enzymes
comprise of homologous catalytic domains fused to varying N-terminal regulatory domains, making
them differently sensitive to regulation by a number of small molecules, including calmodulin/Ca2+
and cNMPs (Omori & Kotera, 2007). Within the mammalian PDEs there are eleven families which
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are further divided by a multitude of splice variants. These exhibit unique tissue expression patterns,
gene regulation, substrate specificities, kinetic properties, enzymatic regulation by phosphorylation
and regulatory proteins, subcellular localisation and interaction with association proteins but all
have high affinities for cAMP and/or cGMP (Omori & Kotera, 2007). PDEs often located with ACs
and downstream protein kinase A (PKA), especially as both are known to attach to scaffold proteins
(Omori & Kotera, 2007; Stefan et al., 2007). These associations create signalling microdomains which
are able to respond to stimuli rapidly and reversibly, thereby integrating and spatially restricting
their cellular effects in both time and space (Di Benedetto et al., 2008; Mongillo et al., 2004; Houslay
et al., 2007). An example of this involves muscle-specific A-kinase anchoring protein (mAKAP) which
is located at the perinucleus in striated muscle (Dodge-Kafka et al., 2005). This AKAP binds to
PDE4A, PDE4D3, PKA and Epac1, localising a compartmentalised signalling network to the nucleus
(Dodge-Kafka et al., 2005). In this system activated PKA both stimulates PDE4D3 to reduce local
cAMP concentrations (Dodge-Kafka et al., 2005) and phosphorylates the PDE at Ser-13, enhancing
its affinity to mAKAP further and allowing for quicker signal termination (Carlisle Michel et al.,
2004). Furthermore, PDE4D3 functions as an adaptor protein that recruits Epac1, maintaining the
signalling pathway (Dodge-Kafka et al., 2005).
1.3.6 Involvement of Carbon Dioxide in Adenylyl Cyclase Regulation
There has been extensive research into the control of ACs by inorganic carbon following the discovery
that sperm development, hypermotility, capacitation and the acrosome reaction in some organisms
(Hyne & Garbers, 1979; Beltran et al., 2007; Xie et al., 2006) is initiated by the bicarbonate sensitive
sAC (Esposito et al., 2004; Xie et al., 2006). This sAC isoform is first expressed during the late
stages of spermatogenesis (Sinclair et al., 2000; Xie & Conti, 2004) and, therefore, is a key molecule
in fertility, with sperm from sAC−/− mice unable to fertilise oocytes in vitro (Esposito et al., 2004;
Hess et al., 2005). sAC is not activated by G-proteins (Braun & Dods, 1975) like most other known
ACs, but is synergistically activated by calcium and bicarbonate ions (Garbers et al., 1982; Litvin
et al., 2003). Importantly, this bicarbonate activation was pH independent both in vivo and in vitro
(Chen et al., 2000). Since then, sAC has been found expressed in somatic cells from most parts
of the body (Sinclair et al., 2000) and has been shown to be involved in processes ranging from
the regulation of the cystic fibrosis trans-membrane conductance regulator (CFTR) in both airway
(Wang et al., 2005) and corneal endothelial cells (Li et al., 2008; Sun et al., 2003); maintenance of pH
by V-ATPases in both the male reproductive tract (Pastor-Soler et al., 2003) and kidney (Paunescu
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et al., 2008); airway cilia beat frequency (Schmid et al., 2007); and nerve growth factor mediated
neuronal differentiation (Stessin et al., 2006).
It is now known that a sAC is not the only AC activated by inorganic carbon. In prokaryotes
numerous examples have been reported, indicating that the response is highly conserved (Esposito
et al., 2004). Examples are mostly class III ACs and include isoforms from Spirulina (Arthrospira)
platensis (Chen et al., 2000), Stigmatella aurantiaca (Cann et al., 2003), Anabaena (Cann et al.,
2003; Hammer et al., 2006), and Synechocystis (Hammer et al., 2006). In mammals, there is even
conclusive evidence that while sAC alone is responsive to both HCO−3 and CO2, all other class III
trans-membrane ACs (types I-IX) are responsive to CO2 (Townsend et al., 2009).
Understanding of the mechanism behind this inorganic carbon activation of ACs first began in 2003
when Litvin et al. published a paper examining the kinetic properties of sAC. Here, bicarbonate
stimulation resulted in an increase in Vmax with little effect on KM (Litvin et al., 2003). These
results were similar to observations for rat olfactory neuron GC-D where bicarbonate caused pH
independent activation (Guo et al., 2009) and for Anabaena cyaB1 (Cann et al., 2003). It appeared
that inorganic carbon acts directly at the active site (Jaiswal & Conti, 2001; Chen et al., 2000),
coordinated by a lysine residue (Cann et al., 2003; Hall et al., 2010) in conjunction with an aspartate
to threonine polymorphism conserved in class III adenylyl cyclases from diverse eukaryotes and
prokaryotes (Cann et al., 2003; Kobayashi et al., 2004; Hall et al., 2010). Using recombinant proteins
Cann et al. demonstrated that adenylyl cyclases that contain this active site threonine such as cyaB
of Stigmatella aurantiaca and Rv1319c of Mycobacterium tuberculosis are bicarbonate-responsive,
whereas adenylyl cyclases with a corresponding aspartate such as Rv1264 of Mycobacterium are
bicarbonate-insensitive (Cann et al., 2003).
The effect of the bicarbonate ion on AC appears to involve both the promotion of active site
closure in addition to its ability to aid the recruitment of one of the two metal ions essential for
catalysis (Steegborn et al., 2005). The involvement of the metal co-factor in the mechanism by which
bicarbonate stimulates ACs was futher supported in a report on human sAC (Geng et al., 2005).
This sAC isoform only exhibits minimal response to bicarbonate in the absence of divalent cations,
but bicarbonate divergently stimulates the Mg2+ bound form and inhibits the Mn2+ bound form
in dose dependent manner. Furthermore, Townsend et al. have shown that inorganic carbon, here
in the form of CO2, interacts directly with the apoenzyme prior to any metal recruitment with the
knock-on effect of increasing kcat (Townsend et al., 2009).
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1.4 Calcium Signalling
In addition to cAMP there is another second messenger of note: calcium. Unlike many other
intracellular signals which can be generated and destroyed, Ca2+ ions can neither be made nor
destroyed; it is the concentration ([Ca2+]) at subcellular locations that constitutes a signal. Calcium
release can have a range of downstream effects depending on the cell type and signalling mechanism.
These range from cell division to apoptosis and include: secretion, muscle contraction and neuronal
excitation. Its use as a signalling molecule is ubiquitous across all kingdoms of life from simple
bacteria to plants and mammals (Hancock, 2005).
Rapid changes in intracellular calcium affect a range of downstream signalling pathways. As a result
cells have tight control over their cytosolic levels, maintaining resting cytoplasmic concentrations at
less than 1 µM (Streb et al., 1983; Zacchetti et al., 1991). If cells are activated cytosolic Ca2+ may
reach 10 µM (Zacchetti et al., 1991). Control is managed both through the continuous action of ATP
powered calcium pumps across the plasma membrane and by storage of Ca2+ ions in subcellular
organelles, including the endoplasmic reticulum (Section 1.4.1), mitochondria (Section 1.4.2) and
acidic endosomal organelles such as lysosomes (Section 1.4.3). Calcium signalling is complicated to
study, due to the number of calcium stores within the cell and the diverse signals involved in its
release and response (Figure 6).
In the cell calcium is maintained in its ionic form Ca2+ or bound to specific molecules. These binding
molecules have two roles: to remove free active calcium from solution and/or to provide a mechanism
to propagate the calcium signal (Hancock, 2005). Proteins which bind to calcium typically do so via
the oxygen molecules of glutamate or aspartate residues which are normally charged at physiological
pH (Hancock, 2005; Musgaard et al., 2011). There are two main calcium binding motifs: EF hands
or C2 domains.
EF-hands consist of two α-helices positioned roughly perpendicular to one another and connected by
a short loop that provides the calcium binding domain (Figure 7A). This loop is typically 12 residues
in length, containing 7 oxygen atoms from the amino acid side-chain carboxyl or hydroxyl groups and
a main chain carbonyl group (Zhou et al., 2009). This provides a binding pocket for a Ca2+ ion which
has pentagonal bi-pyramidal geometry (Zhou et al., 2009) in which the Ca2+ ion can bind to both
the peptide backbone and the side-chains via charge interactions (Zhou et al., 2009). The rest of the
amino acids in the calcium binding loop tend to be hydrophobic, stabilising the two helices (Lewit-
Bentley & Re´ty, 2000). Proteins containing this structural EF-hand domain include parvalbumin,
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Figure 6: Calcium signalling pathway: overview of the signalling networks involving Ca2+ ions.
Abbreviations used: CREB, cAMP Response Element Binding protein; CaM, Calmodulin; CaMK,
CaM Kinase; DAG diacylglycerol; IP3, Inositol Triphosphate; IP3R, IP3 Receptor; MAPK, Mitogen
Activated Protein Kinase; NFAT-3, Nuclear Factor of Activated T cells-3 (transcription factor);
PDE, Phosphodiesterase; PIP2, Phosphatidylinositol 4,5-bisphosphate; PKA/C, Phospho-Kinase
A/C; PLC, Phospho-Lipase C; PI3K, Phospho-tri-inositol Kinase; RyR, Ryanodine Receptor;
SERCA, Sarcoplasmic/Endoplasmic Reticulum Ca2+-ATPases. Figure adapted from Berridge et
al. (Berridge et al., 2012).
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Figure 7: Calcium binding proteins - EF and C2 calcium binding domains.
A. EF-hand domain showing the two perpendicular α-helices in red and the calcium binding loop
in green. Figure adapted from webpage (Maine-University, 2011).
B. Calmodulin from Homo sapiens with two globular Ca2+ ion binding regions connected by a
long α-helix. Ca2+ ions are shown in black and bound by two sets of adjacent EF-hands at each
end of the molecule, allowing calmodulin to bind a total of four Ca2+ ions. Figure adapted from
Chattopadhyaya et al. (Chattopadhyaya et al., 1992).
C. C2 domains from Clostridium absonum α-toxin phospholipase C. Calcium ions shown in cyan,
coordinated within the cavity provided by the N- and C-terminal loops. Anti-parallel β-sandwich
shown in yellow. Figure adapted from Clark et al. (Clark et al., 2003)
D. Structure of Rattus norvegicus protein kinase C βII containing both the regulatory and catalytic
domains tethered by a hinge region. Enzyme regulatory Ca2+ binding C2 domain evident as the
bottom globular region, with the Ca2+ ions in this domain shown in green. Figure adapted from
Leonard et al. (Leonard et al., 2011).
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calmodulin (calcium modulated protein, CaM), S100 proteins and calcineurin (Ya´n˜ez et al., 2012).
Of these, the most notable for this report is the ubiquitously expressed protein calmodulin, which
is involved in the mediation of the Ca2+ signal in a large number of regulatory pathways. These
include the regulation of metabolic activity, gene expression and control of other signalling pathways
(Hancock, 2005). One example of its importance is in the regulation of cAMP signalling where it is
able to activate both AC isoforms and Ca2+/CaM-dependent phosphodiesterases (Section 1.5). CaM
is a small, acidic protein able to bind four molecules of calcium with an affinity for the ion between
the levels typical for a resting and activated system (Hancock, 2005). CaM’s shape resembles a
dumb-bell with two globular regions connected by a long, flexible, mobile α-helix (Figure 7B). Each
lobe contains three α-helices and two Ca2+ binding EF-hand loops with a short anti-parallel β-
sheet between the adjacent EF-hands (Chattopadhyaya et al., 1992). Binding Ca2+ causes major
conformational changes to the molecule, revealing two hydrophobic patches which can then interact
with other molecules (Hancock, 2005), propagating the Ca2+ signal.
C2 domains consist of a β-sandwich composed of 8 antiparallel β-strands that co-ordinate two
or three Ca2+ ions (Figure 7C). The N- and C-terminal loops of the domain come together to
form a cavity on the membrane binding face where the Ca2+ ions can bind (Nalefski & Falke,
1996). This domain has also been shown to be involved in membrane binding, particularly involving
phospholipids, phosphatidylserine and phosphatidylcholine, as well as mediating protein-protein
interactions and small molecule binding (Nalefski & Falke, 1996). The C2 domain is most frequently
found coupled to enzymatic domains, in particular in protein kinase C (Figure 7D), phospholipases
A2, C, D (Section 1.4.1) and phospho-inositol 3 kinase (Nalefski & Falke, 1996).
Ca2+ may also be stored bound to non-protein molecules. In bones and teeth enamel Ca2+ ions are
attached to phosphate molecules to form rigid hydroxyapaptite (Ca10(PO4)6(OH)2), a triangular
structure made up of a central Ca(OH)2 and three surrounding Ca3(PO4)3 groups (Gutowska et al.,
2005). Hydroxyapatite provides a high density store of minerals which is tightly controlled and can
be readily accessed to provide calcium exchange with the extracellular matrix (Section 1.7.3).
1.4.1 Calcium Storage and Release: Endoplasmic Reticulum
Crucial aspects of calcium signalling are the maintenance of low cytoplasmic calcium concentrations
and the ability to allow this to rise rapidly and reversibly. These aspects are controlled through the
use of intracellular stores in which Ca2+ ions can be sequestered. For example, in metazoans cytosolic
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calcium is maintained at nanomolar concentrations whilst within the endoplasmic reticulum (ER),
where the majority of intracellular calcium is stored, these concentrations are in the millimolar
range (Christensen et al., 2002; Zacchetti et al., 1991). Here, calcium ions are bound to specific
protein molecules, rendering the Ca2+ ions inactive. In the ER these proteins are most commonly
chaperones, such as calreticulin, and to a lesser degree, calnexin. In the sarcoplasmic reticulum
(SR) of muscle cells calsequestrin is employed to maintain high SR concentrations following muscle
contraction (Beard et al., 2004).
Despite the presence of these calcium-sequestering proteins, the ER is a dynamic Ca2+ store from
which calcium can be released when appropriate. In order to maintain this store and replenish its
contents after activation, protein pumps transport Ca2+ ions from the cytoplasm into the organelle.
These proteins are called sarco/endoplasmic reticulum Ca2+-ATPases (SERCA) and actively pump
Ca2+ ions against the electrochemical gradient using the energy derived from ATP hydrolysis. This
is achieved through the action of a phosphoryl intermediate generated through the ATP hydrolysis
reaction; this causes a conformational change in the SERCA protein which results in Ca2+ ion
movement across the membrane. Through this process two Ca2+ ions can be transported and
two/three protons counter-transported for every ATP molecule hydrolysed (Musgaard et al., 2011).
The activity of SERCA is not entirely continuous and mechanisms are present to control this Ca2+
transport. An example of this is in muscle cells where phospholamban inhibits SERCA activity
unless phosphorylated by PKA (Vandecaetsbeek et al., 2011).
There are a number of mechanisms through which calcium can be released from the ER; via inositol
triphosphate (IP3) receptors, ryanodine receptors, and calcium-induced calcium release (CICR).
These signalling pathways are covered in the following subsections with particular reference to the
IP3 receptor as the most relevant to the results in this thesis.
Inositol Triphosphate
As shown in Figure 6, IP3 is generated by the enzyme phospholipase C (PLC). The signalling
pathway responsible is similar to the AC activating mechanism described in Section 1.3.5. When
a hormone binds to a G-protein coupled receptor (GPCR) it activates certain G-protein isoforms
attached to the receptor’s intracellular domain, which then diffuse through the cytoplasm to activate
PLC. In the case of PLC these activating G proteins are Gαq (Cockcroft & Stutchfield, 1988) and the
Gβγ subunits of Gi/Go (Klein et al., 2011). Activated PLC hydrolyses the phospho-ester bonds in
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phoshatidylinositol-4,5 bisphosphate (PIP2), a reversibly phosphorylated phospholipid which always
faces the cytosol. This hydrolysis generates two second messengers; membrane bound diacylglycerol
(DAG), which activates protein kinase C (PKC); and the diffusible signal inositol triphosphate
(IP3) (Streb et al., 1983). IP3 is thus available to open ligand-gated channels (Sugawara et al.,
1997) in the ER membrane, allowing calcium eﬄux from the store (Streb et al., 1983). This triggers
the downstream signalling cascades, most notably via PKC. PKC, which is activated through the
combined stimulation of DAG and Ca2+, is implicated in stimulating cytoplasmic Ca2+ removal by
activating Ca2+-transport ATPases and Na+/Ca2+ exchangers (Section 1.4.4), as well as mediating
IP3 levels by blocking receptor mediated hydrolysis of inositol phospholipids by PLC (Nalefski &
Falke, 1996).
IP3 receptors are regulated by IP3 and Ca
2+, as well as being modulated by many other signals,
including Mg2+ ions, ATP (Section 1.4.2), and via phosphorylation (for example by cAMP dependent
protein kinase (Hancock, 2005; Taylor et al., 2009)). These properties allow IP3 receptors to
initiate and regeneratively propagate Ca2+ signals. There are three mammalian isoforms of IP3
receptors present in cells derived from three distinct genes and each with different sensitivities to
IP3 (Sugawara et al., 1997). All three isoforms have high levels of amino acid homology with Types
2 and 3 respectively 69% and 63% similar to Type 1 (Sugawara et al., 1997). All IP3 receptor
gene products have a common overall structure with an amino-terminal arginine- and lysine-rich
cytoplasmic IP3 binding domain, a carboxy-terminal membrane-spanning region comprising six
transmembrane domains, and an inter-linking regulatory domain (Sugawara et al., 1997; Mignery
et al., 1990; Miyawaki et al., 1991; Seo et al., 2012). Each protein forms a subunit which needs to
form a tetramer to create a functional calcium channel. The last pair of transmembrane domains and
the linking luminal loop from each of the four subunits form the channel pore (Taylor et al., 2009).
The channel domain alone is sufficient to enable formation of the tetramer (Mignery et al., 1990;
Miyawaki et al., 1991). As this domain is highly conserved across isoforms it has been suggested
that both homotetramers and heterotetramers may exist between the gene products and their many
splice variants (Monkawa et al., 1995).
IP3 acts as a ligand and binding to the receptor N-terminal domain causes partial closure of a
‘clam-like’ IP3 binding core. This initiates conformational changes which in turn lead to gating
of the pore (Seo et al., 2012). Whilst it is known that IP3 must bind to several of the four IP3
binding sites, it is unclear whether binding to all four is required to activate the channel (Meyer
et al., 1988; Marchant & Taylor, 1997; Boehning & Joseph, 2000). Once open, the receptor activity
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is not controlled by IP3, but instead by the passage of Ca
2+ ions and in this respect Ca2+ is often
referred to as a co-agonist. All IP3 receptors are biphasically regulated by cytosolic calcium with
Ca2+ ions rapidly stimulating and more slowly inhibiting the receptors (Taylor & Laude, 2002).
This biphasic response requires Ca2+ binding to one of two locations on the cytosolic portion of
the protein. Whilst activation involves direct Ca2+ ion binding, inhibition probably requires an
accessory protein, which has not yet been unequivocally identified, but is likely to be calmodulin
(Taylor & Laude, 2002). This biphasic stimulation is important in both propagating Ca2+ signals
from other sources (see below) and moderating the magnitude of Ca2+ signals through IP3 receptor
inhibition at high Ca2+ concentrations.
Ca2+ ion signals generated from IP3 receptors can have varying magnitudes, providing either local
or global signals and thereby increasing the versitility of intracellular Ca2+ signals. Local signals
usually derive from different IP3 concentrations. Small concentrations cause ‘Ca
2+ blips’, spatially
restricted events lasting no more than 130 ms which increase cytosolic Ca2+ to 40 nM (Taylor et al.,
2009). Higher IP3 concentrations of 50-600 nM cause more long-lasting events of approximately 1 s
known as ‘Ca2+ puffs’, which spread no more that a few micrometers and are thought to result from
several closely spaced IP3 receptors opening synchronously (Marchant et al., 1999; Shuai et al., 2006;
Taylor et al., 2009). With further increases in IP3 concentrations, ‘puffs’ become more frequent and
Ca2+ diffusing from one receptor can activate another, regeneratively propagating the Ca2+ signal
(Marchant et al., 1999). These effects are augmented by the phenomenon of IP3 receptor clustering,
whereby low concentrations of IP3, lower than that required for channel gating, cause the receptors
to rapidly and reversibly cluster into groups of approximately four (Shuai & Jung, 2003; Shuai et al.,
2006; Taylor et al., 2009). Furthermore, these IP3 receptor derived Ca
2+ ions may then also activate
other Ca2+ sensitive signalling machinery to further propagate the signal, for example ryanodine
receptors. These signal propagations across receptors and in some cases organelles, are known as
Ca2+ induced Ca2+ release (CICR).
Ryanodine Receptors
In addition to IP3 receptor mediated calcium release, the ER also contains ryanodine receptors
(RyRs), which are also sensitive Ca2+ ions. They are named due to their sensitivity to ryanodine,
an alkaloid from the plant Ryania speciosa which opens the channel at low concentrations and
closes them when higher (Fill & Copello, 2002). RyRs are encoded by three genes in vertebrates,
demonstrating different expression patterns across the body; type 1 is predominantly found in the
skeletal muscle, type 2 in cardiac muscle and type 3 in smooth muscle (Querfurth et al., 1998). Like
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IP3 receptors, RyRs are tetrameric Ca
2+ channels with a carboxyl-terminal calcium pore formed by
between four and ten transmembrane domains and are regulated by signals detected by their large
N-terminal cytosolic domains (Seo et al., 2012).
Like IP3 receptors, RyRs also exhibit biphasic activation by Ca
2+ ions, with low concentrations of
10-100 µM maximally opening the channel and higher concentrations of 1-10 mM closing them (Fill
& Copello, 2002; Diaz-Sylvester et al., 2011). This suggests the existence of two different types of
cytosolic Ca2+ binding sites: activating sites with high affinity and inhibitory sites with low affinity
(Coronado et al., 1994). They are, however, more sensitive than IP3 receptors to Ca
2+ and their main
function is to propagate Ca2+ signals from other stores through CICR. Spatiotemporally-restricted
Ca2+ ion release events from RyRs are known as ‘calcium sparks’. As the receptors tend to cluster,
these ‘sparks’ often lead to activation of surrounding RyRs, leading to augmentation of the signal.
RyRs do not have a second messenger that activates all isoforms in the same way as IP3 activates
IP3 receptors. However RyR2 and 3 (Me´sza´ros et al., 1993) have been shown to be activated by
cyclic-ADP ribose, cADPR (Clapper et al., 1987; Lee et al., 1989). Pyridine nucleotide-derived
cADPR is synthesised in cells by ADP ribosyl cyclase (Genazzani & Galione, 1997) in response to
signals from cell surface receptors such as cholechystokinin receptors. RyRs can also be controlled
by adenine and ATP (Anderson et al., 1989; Chen et al., 1992), Mg2+ ions (Anderson et al., 1989;
Chen et al., 1992; Diaz-Sylvester et al., 2011), CaM (Meissner, 1986), phosphorylation (Seiler et al.,
1984; Takasago et al., 1991), thiol oxidation/reduction, nitrosylation and possibly reactive oxygen
species (Coronado et al., 1994; Fill & Copello, 2002; Meissner, 2004). Furthermore, activation of
either RyRs or IP3 receptors can affect one another and both receptors can either use the same
(Zacchetti et al., 1991) or segregated ER calcium stores (Volpe et al., 1991; Kijima et al., 1993).
1.4.2 Calcium Storage and Release: Mitochondria
Mitochondria can also act as a calcium source, with Ca2+ concentrations within these organelles
reaching 500 nM, although their contribution to the wide range of calcium signalling events has yet to
be fully understood (Walsh et al., 2009). Whilst mitochondria are able to produce a calcium signal,
they mostly act as a calcium sink, blocking local and global calcium oscillations. Mitochondria
can directly influence the calcium concentration in the cytosol of the cell by importing Ca2+ into
the organelle via a relatively fast, energy consuming, Ca2+ sensitive Ca2+ uniporter, which uses
mitochondrial membrane potential as a driving force (Selwyn et al., 1970; Scarpa & Azzone, 1970;
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Rottenberg & Scarpa, 1974). They are also able to slowly release Ca2+ ions from the interior of
the organelle to the cytosol by means of Na+/Ca2+ or H+/Ca2+ exchangers (Carafoli et al., 1974;
Crompton et al., 1978; Fiskum & Lehninger, 1979), for example during programmed cell death
(Walsh et al., 2009).
Mitochondria can also influence Ca2+ signalling indirectly by altering the intracellular concentrations
of ATP, NAD(P)H, pyruvate and reactive oxygen species. These molecules can in turn modulate
components of the Ca2+ signalling machinery either by buffering or stimulating ion release from
internal stores, influx from the extracellular solution, uptake into cellular organelles, or extrusion
by plasma membrane Ca2+ pumps (Walsh et al., 2009). The best examples of how these molecules
modulate Ca2+ signalling is from the ER. Mitochondria and the ER form close links (Rizzuto et al.,
1998) which result in local regulation of ER mediated Ca2+ release. Local modulation can be due
to the fast uptake of Ca2+ by mitochondria, which has been shown to affect IP3 receptors in close
mitochondrial proximity, lowering their sensitivity to IP3 (Hajno´czky et al., 1999), or as a result
of mitochondrial respiratory products. ATP and other adenine nucleotides bind to IP3 receptors
(Maeda et al., 1991) causing an increase in the frequency and average duration of the receptor
opening event (Bezprozvanny & Ehrlich, 1993), particularly through potentiating the binding of IP3
(Spa¨t et al., 1992) and Ca2+ (Mak et al., 1999). Similar effects of ATP on RyRs have been observed
with ATP increasing the open probability of channels and decreasing the Ca2+ activating threshold
(Bull et al., 2007). Another mitochondrial product, NADH, is also known to interact with RyRs;
decreasing the receptors’ open probability (Zima et al., 2004). Furthermore, ATP can both regulate
a passive ER Ca2+ leak, with a reduction in ATP supressing this leak, and inhibiting store-operated
Ca2+ entry (Section 1.4.4). The ability of mitochondria to influence the calcium signalling events
of other organelles has important implications as the location of the organelle can thus alter local
signals and arrest global Ca2+ oscillations (Walsh et al., 2009). In addition to this, Ca2+ temporarily
accumulated in the mitochondria following ER release can be an effective method for reloading the
ER or preventing further Ca2+ release from this organelle (Walsh et al., 2009).
1.4.3 Calcium Storage and Release: NAADP Store
In addition to the ER and mitochondria, there an is additional calcium store located in acidic
vaculolar endosomal compartments such as lysosomes (Christensen et al., 2002). Here the Ca2+
concentration is kept high with the average free Ca2+ available in macrophage lysosomes being 400-
600 µM, less than half the extracellular concentration, but much higher than that of the cytosol
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(Christensen et al., 2002). Despite these organelles’ ER origins, Ca2+ ions found within these stores
are not released via IP3Rs, RyRs or via cADPR, but can be influenced by endocytosis (Christensen
et al., 2002), lysosomal pH (Christensen et al., 2002) and the second messenger, nicotinic acid
adenine dinucleotide phosphate, NAADP (Clapper et al., 1987; Lee et al., 1997; Cancela et al.,
2000; Yamasaki et al., 2004; Churchill et al., 2002). NAADP is a pyridine nucleotide metabolite
which is produced by the same enzyme family as cADPR; the ADP-ribosyl cyclases (Genazzani &
Galione, 1997). Like IP3 and cADPR, it can be produced by cell surface agonists via cholechystokinin
receptors (Yamasaki et al., 2004). NAADP activates Ca2+ ion release through two-pore channels,
TPCs (Ruas et al., 2010; Zhu et al., 2010; Tugba Durlu-Kandilci et al., 2010; Dionisio et al., 2011;
Lin-Moshier et al., 2012). However, it is currently unknown how NAADP activates these channels
at the structural level (Lin-Moshier et al., 2012). Although more potent than either IP3 and cADPR
(Galione, 2006), NAADP only produces calcium gradients across the cell rather than propagated
waves (Section 1.4.5) due to the TPC’s inability to respond to Ca2+ themselves to support CICR
(Galione, 2006; Churchill & Galione, 2000). However, Ca2+ ions released from this store may interact
with the other stores and Ca2+ signalling machinery in the cell to result in a more global calcium
signal (Galione, 2006).
Calcium concentrations within these endosomal organelles are maintained by the activity of Ca2+/H+
exchangers across the membrane. Due to the proton requirement of this exchanger the vacuolar pH
acts as a driving force for Ca2+ ion uptake. Thus, vacuolar H+-ATPase, the enzyme responsible
for maintaining the proton gradient, is critical in maintaining lysosomal Ca2+ uptake (Christensen
et al., 2002).
1.4.4 Calcium Storage and Release: The Extracellular Environment
The extracellular matrix (ECM) has a high level of stored calcium and entry into cells is tightly
controlled. Access to this extracellular store, however, is required under certain conditions and
is most notable with store operated calcium entry (SOCE) and cell depolarisation. SOCE is a
method by which the ER calcium store is replenished using calcium derived from outside the cell,
across the plasma membrane (Rosado, 2006). Small molecules of stromal interaction molecule 1
(STIM1) located in the ER lumen, detect calcium concentrations via ER lumen EF-hand domains
(Liou et al., 2005). In response to a depletion in ER Ca2+ concentration, dimeric STIM1 molecules
cluster and relocate near to the plasma membrane (Liou et al., 2005; Stathopulos et al., 2006; Park
et al., 2009). Here the collected cytoplasmic STIM C-termini associate with phosphatidylinositol 4,5-
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bisphosphate in the plasma membrane to directly activate a subunit of the calcium release-activated
calcium channel protein 1 (CRAC1/Orai1) via protein-protein interaction (Feske et al., 2006; Wu
et al., 2007; Park et al., 2009). This interaction then simulates Ca2+ entry via Orai1 enabling store
replenishment and maintenance of Ca2+ signals when they are required over a prolonged periods,
such as during cell proliferation (Berridge, 2002).
Another calcium entry route into cells is via voltage-dependent calcium channels (VDCCs), which
are a critical entry pathway in many cells (Zong et al., 1995). These channels are classified into
E-, L-, P/Q-, N-, R- and T-type subtypes by their pharmacological and electrophysical properties
(Hayashi et al., 2007). Of most relevance to this thesis are the L-type channels which are not only
regulated by cAMP (Zong et al., 1995), but also show substantial distribution throughout renal
vascular and tubular tissue (Hayashi et al., 2007). However, being voltage-gated, these channels
are activated with membrane depolarisation and, therefore, are most active in nerve and muscle
cells. At resting membrane potential, VDCCs are normally closed. They are opened by membrane
depolarising potentials and then allow Ca2+ to enter the cell. They may also form close relationships
with other elements of a cell’s signalling machinery, an example of this being between L-type channels
and ryanodine receptors. In skeletal muscle L-type voltage-gated channels are in direct contact with
RyR1 and membrane depolarisation causes a conformational change in the channel opening RyR1
through direct protein-protein interaction (Berridge, 2002). In cardiac muscle this interaction is
more indirect as the two channels are not directly linked. Instead, membrane depolarisation causes
a small Ca2+ influx through the L-type channel which then activates RyR2 to release Ca2+ ions
from the ER (Fill & Copello, 2002).
Proteins in the plasma membrane do not only regulate calcium entry. Being under constant pressure
to maintain low intracellular calcium concentrations, cells have developed a sophisticated system for
the elimination of Ca2+ ions from the cytoplasm after a signal has developed. This system not
only includes calcium uptake into stores, but also Ca2+ extrusion into the extracellular space by an
ATP-driven plasma membrane Ca2+ ATPase pump (PMCA) and a Na+/Ca2+ exchanger. PMCA
(Schatzmann, 1966) serves as a high-affinity system (KM of 100 to 200 nM), ejecting Ca
2+ ions
against the electrochemical gradient (Strehler & Zacharias, 2001). Similar to SERCA in the ER,
this Ca2+ ion extrusion is powered by the energy derived from ATP hydrolysis with a stoichiometry
of one Ca2+ ion extrusion for each molecule of ATP hydrolysed (Strehler & Zacharias, 2001; Leva Di
et al., 2008). PMCA is controlled by cytoplasmic Ca2+ and a number of regulators, including CaM.
Cytoplasmic Ca2+ activates the pump, whilst CaM increases its affinity and maximal transport rate
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(Leva Di et al., 2008). Na+/Ca2+ exchange works against the Ca2+ gradient by using the high
Na+ electrochemical gradient, allowing Na+ ions to flow down their gradient into the cell. By this
mechanism a single calcium ion can be extruded for every three sodium ions imported (Yu & Choi,
1997). Whilst PMCA has a higher affinity for Ca2+, the Na+/Ca2+ exchanger can pump Ca2+
at a higher rate. Thus, following a calcium signal it is the Na+/Ca2+ exchanger which rapidly
returns the cytoplasm to near normal concentrations whilst PMCA then further lowers intracellular
concentrations from this point (Carafoli, 1991).
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1.4.5 Calcium-Induced Calcium Release, Waves and Oscillations
Most proteins involved in Ca2+ signalling respond to the Ca2+ ion signal itself. In this way Ca2+
signals can be propagated and controlled. An example of this is when Ca2+ release from one store
initiates the eﬄux of Ca2+ ions from another via CICR. It is these interactions between receptors,
stores and signalling pathways that shapes the resultant Ca2+ signal, affecting its outcome. Due
to these interactions, local and global signalling events can take the shape of gradients, waves or
oscillations.
Ca2+ ions released from a single point migrate for approximately 50 µs, covering only 0.1-0.5 µm.
If they are recognised by other Ca2+ responsive molecules within this distance, signal propagation
will occur. This creates a calcium gradient that can reach up to 1-10 µm, but which lasts less that
a millisecond (Hancock, 2005). Gradients are important in cell migration, exocytosis, ion transport
and gap junction regulation (Hancock, 2005). If these gradients become established a Ca2+ wave or
a more global oscillation may be generated. These signalling events are initiated when one store is
emptied to the point where the resultant high cytosolic Ca2+ concentrations inhibit further release.
Whilst Ca2+ ions from this site may go on to stimulate neighbouring receptors propagating the
signal, at this first location the cytosolic Ca2+ concentration drops. This is due to both an absence
of further Ca2+ release and activation of Ca-ATPases, which return the Ca2+ ions into the store
once more. The spatial differences in Ca2+ release and re-absorption thus creates a signalling wave.
Such waves can move through the cytosol at speeds of 5-100 µm/s and can even travel between cells
via gap junctions (Marchant & Taylor, 1997).
Calcium oscillations not only involve CICR and store regulated Ca2+ ion release, but also receptor
activation at the plasma membrane (Berridge et al., 1988; Cancela et al., 2000). One example model
of calcium oscillation involves IP3 generation. In this model activation of a plasma membrane
receptor stimulates PLC, which in turn generates IP3 and results in Ca
2+ ion release via IP3
receptors. The released Ca2+ ions then diffuse through the cytoplasm to once more stimulate
PLC, producing further IP3 molecules and setting up an oscillation. As IP3 receptors are inhibited
at high Ca2+ concentration, these oscillations finally desist as these channels become closed and
Ca2+ is returned to the ER once more. With lower cytosolic Ca2+ concentrations, PLC activity
also drops, terminating the signal. Similar alternate models exist which highlight the interactions
between the second messengers IP3, cADPR, and NAADP and their activation of common oscillator
units, including IP3 and ryanodine receptors (Cancela et al., 2000). As a result of these waves and
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oscillations, the calcium signal is often made up of the ion concentration in addition to the wave
amplitude or frequency (Taylor et al., 2009).
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1.5 Calcium Interaction with the AC and cAMP pathway
The Ca2+ and cAMP pathways are highly interlinked, both up and downstream of the second
messengers as well as directly at the point of generation.
1.5.1 Direct Interaction - Ca2+/CaM regulation of ACs and cAMP modulation of IP3
receptors
Whilst all tmAC isoforms are inhibited by high (∼100 µM) concentrations of calcium due to
competition between these divalent ions and the Mg2+ co-factor (Guillou et al., 1999), certain
tmAC isoforms are dynamically regulated at lower Ca2+ concentrations with isoforms I, III and
VIII activated by Ca2+/Ca2+ bound calmodulin (Bakalyar & Reed, 1990; Cali et al., 1994; Fagan
et al., 1996), and isoforms V and VI inhibited (Ishikawa et al., 1992; Yoshimura & Cooper, 1992;
Guillou et al., 1999). While the Ca2+ concentrations required to activate AC I are in the normal
physiological range (0.1-1 µM) the levels required for type III are supra-normal (Cooper et al., 1995).
Furthermore, as previously mentioned, Ca2+ ions also activate sAC, by replacing the Mg2+ ions in
the active site, increasing the enzyme’s affinity for ATP and thus its KM (Litvin et al., 2003). In
fact, sAC activity is highest with a magnesium as ion A and a calcium as ion B in the active site
(Kamenetsky et al., 2006). The source of this regulatory calcium appears to be predominantly from
capacitative Ca2+ entry/SOCE (Cooper et al., 1994; Sunahara & Taussig, 2002; Willoughby et al.,
2005). AC VIII, for example, has been unequivocally demonstrated to only respond to only STIM1-
Orai1 mediated SOCE Ca2+ ions whilst being unaffected by Ca2+ released from intracellular stores,
agonist induced cellular influx, or increases in Ca2+ concentration by the ionophone ionomycin
(Fagan et al., 1996; Martin et al., 2009).
AC isoforms can also be regulated by other elements of the calcium signalling machinery. ACs II,
IV and VII are stimulated by PKC (Cooper, 2003; Linder & Schultz, 2003) with isoform II less
susceptive to Gαs activation in the presence of PKC and VII more so (Cooper et al., 1995). AC
VI is inhibited by PKC through phosphorylation of the enzyme’s N-terminus and ACs I and III are
inhibited by CaM kinases and AC IX by calcineurin (Cooper, 2003; Kamenetsky et al., 2006).
Cyclic-AMP has also been shown regulate the formation and phosphorylation of IP3, the activities
of Ca2+ channels and pumps and the formation of other Ca2+ mobilising messengers (Tovey et al.,
2008). The best characterised interaction is the sensitisation of IP3 receptors to IP3 by cAMP.
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In 2008 Tovey et al. demonstrated that in human embryonic kidney cells intracellular signalling
after stimulation by parathyroid hormone (Section 1.7.3) involved ‘cAMP junctions’. In these
‘cAMP junctions’ AC VI and IP3 receptor 2 were selectively coupled, allowing local delivery of
supramaximal concentrations of cAMP to the IP3 receptor. This cAMP delivery then directly
increased the receptor’s sensitivity to IP3 (Tovey et al., 2008). Following on from this, in 2010 the
group published another paper demonstrating that all IP3 receptor isoforms were similarly sensitised
by cAMP through binding to a novel site (Tovey et al., 2010). The effect of cAMP on IP3 receptors
alone has no effect on Ca2+ release and does not mediate an increase in IP3 affinity but instead
increases the effectiveness with which IP3 binding is coupled to channel opening (Tovey et al.,
2010).
All three IP3 receptors can also be phosphorylated at multiple sites by PKA. This phosphorylation
in turn increases receptor activity, for example PKA phosphorylation of IP3 receptor 1 increases
the receptor’s IP3 sensitivity around 2-fold (Wojcikiewicz & Luo, 1998; Dyer et al., 2003; Tovey
et al., 2010). Similarly, PKA can phosphorylate RyRs releasing bound inhibitory proteins such as
FKBP12.6 and calstabin-2, release of which results in a Ca2+ ion leak from these receptors (Marx
et al., 2000; Wehrens et al., 2006). Furthermore, cAMP can activate cyclic nucleotide-gated ion
channels, allowing Ca2+ ions from outside the cell to permeate the cell (Kamenetsky et al., 2006).
1.5.2 Upstream of Second Messenger Generation - Plasma Membrane Receptors and
G-proteins
Both cAMP and Ca2+ signals can be generated by GPCRs and regulated by G proteins. This can
lead to a multiplicity of signalling interactions due to interplay between the G protein Gα and Gβγ
subunits, PLC, and differentially regulated AC isoforms. Some receptors are reported to negatively
couple to AC whilst at the same time positivity coupling to PLC. Examples include adenosine
A1, muscarinic m4, somatostatin and the α-2-adrenegic receptor (Bugrim, 1999). On the other
hand, other receptors are able to activate both PLC and AC enzymes such as the α-1-adrenegric
and receptors for growth factors, endothelin-1, vasopressin, and lutinizing hormone (Bugrim, 1999).
These mulitple combinations of simultaneous regulation between pathways are due to the ability of
one GPCR to produce both Gα and Gβγ G-proteins. On occasions where Gαs or Gαi subunits are
mobilised AC isoforms may be respectively activated or inhibited while the simultaneously released
Gβγ subunits activate PLC isoforms β1, β2 and η2 (Blank et al., 1992; Boyer et al., 1992; Camps
et al., 1992; Zhou et al., 2008) and increase IP3 production (Figure 8A). On the other hand, if
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Figure 8: G protein regulation of AC and PLC. Figure taken from Bugrim et al. (Bugrim, 1999).
A. Receptors coupled to either Gαs or Gαi. AC is either activated or inhibited by the G protein α
subunit while at the same time Gβγ activates PLC. B. Receptor coupled to Gαq. PLC is activated
by Gαq while different isoforms of AC are either activated or inhibited by the Gβγ subunits.
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Gq is involved, PLC is activated via the Gαq subunit and the Gβγ can activate or inhibit AC,
depending on the AC isoform present (Figure 8B). To complicate matters further some receptors
can also signal to multiple G-protein subtypes. An example is the calcium-sensing receptor CaR
which responds to changes in extracellular calcium by inducing intracellular signalling and can
modulate cellular function to cause parathyroid hormone secretion from the parathyroid glands or
calcium reabsorption in the kidneys (Section 1.7.3). This GPCR couples to both Gαq and Gαi to
both mobilise intracellular calcium through the activation of phospholipases and suppress cAMP
formation (Ward, 2004).
1.5.3 Signal Termination - Ca2+/CaM Regulated PDEs and cNMP Senstitive Ca2+-
ATPases
Interactions between the two signalling pathways can also occur at the signal termination step. In the
same way that cAMP generation by individual AC isoforms can be regulated by Ca2+ ions, so can its
degradation by PDEs. Ca2+/CaM activates PDE1 whilst PDE2 can be activated by Ca2+ activated
PKC (Geoffroy et al., 1999; Omori & Kotera, 2007). In PDE1 this regulation is provided through
a methionine rich, hydrophobic Ca2+/CaM binding site at the N-terminus. Ca2+/CaM binding to
this site causes a conformational change which prevents the N-terminal region from obstructing the
active site, thus activating the enzyme and stimulating cAMP hydrolysis (Omori & Kotera, 2007).
Cyclic-nucleotides can also play a part in the termination of a Ca2+ signal through regulation of
Ca2+-ATPases. An example of this is from cardiac cells where phospholamban regulates the activity
of Ca-ATPases in SR membranes in a manner dependent on cAMP-dependent protein kinase (Tada
& Toyofuku, 1998), which is in turn activated by cAMP. Closely related cyclic nucleotide cGMP has
also been demonstrated to enhance SR sequestration of Ca2+ ions in smooth muscle, purportedly
through activation of Ca2+-ATPases (Twort & van Breemen, 1988).
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1.6 Role of Carbon Dioxide in vivo
1.6.1 Environmental Carbon Dioxide
Carbon dioxide is currently maintained at an atmospheric level of 370-90 µmol/mol, 0.0387%
(Hetherington & Raven, 2005; Taylor & Cummins, 2011), although it is proposed that this is steadily
increasing due to anthropomorphic production, including the burning of fossil fuels and deforestation
(Watson et al., 2011). Naturally, carbon dioxide levels are generally maintained at a controlled level,
with the gases in the atmosphere constantly equilibrating with dissolved gas in the oceans. Long-
term regulation is provided over millions of years via the rock cycle, with volcanic activity providing
a source and sedimentation and subduction sequestering the gas (Hetherington & Raven, 2005).
Carbon dioxide is critical for life on Earth, particularly as a substrate for ribulose-1, 5-bisphosphate
carboxylase-oxygenase (Rubisco); an essential step in the Calvin cycle of photosynthesis enabling
the synthesis of sugars. This enzyme forms the most abundant protein on Earth in terms of
mass (Hetherington & Raven, 2005) and catalyses two major reactions. These reactions include
a carboxylase reaction whereby a carbon dioxide molecule is added to an organic molecule and
an oxygenase reaction adding an oxygen molecule to this same organic compound (Andersson,
2008). Carbon dioxide is also a key by-product in the catabolism of sugars, lipids and proteins
via various biochemical pathways, in particular glycolysis and the Krebs cycle, and is therefore
produced constantly by the aerobically respiring cell. The biosphere regulates atmospheric levels of
CO2, with fluxes in respiration and gross photosynthesis in the region of 150 Pg (petagrams, x 10
15)
of carbon per annum (Hetherington & Raven, 2005). Historically these fluxes have been responsible
for the largest changes in atmospheric composition. The best example of this is the evolution of
photosynthetic organisms, debatably as far back as 3.45-3.80 billion years ago (Hetherington &
Raven, 2005), which caused a downward shift in the amount of free CO2 and increased atmospheric
oxygen levels. Reciprocally, these changes in atmospheric concentrations affected life itself. As an
example, it is proposed that as Rubisco must have evolved before global oxygenation, its oxygenase
activity may not have appeared until later (Hetherington & Raven, 2005). Another example is that
many contemporary photosynthetic and aquatic organisms have ‘inorganic carbon concentrating
mechanisms’ and micro-compartments known as carboxysomes where CO2 is elevated around the
active site of Rubisco and prevented from escape by a diffusion barrier such as a protein shell (Badger
et al., 2006). These mechanisms were evolutionary adaptations in response to different atmospheric
conditions (Badger et al., 2006) to overcome the problems associated with low atmospheric carbon
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dioxide levels, such as the kinetic limitations of Rubisco (Hetherington & Raven, 2005; Badger et al.,
2006; Andersson, 2008).
Temporal changes in environmental carbon dioxide concentration are not only restricted to the
millienia time-frame. For example, estuarine systems are characterised by large seasonal and diurnal
fluctuations in CO2 and pH (Section 1.6.2). In esturine sytems, these fluctuations are due to
variations in freshwater influx, soil drainage, biota composition and activity and gas exchange rates
with the atmosphere and ocean waters (Tomanek et al., 2011). Furthermore, naturally occuring
niche habitats with variations in CO2 can be spatial, for example in the case of burrowing animals
where gas exchange to the atmosphere is restricted (Lechner, 1976).
1.6.2 Carbon Dioxide Equilibrium in Solution and in vivo Chemistry
Carbon dioxide is not an inert gas and in solution reacts with water molecules to produce carbonic
acid and ultimately bicarbonate ions and protons (Figure 9) until equilibrium is established. As a
result any increase in carbon dioxide increases solution acidity through the production of protons
and visa versa. As this reaction has a pKa of 6.2, which is close the physiological pH of 7.2 (Bonar &
Casey, 2008) CO2, HCO
−
3 and pH are inextricably linked in biological system. Acid-base homeostasis
is crucial to sustain CO2 production and respiration especially as cellular enzymes and chemical
reactions are sensitive to pH (Tresguerres et al., 2010) and large alterations to pH can be deleterious
to an organism (Richerson, 2004). In contrast, it is also important to note that due to the nature of
this equilibrium, CO2/HCO
−
3 are also important in buffering intra- and extra-cellular physiological
fluid pH (Tresguerres et al., 2010).
CO2 + H2O
1↔ H2CO3 2↔ HCO−3 + H+
Figure 9: Carbon dioxide in solution
The reaction illustrated in Figure 9 can be split into steps (1) and (2). Whilst (2) occurs naturally
at a very fast rate, step (1) is a slower and becomes rate limiting (Boron, 2006). To address this,
organisms contain the ubiquitous enzyme carbonic anhydrase (CA), which is able to catalyse the
whole reaction. CA is one of the fastest enzymes known with CAII having a maximum turnover
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rate of the CO2 hydration step of more than 1 x 10
6 s−1, close to the limit of diffusion (Sly &
Hu, 1995; Christianson & Cox, 1999). Catalysis proceeds via nucleophilic attack on carbon dioxide
by conserved threonine and glutamine acid residues in CA active site. These amino acid residues
contribute to a hydrogen bonded network with the enzyme’s zinc co-factor, holding the active site
in the right orientation for nucleophilic attack at low entropy (Sly & Hu, 1995; Christianson & Cox,
1999). High turnover is achieved through the use of a histidine mediated proton shuttle to regenerate
amino acid charges in the active site (Sly & Hu, 1995; Christianson & Cox, 1999).
Carbon dioxide can also react with amino acids to form carbamates. Carbamates form as a result of
the nucleophilic attack of uncharged amines upon CO2 (Figure 10).Under physiological conditions
only the N-terminal α and -amino groups of lysine residues are suitably dissociated to react with
CO2 in this way although, with the correct surrounding amino acids, other amine groups are possible
targets (Lorimer, 1983). Carbamate formation is exothermic and readily reversible, thus providing a
useful feature for biological regulation. As the formation of a carbamate converts a neutral or cationic
group to an anionic one, this newly formed species is often stabilised by electrostatic interactions
with surrounding amino acids (Lorimer, 1983). Examples of naturally occuring carbamates include
haemoglobin in metazoans and Rubisco in plants. In haemoglobin the N-terminal α and -amino
groups in the α- and β-chains can react to form carbamates (Kilmarti et al., 1973; Gros et al., 1981).
These modifications help stabilise the protein when it becomes deoxyhaemoglobin and increases
the likelihood of the release of remaining oxygen molecules bound to the protein (Lorimer, 1983).
In the Rubisco active site a Mg2+ ion is bound to glutamate and aspartate residues, as well as a
lysine carbamate. This carbamate is formed from a reaction between the lysine and the air in the
rate-determining step and renders the amino acid charged and, therefore, able to bind the enzyme’s
Mg2+ co-factor to facilitate catalysis (Lorimer, 1983; Lundqvist & Schneider, 1991).
R-NH2 + CO2 ↔ R-NH-COO− + H+
Figure 10: Formation of carbamates: carbon dioxide reacts with the N-terminal amino groups
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1.6.3 Inorganic Carbon Entry into Cell
When considering inorganic carbon in the physiological environment both CO2 and HCO
−
3 species
must be considered (Section 1.6.2). Both species can cross biological membranes with their movement
typically faciliated by proteinaceous transporters. However, whilst CO2 transport by aquaporins
and Rhesus channels has been demonstrated there is also contrasting evidence suggesting that CO2
diffuses freely across membranes, with little contribution from protein transporters. Both of these
theories are presented below.
Carbon Dioxide Transport
Until recently it had been a general consensus that gases can pass through biological membranes
by virtue of their high diffusibility through the lipid phase (Endeward et al., 2008). However,
membranes exhibit different levels of permeability, which can not be accounted for by this simple
diffusion principle. For example, some apical epithelial membranes appear to have poor permeability
to CO2 (Waisbren et al., 1994; Endeward & Gros, 2005; Azzam et al., 2010) whilst others, such as
the membrane of red blood cells, exhibit extremely high permeability. The high CO2 permeability
of red blood cells has been attributed to the presence of two proteins: aquaporin 1 (Endeward et al.,
2006) and Rhesus complex RhAG (Endeward et al., 2008).
Aquaporins (AQPs) refer to a family of 13 isoforms of channel with tissue specific expression (Herrera
& Garvin, 2011). AQP channels are involved in the passive transport of water molecules across
membranes but AQP1 (and to some degree 4 and 5) has also been demonstrated to transport CO2
(Herrera & Garvin, 2011; Musa-Aziz et al., 2009). Individual subunits of AQP1 are 28 kDa and are
made of six bilayer spanning domains which form a functional water pore (Herrera & Garvin, 2011).
These subunits associate with one another to form a homotetramer, the generation of which leaves a
fifth pore of hydrophobic amino acids at the centre of the four monomers. This fifth pore forms a path
for non-polar molecules such as CO2 (Endeward et al., 2006; Herrera & Garvin, 2011; Wang et al.,
2007), whilst the four aquapores have been shown to have limited CO2 permeability (Wang et al.,
2007). AQP1 is highly expressed in cells requiring gas transport including pulmonary capillaries,
epithelial cells and vascular smooth muscle (Herrera & Garvin, 2011) in addition to red blood cells
where AQP1 has been demonstrated to be responsible for ∼60% of the cells’ CO2 permeability
(Endeward et al., 2006). AQP1 is also abundantly expressed in the renal proximal tubule where it
has a role in facilitating bicarbonate reabsorption from the glomerular filtrate (Section 1.7.3).
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Rhesus channels are predominantly ammonia channels (Ripoche et al., 2004; Li et al., 2006b;
Endeward et al., 2008), encoded in humans by the erythroid RHAG and the non-erythroid RHBG
and RHCG genes (Winkler, 2006). Rhesus proteins comprise of 11 conserved transmembrane helices
which hetero-trimerise to form a pore lined by hydrophobic side chains, through which ammonia can
travel in the RhAG isoform (Li et al., 2006b; Winkler, 2006). Endeward et al. demonstrated that
these channels are not selective for one gas but also allow the passage of CO2 as well as NH3 and
thus contribute to the high CO2 permeability of red blood cell membranes (Endeward et al., 2008).
This is due to the fact that the molecular diameter of CO2 (2.9 to 3.3 A˚) is quite similar to that of
NH3 (3.0 to 3.15 A˚), allowing either to pass through the hydrophobic environment of the channel
(Endeward et al., 2008).
The AQP and RhAG channel routes for CO2 entry into cells, however, is only one paradigm.
Missner et al. published a paper in 2008 demonstrating that inorganic carbon movement across a
membrane is via passive diffusion of CO2 (Missner et al., 2008), instead of facilitated passage through
channels. The authors demonstrate that at physiological pH, movement of inorganic carbon across
a membrane is restricted by the near-membrane unstirred layer which acts as a diffusional barrier
to the membrane. Here, carbonic anhydrases convert any HCO−3 ions from the extracellular bulk to
CO2 allowing diffusion across to the intracellular comparment where the reverse can occur enabling
both CO2 and HCO3
− to exist within the cell (Missner et al., 2008). Based on this principle,
the entry pathways into any protein channels extend beyond the unstirred layer and thus be an
unlikely route for the gas to cross the membrane. The authors substantiate this theory further by
demonstrating that CO2 fluxes across AQP1 expressing cells and non-expressing cells are identical.
Recently a correspondence was published by Boron et al. to discuss these two contrasting theories
(Boron et al., 2011). This publication suggests that the two contrasting paradigms may be a result of
differences in experimental design, particularly the use of artificially generated membranes compared
to in vivo extracts. The authors suggest that whilst the effects observed by Missner et al. may be true
in a pure membrane preparation, the presence of membrane-spanning proteins within the membrane
could potentially decrease the efficiency by which CO2 moves from aqueous to lipid phase and back.
An example of this may include red blood cells where integral membranes make up more than 50%
of the cell surface membrane, thus requiring the presence of specialised proteins to facilitate CO2
transport (Boron et al., 2011). As such, gas conduction through AQP1 and the RhAG complex
may only be physiologically relevant in either membranes of low gas permeability, or in cells where
a major fraction of the cellular membrane is occupied by the channels (Wang et al., 2007).
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Bicarbonate Ion Transport
Being charged, HCO−3 ions are not able to diffuse through the lipid membrane and need specialised
transport proteins to facilitate transmembrane bicarbonate flux. These bicarbonate transporters
fall into one of two families: SLC4 or SLC26 (Sterling & Casey, 2002). Differences in the tissue
distribution, electrogenicity, and regulation of each of these anion exchanger proteins allows for
precise regulation of HCO−3 transport throughout the human body (Bonar & Casey, 2008).
The SLC4 family consists of ten genes, of which eight of the encoded proteins transport HCO−3 ions.
Functionally, these eight proteins fall into two major groups: three Cl−-HCO−3 anion exchangers
(AE1-3) and five Na+ dependent HCO−3 transporters (NBCe1, NBCe2, NBCn1, NDCBE, NCBE)
(Romero et al., 2004). Anion exchangers perform reversible electroneutral exchange of Cl− for
HCO−3 ions across a membrane, driven simply by concentration gradient. For most cells the inward
Cl− chemical gradient dominates, driving the exchange of extracellular Cl− for intracellular HCO−3
(Romero et al., 2004). The three isoforms share a common structure with cytosolic N- and C-
terminal domains flanking a central transmembrane domain, which exhibits 80% sequence homology
between isoforms (Bonar & Casey, 2008). The isoforms do, however, exhibit differences in tissue
distribution, apical or basolateral epithelial expression, electrogenicity, regulation and physiological
roles (Bonar & Casey, 2008).
NBC proteins exhibit similar structures to the AEs, but use the transmembrane Na+ electro-chemical
gradient to support transport. NBCe1 and NBCe2 are electrogenic Na+-HCO−3 co-transporters
which move these ions in the same direction with a stoichiometry of 1:2 or 1:3 (Romero et al., 2004).
Being electrogenic, one complete cycle of transport activity results in the net movement of charge
across the membrane, carrying electrical current and shifting membrane potential. NBCn1 works in
the same way as NBCe1 and NBCe2, co-transporting Na+ and HCO−3 ions, but is electroneutral with
a stoichiometry of 1:1 and thus transport carries no electrical charge. NDCBE and NCBE transport
HCO−3 differently, being electroneutral sodium-driven Cl
−-HCO−3 exchangers. NDCBE is a hybrid
co-transporter/exchanger that co-transports one Na+ and two HCO−3 ions into the cell in exchange
for a single Cl− (Grichtchenko et al., 2001; Romero et al., 2004). Whilst NCBE was originally
described as a sodium-driven Cl−-HCO−3 exchanger, the involvement of Cl
− ions is inconclusive and
further work is required to establish its mode of activity (Romero et al., 2004).
The C-terminal cytoplasmic domain of all the SLC4A anion exchangers contains a ∼40 residue acidic
motif involved in interactions with carbonic anhydrases, providing the exchangers with HCO−3 and
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increasing the ion flux through the transporter by about 40% (Sterling & Casey, 2002). This CA
activity is of particular note with AE1 (Vince & Reithmeier, 1998) which plays a key role in inorganic
carbon homeostasis, both in erythrocytes carrying CO2 from systemic tissues to the lungs and in
HCO−3 reabsorption from the lumen of the renal collecting duct (Section 1.7).
The human SLC26 family consists of ten genes encoding anion exchangers capable of transporting
a wide variety of monovalent and divalent anions through their hydrophobic transmembrane core
(Mount & Romero, 2004). Of these SLC26A3, SLC26A4, SLC26A6 and possibly SLC26A7, SLC26A8
and SLC26A9 transport HCO−3 ions (Mount & Romero, 2004; Bonar & Casey, 2008), usually with
the counter exchange of Cl− ions. Between isoforms, however, the stochiometry of Cl−-HCO−3
exchange differs, with SLC26A3 transporting ≥ 2 Cl− per HCO−3 ion and SLC26A6 ≥ 2 HCO−3 ions
per Cl− (Mount & Romero, 2004).
1.6.4 Sensing Inorganic Carbon
Whilst inorganic carbon is involved in the regulation of certain elements of cell signalling such as
ACs (Section 1.3.6), it also has a signalling role itself. In plants, Rubisco acts as a primary CO2
sensor. As this photosynthetic enzyme is rate-limited by the availabilty of CO2, it is therefore a
vital step in controlling flux through the plant’s metabolism. CO2 also competitively inhibits the
Rubisco oxygenation reaction, which produces glycolate leading to photorespiration (Long et al.,
2004) and thus CO2 levels control rates of biomass production. Sensation of differing atmospheric
CO2 concentrations also controls transpiration rates through the regulation of stomatal opening
(Long et al., 2004; Messinger et al., 2006; Mott, 1988) and expression. Stomatal pore number in
Arabidopsis thaliana is controlled by the gene HIC (high for carbon dioxide) which encodes a negative
regulator of stomatal development that responds to CO2 concentration (Gray et al., 2000). This
gene encodes a putative 3-keto acyl coenzyme-A synthase, an enzyme involved in the synthesis of
long-chain fatty acids (Gray et al., 2000) typically found in the cuticle of leaves (Woodward, 2002).
These fatty acids have been postulated to provide short-distance cell-to-cell signalling, which is then
translated into a more systemic signal involving abscisic acid, ethylene and jasmonates. This enables
CO2 detection in mature leaves to control stomatal development in immature leaves (Woodward,
2002).
At the whole organism scale CO2 can have profound effects. In both the plant fungal pathogen
Mucor racemosus and the mammalian pathogen Candida albicans exposure to elevated CO2 induces
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morphogensis from spherical, budding yeast-like cells to a virulent hyphae/mycelium morphology
(Larsen & Sypherd, 1974). In Candida, this change in morphology is regulated by the HCO3
−
responsive AC Cyr1p (Sheth et al., 2008) and elevated CO2 leads to the downregulation of heat shock
protein HSP12. Thus CO2 may play a role in biofilm formation (Sheth et al., 2008), potentially
improving the virulence of the pathogen.
Just as CO2 can enable an organism to adapt its growth and undergo morphological change, other
organisms adapt their behaviour in response to the gas. Organisms respond in different ways,
either eliciting attraction or avoidance. In female blood-feeding mosquitos from species Anopheles
gambiae, Culex quinquefasciatus and Anopheles aegypti, this signal is perceived as an attractant to
their blood food source (Dekker et al., 2005; Turner et al., 2011). In these insects CO2 is detected by
heteromeric receptor proteins similar to those in Drosophila (see below), activating the cpA neuron
(Turner et al., 2011). CO2 can also act as an attractive cue for many insects that seek plants as food
sources and oviposition sites. An example of this is the moth Manduca sexta, which uses labial pit
organs whose receptor neurons project afferents to the antennal lobe to sense CO2 released from its
preferred host, Datura wrightii flowers (Guerenstein et al., 2004; Thom et al., 2004; Goyret et al.,
2008). Some insects even use the CO2 signal generated from plant wounds or rotting meat as an
attractant. The Queensland fruit fly Bactrocera tryoni, for example, uses this signal as a strong
oviposition cue (Stange, 1999).
Avoidance is also a common behavioural response and can be observed in both the fruit fly Drosophila
melanogaster and the nematode Caenorhabditis elegans. Drosophila have CO2 responsive neurons,
able to sense the gas through 7TM receptors Gr21a and Gr63a, which are co-expressed in antennal
olfactory sensory ab1C neurons (Jones et al., 2007; Kwon et al., 2007). The intracellular signalling
network is at present unknown, although the G-proteins Gαq and Gγ30A have been postulated (Yao
& Carlson, 2010). CO2 avoidance occurs at levels as low as 0.1% (Suh et al., 2004) and is proposed
as an alarm response (stressed flies release 3- to 4-fold more CO2 than unstressed flies (Suh et al.,
2004)) and as CO2 has profound deleterious effects. In Drosophila elevated CO2 causes defects
in egg laying, hatching and embryonic development (Helenius et al., 2009). Furthermore, elevated
CO2 can also disrupt the fly’s immune response by repressing expression of antimicrobial peptides
regulated by Relish (Helenius et al., 2009). This in turn can lead to increased Drosophila morbidity
due to infection by a number of bacterial species, including Enterococcus faecalis, Agrobacterium
tumefaciens and Staphylococcus aureus (Helenius et al., 2009). These long term deleterious effects
are not unique to Drosophila. Long-term exposure to CO2 at levels exceeding 9% causes aberrant
58
motility, age-dependent deterioration of body muscle organisation, slowed development, and reduced
fertility and brood size in Caenorhabditis elegans (Sharabi et al., 2009). C. elegans also exhibit
avoidance behaviour of CO2 levels 0.5% and above, characterised by the cessation of forward
movement and the rapid initiation of backward movement (Hallem & Sternberg, 2008). CO2
detection occurs via two sets of neurons located in the head: the BAG O2 sensors and the AFD
thermosensors (Bretscher et al., 2011). Here CO2 activates the cGMP signaling pathway via the ETS-
5 transcription factor which controls the expression of a single target gene encoding receptor-type
guanylate cyclase GCY-9 (Brandt et al., 2012). This signalling pathway also includes cGMP-gated
heteromeric channel TAX-2/TAX-4 (Hallem & Sternberg, 2008; Hallem et al., 2011) and atypical
soluble guanylate cyclases (sGCs) GCY-31 and GCY-33 to evoke Ca2+ signals and neuron activity
(Bretscher et al., 2011). Downstream of this initial detection step CO2 avoidance is modulated
by multiple signaling molecules, including the neuropeptide Y receptor NPR-1 and the calcineurin
subunits TAX-6 and CNB-1 (Hallem & Sternberg, 2008).
The involvement of GC and cGMP signalling in CO2 detection has also been demonstrated in mice.
Mice can smell CO2 in the air at concentrations as low as 0.066% using specialised olfactory neurons
that express the GC isoform GC-D (Hu et al., 2007). Detection involves CA-II mediated catalysis of
CO2 to HCO
−
3 (Hu et al., 2007; Sun et al., 2009) which stimulates GC-D directly at the intracellular
cyclase domain (Sun et al., 2009; Guo et al., 2009). This HCO−3 interaction with GC-D has been
demonstrated in the rat isoform to increase enzyme Vmax whilst unaffecting the KM for GTP (Guo
et al., 2009), similar to the observations for sAC (Section 1.3.6). Activated GC-D then produces
cGMP which opens CNG channels, stimulating the neuron to depolarise (Hu et al., 2007).
In humans, however, GC-D is a pseudogene and thus we are unable to detect CO2 through our
olfactory organs (Young et al., 2007), although detection is possible via the sour-sensing taste cells
on the tongue, which exhibit direct responses to both dissolved and gaseous CO2. However, as
this mechanism acts through CA IV activation and the ‘sour-sensing’ ion channel PKD2L1, the
true signal may instead be the CA generated protons (Chandrashekar et al., 2009). In addition to
gustation, there are a number internal systemic locations able to sense changes in inorganic carbon,
predominantly chemoreceptors in the carotid body and medulla oblongata. Chemoreception at these
locations is involved in regulating body gases and systemic pH levels through control of breathing
rate and kidney function. These topics will be covered in depth in Section 1.7, including descriptions
of associated clinical problems when these homeostatic processes go awry.
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1.7 Hyper/Hypocapnia: Control and Clinical Relevance
Control of systemic inorganic carbon is important as, when left unregulated, it can lead to toxic
changes in body fluid pH and death (Richerson, 2004). Homeostasis is, therefore, required to avoid
cellular damage as a result of abnormal levels of inorganic carbon, anoxia, and pH change. Whilst
various serum constituents, particularly amino acids, are able to innately buffer small changes in pH,
homeostasis is mainly controlled via pulmonary (Section 1.7.1), renal and hepatic responses (Section
1.7.3). Futher homeostasis is also provided by the natural buffering capacity of bone (Section 1.7.3)
and the alterations made to blood volume and pressure in order to dilute the effects on bodily fluids
(Marshall & Bangert, 2008).
These homeostatic mechanisms work well under normal conditions to maintain appropriate inorganic
carbon and pH levels, but when an underlying disease presents this can lead to a pathological acid-
base disorder. There are several categories of disorder (Figure 11), depending on the direction of
pH change away from the norm, the system compromised, and the systemic levels of CO2, HCO
−
3
and various other ions, including chloride, phosphorus, sodium, potassium, calcium, and magnesium
(Atkins, 1969). An excess of acid is termed an acidosis and an excess in bases an alkalosis. These
disorders are often associated with alterations to the equilibrium of inorganic carbon in solution
(Section 1.6.2), with hypercapnia referring to an elevation of CO2 and hypocapnia, a decrease. Due
to the effects of CO2 in solution, hypercapnia is often associated with an increase in blood H
+
ions, a drop in pH and thus an acidosis. Classification of the processes that cause the imbalance
is based on the etiology of the disturbance, either respiratory or metabolic, and the time-frame of
the event: acute or chronic. Thus, acute respiratory acidosis may occur following choking, where
systemic CO2 levels rise rapidly and pH drops (Siggaard-Andersen, 2005), whilst chronic metabolic
alkalosis may occur over an extended period following a kidney malfunction that prevents or interupts
bicarbonaturia (Marshall & Bangert, 2008). Each differentiated disorder is characterised by pH,
pCO2 and [HCO
−
3 ] deviations from the norm (Figure 12).
On detection of an acid-base disorder (Section 1.7.1), the mechanisms that maintain acid-base
homeostasis may alter their function to compensate (Table 3). Most commonly, this involves
alteration of breathing rate to combat metabolic acidosis/alkalosis and modification of renal excretion
rates for respiratory disorders. A good example of this is in individuals suffering ketoacidosis
as a result of diabetes mellitus. These individuals have an inability to completely metabolise
triacylglycerols from adipose tissue, which results in a build-up of ketoacids in the body. This
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Figure 11: The Siggaard-Andersen acid-base chart used by medical professionals to diagnose acid-
base disorders. Under normal conditions the systemic acid-base balance maintains a pH around 7.4
in the extracellular fluid by excreting CO2 in the lungs and HCO
−
3 ions from the kidneys. However,
when this control is disrupted an acid-base disorder may present, characterised by changes in arterial
blood pH, carbon dioxide tension (pCO2) and concentration of titratable hydrogen ions (H
+). As
shown, a pH, log pCO2 chart can be used to illustrate these conditions as shown. The chart displays
normal values, as well as those expected in typical acid-base disturbances, including acute and
chronic respiratory acidosis and alkalosis, and acute and chronic metabolic acidosis and alkalosis.
Figure adapted from Siggaard-Anderson (Siggaard-Andersen, 2005).
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Figure 12: Acid-base disorders and the pH, pCO2 and [HCO
−
3 ] associated. Acid-base disorders are
characterised by their onset time-frame (acute or chronic), etiology (respiratory or metabolic) and
their pH deviation from the norm (acidosis or alkalosis). Due to the nature of dissolved CO2, these
disorders are accompanied by alterations in systemic pH, pCO2 and [HCO
−
3 ], measurement of which
forms a diagnostic tool. Figure adapted from Huckfinne (Huckfinne, 2010).
Process pH Ci Levels
Compensatory Compensatory
Mechanism Effect
Metabolic Acidosis Down
CO2 normal/decreasing Respiratory CO2 downHCO−3 down
Respiratory Acidosis Down
CO2 up Renal HCO−3 upHCO−3 normal/increasing
Metabolic Alkalosis Up
CO2 normal/increasing Respiratory CO2 upHCO−3 up
Respiratory Alkalosis Up
CO2 down Renal HCO−3 downHCO−3 normal/decreasing
Table 3: Compensatory mechanisms activated by acid-base disorders and their effects.
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manifests as a metabolic acidosis and, in order to compensate, individuals experience excessive
urine production in order to remove ketoacids and re-absorb bicarbonate ions. In severe, acute
cases, however, individuals experience heavy, laboured gasping, known as ‘Kussmaul breathing’, as
the body tries to expel as much CO2 as possible in an attempt to increase blood pH once more
(Marshall & Bangert, 2008).
This report is primarily concerned with how inorganic carbon concentrations can affect cellular and
systemic biochemistry and physiology. Under normal conditions tissues are maintained at pH 7.4
and a pCO2 of 40 ± 5 mmHg, which equates to about 5.3% (Azzam et al., 2010; Briva et al., 2010).
Hypercapnia occurs when this pCO2 rises above 45 mmHg and is generally caused by hypoventilation,
lung disease, or diminished consciousness. Hypercapnia is common in patients with diseases such as
chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), bronchopulmonary dysplasia
(BPD) and muscular dystrophies (Li et al., 2006a; Vohwinkel et al., 2011). In COPD patients it is
not unusual for pCO2 to reach 60-80 mmHg in the arterial blood (Connors et al., 1996) and levels
as high as 250 mmHg have been described in individuals with uncontrolled asthma (Mutlu et al.,
2002). Patients with hypercapnia generally have a worse prognosis (Belkin et al., 2006; Kessler
et al., 1999), associated with a decrease in wound repair (Doerr et al., 2005). At the cellular level,
cells grown in the presence of high CO2 have been shown to have reduced proliferation, independent
of extracellular pH and osmolarity (Vohwinkel et al., 2011), as well as depressed glycolysis rates
(De Zengotita et al., 2002). In the context of disease, these effects on proliferation may prove
detrimental to recovery. Elevated CO2 can also cause oxidative stress and injury (Doerr et al., 2005)
and inhibit alveolar fluid reabsorption (Briva et al., 2007; Vada´sz et al., 2008a), potentially impairing
gas exchange, and increasing the likelihood of infection and pulmonary oedema (Vada´sz et al.,
2008a). Furthermore, hypercapnia and the often concomitant acidosis may have deleterious effects
on vascular and cardiac tissues. In accordance with this, the leading cause of hospitalisation and
morbidity among COPD patients is cardiovascular events (Sin & Man, 2005). Azzam et al. suggests
that as chronic hypercapnia is known to cause permanent damage to muscle cells in C.elegans
(Sharabi et al., 2009), a similar mechanism might explain the cardiovascular complications (Sin &
Man, 2005) and reductions in muscle mass observed with COPD patients (Maltais & Debigare´,
2003).
At the other extreme, hypocapnia is characterised by pCO2 levels less that 35 mmHg and usually
results from chronic hyperventilation. Hypocapnia can occur as a complication of pathophysiological
situations, including high-altitude hypoxemia, pulmonary disorders such as asthma and acute lung
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injury (Laffey & Kavanagh, 2002), central nervous system diseases, anxiety-hyperventilation, hepatic
failure, chronic vomiting, sepsis and salicylate intoxication (Adrogue & Madias, 1998). With these
pathologies patients initially experience a moderate acute decrease in HCO−3 occurs due to tissue
buffering and Cl− ion release from cells (Laffey & Kavanagh, 2002). This is followed by the
progression of chronic hypocapnia as a result of renal homeostatic mechanisms, which may require up
to 2-3 days to be established (Adrogue & Madias, 1998; Laffey & Kavanagh, 2002). One of the most
common causes of hypocapnia is pregnancy, where the arterial pCO2 is maintained approximately
10 mmHg lower than normal by the high circulating levels of the hormone progesterone (Laffey &
Kavanagh, 2002).
1.7.1 Chemoreceptors and Control of Respiration
Changes to systemic carbon dioxide are monitored throughout the body at peripheral chemoreceptors,
but most importantly at those located within the aortic and carotid bodies. Chemoreceptors in the
carotid body are also able to detect changes in pH, often related to the level of CO2 (Section
1.6.2). These sensors are proposed to be regulated by HCO−3 sensitive sAC and the output signal
is cAMP dependent (Nunes et al., 2009). Further monitoring occurs within the brain at central
chemoreceptors located on the highly vascularised ventro-lateral surface of the medulla oblongata,
which is capable of detecting changes in the pH and pCO2 of cerebrospinal fluid (Eldridge et al.,
1985; Shams, 1985).
These chemoreceptors are able to send nervous signals within the body in order to compensate
for any acid-base alterations. The fastest compensation mechanism initiated is via alteration of
breathing rate and, therefore, the amount of exhaled CO2. An increase in pCO2 of just 1 mmHg
causes a 20-30% increase in ventilation (Feldman et al., 2003), a change primarily instigated by
the central chemoreceptors of the brain on the respiratory centre of the medulla oblongata (Laffey
& Kavanagh, 1999). Here, CO2 sensitive connexin-26 hemichannels, located on astrocytes, open
to release ATP which increases respiration rate through excitation of respiratory neurons (Gourine
et al., 2005; Huckstepp et al., 2010a,b; Wenker et al., 2012). Respiratory neurons in turn send
impulses to the intercostal muscles and diaphragm via the intercostal and phrenic nerves respectively,
altering breathing rate (Laffey & Kavanagh, 1999). Peripheral chemoreceptors are also involved,
although these chemoreceptors are not able to sense CO2, only pH. Under normal conditions these
chemoreceptors send a continual signal to the brainstem via cranial nerves IX and X, but when a
drop in plasma pH is detected this signal intensifies and results in an increase in ventilation rate
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(Buckler et al., 1991; Huckstepp & Dale, 2011).
The ability to monitor blood pH and gases and control breathing rate is of paramount importance in
acid-base homeostasis. As covered in Section 1.7, the inability to maintain this balance can lead to
a multitude of pathological states. Due to the accessible nature of the ventilatory system, alteration
of the gas content of inspired air can also be used medically to manipulate systemic acid-base levels.
An example of this is the use of depressed mechanical ventilation to induce permissive hypercapnia.
In contrast to the paradigm that the effects of hypercapnia are potentially damaging (Section 1.7),
the use of permissive hypercapnia is of increasing interest as a treatment for a range of pathological
disorders, including acute lung injury, ischaemia-reperfusion injury, and acute respiratory distress
syndrome. Clinical treatment of these disorders involves decreasing the tidal volume and inspiratory
pressures of artificial ventilation and thus allowing pCO2 to increase, often as high as 100 mmHg
(Laffey et al., 2004; Ismaiel & Henzler, 2011; Oliver et al., 2012). This practice limits the amount
of potential damage caused by overstretching lungs with compromised compliance (Broccard et al.,
2001; Sinclair et al., 2002; Amato et al., 1998), for example in patients with acute respiratory
distress syndrome (Amato et al., 1998), and allows permissive hypercapnia to develop (Sinclair
et al., 2002). The protective effects of permissive hypercapnia have been attributed to the effect
of CO2 on the haemoglobin oxygen dissociation curve, which shifts to improve arterial oxygenation
(Azzam et al., 2010). Additional protection is provided by the concomitant acidosis which decreases
cardiac contractility and increases cardiac output and the often simultaneous effects of hypoxia
on pulmonary vasoconstriction which increases oxygen delivery to the alveoli (Laffey & Kavanagh,
1999). Together, these effects result in a net increase in pO2, furthered by an increase in regional
blood flow (Laffey & Kavanagh, 1999). There is also a well-documented anti-inflammatory influence
of CO2 which may provide further benefits to using permissive hypercapnia in a clinical setting
(Section 1.7.2). Furthermore, hypocapnia is known to cause bronchospasm, hyperventilation (Laffey
& Kavanagh, 2002) and increased production of dysfunctional surfactants. This could worsen lung
compliance and further damage the affected tissue and consequently should be avoided (Laffey &
Kavanagh, 2002).
In contrast, in patients administered near pure oxygen, this respiratory stimulant can cause hyper-
ventilation and thus lead to hypocapnia (Iscoe & Fisher, 2005). This is due to the Haldane effect,
which describes that oxygenated haemoglobin binds to less CO2 and so systemic inorganic carbon
transport can only occur via dissolved gas/ions. This dissolved gas leads to increased local tissue
pCO2, particularly at the central chemoreceptors, driving inspiration and leading to hyperventilation
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(Iscoe & Fisher, 2005). The basis for giving patients O2 gas is to increase blood pO2 and thus
increase delivery to the tissues. However, this has a counter-productive two-fold effect: firstly the
induced hypocapnia and resultant metabolic alkalemia causes vasoconstriction of CO2 responsive
vascular beds, reducing O2 delivery. Secondly, it also increases the haemoglobin affinity for O2,
further reducing off-loading into tissues (Iscoe & Fisher, 2005; Adrogue & Madias, 1998; Laffey &
Kavanagh, 2002). Hypocapnia can also increase the metabolic demand of a tissue through cellular
excitation or contraction (Laffey & Kavanagh, 2002), further augmenting the requirement for oxygen.
Thus, this misinformed delivery of O2 and the resultant metabolic alkalemia can lead to a number
of clinical oversights. Common examples include a decline in fetal pO2 during labour, worsening
fetal outcome (Iscoe & Fisher, 2005), and a counter-productive decrease in cerebral and myocardial
blood flow (Iscoe & Fisher, 2005; Adrogue & Madias, 1998) in stroke and myocardial ischaemia
patients respectively (Iscoe & Fisher, 2005). This latter example occurs as a result of arteriolar
constriction (Adrogue & Madias, 1998) and reduced oxygen delivery (Laffey & Kavanagh, 2002).
The concomitant alkalemia can also have deleterious effects on the recovery rate of these patients as
it increases neuron excitability which results in deleterious seizures (Laffey & Kavanagh, 2002) or
ventricular arrhythmias (Adrogue & Madias, 1998) in cerebral and cardiac patients respectively.
Whilst long durations of hypocapnia can adversely affect patient outcome, transient clinical induction
can be advantageous. This can be the case in patients with severely augmented intracranial pressure
as a result of head trauma or brain tumour (Neumann et al., 2008), neonatal pulmonary-artery
hypertension and alongside general anesthesia to minimise the spontaneous respiratory effort (Laffey
& Kavanagh, 2002). The majority of the positive effects of this short term hypocapnia are associated
with the vasoconstriction caused by the often concomitant alkalosis (Laffey & Kavanagh, 2002).
1.7.2 Systemic Effects of Hyper/Hypocapnia on the Immune System
Sections 1.7 and 1.7.1 present somewhat contrasting consequences of hyper- and hypocapnia in
a clinical setting. Whilst the extent of the advantages and disadvantages may depend on the
pathological condition presenting, a large part has been attributed to the effects of CO2 on the
immune system. Acidosis has been known to attenuate a range of inflammatory processes including:
neuronal apoptosis, phospholipase A2 activity, neutrophil Na
+/H+ exchange (Laffey & Kavanagh,
1999), pro-inflammatory cytokine production, and neutrophil recruitment (Laffey et al., 2004).
There is now evidence that some of these inflammatory alterations are caused by CO2 and not
the associated acidosis. Cummins et al. demonstrated a pH independent attenuation of the NF-κB
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pathway with elevated CO2. Under these conditions NF-κB regulatory protein IKKα is reversibly
translocated to the nucleus, where it is able to alter gene expression (Cummins et al., 2010) and
repress NF-κB activity (Lawrence et al., 2005). In addition the same group have also shown that
the anti-inflammatory NF-κB family member RelB is also cleaved and translocated to the nucleus
where it can suppress cytokine-stimulated inflammatory gene expression (Oliver et al., 2012). The
NF-κB pathway is a major regulator of inate immune and inflammatory gene expression and the
effects of CO2 can be demonstrated to inhibit bacterial lipopolysaccharide induced gene expression
(Takeshita, 2003; Cummins et al., 2010). These effects may underlie the therapeutic benefits of
permissive hypercapnia observed in conditions where infection or wounding is present (Hanly et al.,
2006; Costello et al., 2009; Nichol et al., 2009). This is of paramount importance when considering
that the most common predisposing cause of acute respiratory distress is infection (Nichol et al.,
2009). However, it is also worth noting that, in the wrong setting, this attenuation of the immune
response may prove counter-productive and thus harmful to recovery (Doerr et al., 2005; O’Croinin
et al., 2008; O’Toole et al., 2009).
The effects of CO2 on the immune system may also have a prophylactic as well as therapeutic use.
This is not only evident in cases of acute endotoxin-induced lung injury (Laffey et al., 2004), but also
with trigeminal neuron activated migraine and seasonal allergic rhinitis (Casale et al., 2008). With
the latter examples, prophylaxis has been demonstrated using non-physiological concentrations of
CO2 of 100%. Casale et al. showed that two intra-nasal one minute applications of 100% CO2
provided both rapid (ten minutes) and sustained (twenty-four hours) relief from allergic rhinitis
symptoms including congestion, rhinorrhea, itching and sneezing (Casale et al., 2008). This relief was
provided through the prevention of mast cell agonist induced Ca2+ ion release and cell degranulation
(Strider et al., 2011).
Further effects of hypercapnia and the often concomitant acidosis include the attenuation of reactive
oxygen species (ROS) production, including repressed leukocyte superoxide formation and lipid
peroxidation (Laffey & Kavanagh, 1999), as well as xanthine oxidase inhibition (Shibata et al.,
1998). These alterations to ROS can have profound effects particularly as oxygen-derived free
radicals are central to the pathogenesis of acute lung injury and ischaemia reperfusion injury (Laffey
& Kavanagh, 1999). In the case of reperfusion injury, the return of blood to an ischaemic area often
causes inflammation and oxidative damage which may lead to the production of free radicals from
membrane breakdown. These free radicals cause cytochrome c release and caspase-9/-3 cleavage,
leading to DNA fragmentation and apoptosis (Chen et al., 2012). Thus, in this setting, use of
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permissive hypercapnia may have clinical precedent. Demonstrations of this have been shown in
rats where hypercapnic acidosis is shown to protect rats against heart ischaemia, brain ischaemic
stroke, and lung ischaemic reperfusion injury (Laffey & Kavanagh, 1999).
Elevated CO2 is also an important consideration in growing tumours as prior to vascularisation
pCO2 levels can increase within the cellular mass. Previous studies have shown that in experimental
animal systems pCO2 levels of 70-80 mmHg can be observed within tumours, compared to 40 mmHg
in the blood (Gullino et al., 1965). Before sufficient angiogenesis can occur and vasculature develop,
spheroids of cancer cells exhibit difficulties in maintaining pH and rely on inorganic carbon to
provide an extracellular mobile pH buffer to chaperone protons away from cells (Hulikova et al.,
2011). Due to this poor pH homeostatic mechanism, acidic pH has become a hall-mark of cancer,
further augmented by the characteristic elevated metabolism of cancer cells, and has been suggested
to exert selection pressure over normal cells to promote tumour invasiveness. Nevertheless, when
acid extrusion and removal is compromised in experimental spheroids, they become highly uniform
and inadequate at the core (Hulikova et al., 2011). This artificial disruption of acid extrusion can also
be mimicked in the absence of CO2/HCO
−
3 or with CA inhibition, thus highlighting the importance
of the Ci buffer (Hulikova et al., 2011).
CO2 levels can also have another effect on tumour growth through the aforementioned alteration of
immune response gene expression. As an example of this, Samspon and Chaplin demonstrated that
increasing pCO2 concentrations from 5% to 7% decreased the amount of phorbol 12-myristate 13-
acetate induced production of the potent cytotoxic cytokine TNFα (tumour necrosis factor α) from
the monocyte cell line U937 (Sampson & Chaplin, 1996). This suppression of TNFα by elevated
CO2 has since been further demonstrated in human alveolar A549 cells (Oliver et al., 2012). In a
tumorgenic system, this cytokine acts as an important angiogenic factor and, therefore, the effect of
CO2 on its release requires further study. (Sampson & Chaplin, 1996).
1.7.3 Control of Hyper/Hypocapnia - Kidney Function
Whilst alteration of respiratory rate is a quick and effective method to control physiological pCO2
and pH, chronic alterations or respiratory derived acid-base disorders require different mechanisms to
return to normal. In these cases compensation is provided both through hepatic and renal responses.
The liver is able to dispose of a small amount of CO2 through the anaplerotic carboxylation of
pyruvate to form oxaloacetate, but the majority of regulation is provided by the kidneys where
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Figure 13: Diagram illustrating acid-base transport in renal proximal tubules.
The proximal tubule reabsorbs HCO−3 by using active transport processes to secrete H
+ into the
tubule lumen. This causes lumen HCO−3 to form CO2 and H2O under the influence of CA VI.
The lumenal CO2 and H2O can then enter the cells via AQP1, where HCO
−
3 ions are again formed
through the action of CAII. Once inside the cell, HCO−3 exits across the basolateral membane via
NBCe1. This process is controlled internally through CO2 and HCO
−
3 sensors in the cells’ basolateral
membrane and by systemic signals, such as parathyroid hormone.
Abbreviations used: NHE3, Na+-H+ exchanger 3; AQP1, aquaporin 1; CA II and CA IV, carbonic
anhydrases II and IV; NBCe1-A, electrogenic Na+/HCO3
− co-transporter 1, splice variant A.
Figure adapted from Boron (Boron, 2006).
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HCO−3 ions are excreted via the urine (Marshall & Bangert, 2008). An example of this is during
respiratory acidosis, which is characterised by in increase in blood pCO2 that causes a decrease in
blood pH and an increase in [HCO−3 ]; and this raises the re-absorption of HCO
−
3 from the urine
to buffer the blood pH (Bouyer et al., 2003). There are several mechanisms to control this loss
of HCO−3 through the kidneys, 80% of which takes place in the proximal tubules (Wang & Deen,
1980; Chen & Boron, 1995a), 10% in the thick ascending limb and 10% in the distal nephron
(Boron, 2006). The proximal tubule (PT) is located within the renal cortex and is a unique region
containing morphologically specialised epithelial cells with numerous apical brush border microvilli
and basal interdigitating folds (Shlatz et al., 1975). Its key function is to re-absorb nutrients and
ions downstream from the glomerular filtrate, according to the body’s current needs.
Whenever blood pH levels drop due to increased systemic CO2, HCO
−
3 reabsorption from the PT
increases, independent of any changes to pH at the basolateral membrane (Bouyer et al., 2003).
A diagrammatic representation of the process is presented in Figure 13. HCO−3 reabsorption is
initiated through the active secretion of protons into the tubule lumen by Na+/H+ anti-porters
(Boron & Boulpaep, 1983; Murer et al., 1976) and V-type H+ pumps (Boron, 2006; Paunescu et al.,
2008). Most of the protons secreted by the PT cells titrate the filtered HCO−3 to form CO2 and
H2O. This reaction is catalysised by CA IV, which is tethered to the apical membrane (Sly & Hu,
1995). CO2 and H2O are then able to enter the PT cells via AQP1 channels (Section 1.6.3) in the
apical membrane (Boron, 2006; Missner et al., 2008). In the lumen, ‘new HCO−3 ’ is also created
to neutralise the volatile mineral acids generated by metabolism (Boron, 2006; Bouyer et al., 2003).
Any protons remaining are buffered by creatine and ammonium and dihydrogen phosphate ions
(Bouyer et al., 2003; Boron, 2006; Marshall & Bangert, 2008).
Reabsorbed Ci from this process does not remain in the cell, but instead is transported across
the basolateral membrane into the interstitial fluid and eventually to the blood. This is achieved
through the conversion of CO2 to HCO
−
3 ions by cytoplasmic CA II (Sly & Hu, 1995). HCO
−
3 can
then be basolaterally transported out of the cell through the activity of electro-neutral Na+/HCO−3
co-transporters 1.6.3, namely NBCe1-A (Boron & Boulpaep, 1983; Seki et al., 1996; Boron, 2006).
NBCe1 is the predominant basolateral pathway in the S1 and S2 segments of the PT, where the
majority of the HCO−3 reabsorption occurs, but a basolateral Cl
−-HCO−3 is also important in the
S3 segment (Kondo & Fro¨mter, 1987; Seki & Fro¨mter, 1990).
Proximal tubule cells have been postulated to have either CO2 or HCO
−
3 sensors on their basolateral
membrane, able to detect hyper- or hypocapnic concentrations of Ci and resultantly stimulate apical
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Na+/H+ anti-porters to respond accordingly (Chen & Boron, 1995a,b). However, the overall level of
HCO−3 reabsorbed is controlled by parathyroid hormone, PTH, an important homeostatic hormone
involved in HCO−3 , Ca
2+, and phosphate homeostasis (Agus et al., 1973).
Parathyroid Hormone
PTH is an 84-amino acid polypeptide hormone (Azarani et al., 1995) secreted continuously from the
chief cells of the parathyroid gland under the fine and precise control of blood calcium (Sherwood
et al., 1966). Hormone release is stimulated in response to systemic decreases in serum Ca2+ levels
(Sherwood et al., 1966). This Ca2+ decrease is detected via a 7-TM Ca2+ sensitive receptor coupled
to PLC (Dare` et al., 1998), in addition to a further level of control by intracellular Ca2+ and
cAMP (Willgoss et al., 1980). However, PTH is not exclusively involved in Ca2+ homeostasis, but
also has important roles in the regulation of systemic phosphate, HCO−3 and, therefore, pH. The
complementary 7-TM G-protein coupled PTH receptor (Short & Taylor, 2000) is found predominantly
in the target cells of osteo-blasts (see below) and renal proximal tubule cells (Aurbach & Potts, 1964;
Melson et al., 1970; Shlatz et al., 1975).
Bone is an important PTH responsive organ, where osteoblasts (fully differentiated bone cells
embedded in the extra-cellular matrix) react to the hormone through a variety of different mechanisms,
including the production of cAMP (Chase & Aurbach, 1970). Most notably at this location, PTH
acts to increase the calcium concentration of the blood by activating the release of Ca2+ from bones
(Raisz, 1965), predominantly through the destruction and re-absorption of osteoblasts (Forrest
et al., 1985; Raisz, 1965). Osteoblast breakdown is carried out by a normal, non-pathological
mechanism carried out by another bone cell type: osteoclasts, themselves indirectly stimulated
by PTH (McSheehy & Chambers, 1986). This same mechanism is also important in increasing
serum phosphate levels (Doyle & Jan de Beur, 2008). Furthermore, bone cells have a role in acid-
base homeostasis as any decreases in proton levels, as typical with metabolic acidosis, have been
shown to stimulate osteoclast and inhibit osteoblast activity (Goldhaber & Rabadjija, 1987; Krieger
et al., 1992). Systemic pH decrease thus results in marked eﬄuxes of sodium and potassium ions,
as well as depletion of mineral carbonates (Bushinsky et al., 2002). This provides an ionic flux
capable of buffering some of the available protons, often with sodium and potassium ions exchanging
for hydrogen and the carbonate binding protons to produce HCO3
−, which results in significant
neutralisation of the increased acidity (Bushinsky et al., 2002). In fact, by this mechanism, for
each millimole of calcium released from the bone, approximately 12 mmol of protons are neutralised
(Bushinsky et al., 2002). Unlike in renal cells, however, these effects do not appear to be PTH
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controlled and are instead mediated by physio-chemical bone mineral dissolution and additional
osteoclast activity (Bushinsky et al., 2002). These effects on acid-base homeostasis are particularly
relevant as bone contains approximately 80% of the body’s stored Ci, including carbonate, HCO−3
and CO2 (Bushinsky et al., 2002). Two thirds of this is in the form of carbonate complexed
with hydrogen, calcium, potassium, sodium and other cations, located in the lattice of the bone
crystals where it is relatively inaccessible to systemic circulations. The other third is located in
the hydration shell of hydroxyapatite (Section 1.4) where it is readily accessible to the systemic
circulation (Bushinsky et al., 2002).
In the renal PT, PTH acts to increase calcium (Agus et al., 1973) and decrease HCO−3 and phosphate
re-absorption from the urine (see below), in addition to decreasing volume re-absorption as a knock-
on effect of regulating HCO−3 (Pollock et al., 1986). PTH also has a number of other effects on these
cells, including stimulation of gluconeogenesis and the inhibition of Na+/K+-ATPases (Friedlander &
Amiel, 1994). As first suggested by Chase and Aurbach, intracellular transduction of the PTH signal
is predominantly via AC (Chase & Aurbach, 1967; Agus et al., 1971), which results in an increase in
nephrogenous (Broadus et al., 1977) and urinary excreted cAMP (Chase & Aurbach, 1967). However,
it is now known that signalling can also occur from the same receptor (Abou-Samra et al., 1992)
via a G protein - PLC - Ca2+ - PKC route, coupled to discrete high affinity receptors (Cole et al.,
1987; Hruska et al., 1987; Azarani et al., 1995). These two pathways are purported to be spatially
separated, with the AC coupled pathway predominantly located at the basolateral membrane (Shlatz
et al., 1975) and the PLC pathway potentially apical (Cole et al., 1987). In addition, each signalling
route is coupled to a downstream receptor with different affinities; AC coupled receptors being of
low affinity in comparison (Cole et al., 1987). This information has led to the suggestion that PTH
transduction under normal conditions is PKC mediated, as a response to PTH can be seen as low as
picomolar concentrations (Pollock et al., 1986), whilst PKA activation may be tumorigenic in nature
(Azarani et al., 1995). However, discovery of ‘cAMP junctions’ between AC VI and IP3 receptors
may affect this paradigm as they enable the delivery of super-maximal concentrations of cAMP
directly to the target enzyme at distances impenetrable to PDEs (Tovey et al., 2008). It may also
be worth noting that both the PLC/PKC and cAMP/PKA pathways converge on MAPK-kinase
and it has been suggested that this downstream signalling molecule may serve to transduce both
signals (Cole, 1999; Bacic et al., 2003). Demonstration of this can be provided using MAPK-kinase
antagonists which prevent PTH stimulated NaPi-IIa internalisation (Bacic et al., 2003; Cole, 1999)
and regulation of Na+/H+ exchange (Bacic et al., 2003). Nevertheless, AC and cAMP is widely
accepted as the mediator of the majority of PTH’s hormonal effects on both bone and kidney.
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Results to illustrate this include the ability of the AC agonist forskolin to reproduce PTH mediated
changes in luminal pH, as a result of alterations in downstream Na+/H+ transporter activity (Pollock
et al., 1986), as well as the ability of PKA inhibitors to attenuate these effects (Nogueira et al., 2008).
Furthermore, Martin et al. found that inhibition of PLC did not affect PTH regulation of phosphate
transport and the authors note that the evidence to support the PKC route is mainly based on the
use of PKC inhibitors, which are often not specific for PKC and also inhibit PKA (Martin et al.,
1994).
As the PTH response is involved in the systemic regulation of inorganic carbon, it would be
interesting to establish whether there is also a further intracellular level of control via AC. This
is of particular interest, both due to the multitude of interactions currently established between
AC isoforms and Ci (Section 1.3.6), as well as the contradicting deleterious and benefical effects
of hypercapnia and permissive hypercapnia (Sections 1.7, 1.7.1 and 1.7.2). Work carried out by
Rodriguez et al. with parathyroidectomised rats (therefore unable to produce PTH) demonstrated
that administration of acetazolamine, a carbonic anhydrase inhibitor, decreased cAMP in their urine,
independent of any changes in pH. In fact, acetazolamine was shown to have a dose-dependent effect
on AC activity (Rodriguez et al., 1974); perhaps an indication that it was not the inhibitor itself
acting on the enzyme, but rather the changes in Ci brought about by alterations in the CA activity.
This hypothesis of Ci directly influencing the intracellular signalling is further supported by the
observation that respiratory alkalosis results in a resistance to the phosphaturic effect of PTH and
cAMP, an effect shown to be a result of the decrease in pCO2, not the concomitant pH change (Hoppe
et al., 1988). Experimental demonstration of a decrease in PTH induced cAMP accumulation at
elevated pCO2 is provided in Chapters 3 and 4, with the physiological effects on the downstream
Na+/H+ exchanger and NaPi-IIa provided in Chapter 5.
Regulation of HCO−3 Excretion and Na
+/H+ Exchanger Activity
In the kidney, the PTH response constitutes a fundamental step in the regulation of HCO−3 re-
absorption via the inhibition of apical membrane (Friedlander & Amiel, 1994) Na+/H+ anti-porters
NHE (Murer et al., 1976; Schwartz, 1981; Pollock et al., 1986). As explained above, by acidifying
the PT lumen, HCO−3 ions in the glomerular filtrate can be converted to CO2 and reabsorbed into
the cell. There are nine isoforms of mammalian NHE distinguished by their kinetic characteristics,
drug sensitivity, modulation by protein kinases, response to external stimuli, and tissue and cellular
distribution (Tse et al., 1992). Pharmacological (Wu et al., 1996), genetic (Schultheis et al., 1998),
and immunohistochemical (Biemesderfer et al., 1993, 1999) data indicate that the NHE3 isoform is
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predominantly responsible for this activity. NHE3 is specific to the intestine and kidney (Tse et al.,
1992; Schultheis et al., 1998) and its C-terminus contains a regulatory domain (Tse et al., 1992),
which is targeted by AC/PKA (Nogueira et al., 2008). Phosphorylation at this site inhibits the
anti-porter (Fan et al., 1999) and in the long term PKA activity decreases transcription and thus
expression through interactions with the NHE3 promotor region -152 to +55 (Nogueira et al., 2008).
PTH also causes a redistribution of NHE3 from the apical microvilli to the base of the intermicrovillar
cleft (Fan et al., 1999; Leong et al., 2004), where endocytosis from the apical to subapical region
occurs (Nogueira et al., 2008). This redistribution is associated with the activity of two adaptor
proteins: NHE-regulatory factors NHERF-1 and -2. These proteins are known to assemble macro-
molecular complexes and determine the localisation, trafficking and signalling of select GPCRs
(Ardura et al., 2011). They share a common structure, including two tandem PDZ (Post-synaptic
Density-95, discs large, Zonula occludens-1) protein interaction domains and a C-terminal MERM
(Erzin-Radixin-Moesin-Merlin) binding domain and are both able to self-associate and hetero-
dimerise (Cunningham et al., 2004). Under basal conditions, NHE3 and NHERF-2 closely associate,
but within one minute of intracellular Ca2+ elevation NHERF-2 releases the exchanger. NHE3
is then mobile and able to redistribute from the brush border into the intervilli clefts where ion
transport may be compromised (Cha et al., 2010), in addition to the transporter being susceptible
to endocytosis (Zhu et al., 2011).
NHERFs also have an additional role in PTH signalling at the hormone receptor level. NHERF-1
interacts with PTH receptor 1, PTHR1 (Mahon et al., 2003a), to attenuate PTH induced cAMP
synthesis (Karim et al., 2008). Under basal conditions, NHERF-1 binds to PTHR1 via its PDZ
binding motif and this interaction tethers the receptor to the actin cytoskeleton and plasma membrane
(Ardura et al., 2011). NHE3 can also bind directly to NHERF-1 and actin via erzin and thus may
form a signalling microdomain with the PTH receptor. Upon PTH stimulation NHERF-1 dissociates
from PTHR1, which is then trafficked to clathrin-coated pits for internalisation. Recruitment of β-
arrestins is delayed until NHERF-1 dissociates, but when detached, the receptor is endocytosed and
eventually recycled to the membrane or targeted for degradation (Ardura et al., 2011).
Further regulation of NHE activity occurs via IRBIT (IP3 receptor binding protein released with
IP3). At the IP3 receptor phosphorylated IRBIT competitively binds to the IP3 binding site,
inhibiting receptor activity and preventing Ca2+ ion leakage (Ando et al., 2006). With NHE3,
phosphorylated IRBIT binds the C-terminal domain to provide Ca2+ dependent stimulation via
CaM and CaMKII (He et al., 2008). This interaction initiates exocytotic insertion of the NHE3-
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IRBIT complex into the plasma membrane. Whilst this interaction does not occur as a result of PTH
signalling, it is worth noting as the response is involved in fluid reabsorption via similar mechanisms
as HCO−3 . An example of this is after stimulation by angiotensin II, which acts by decreasing cAMP
and increasing Ca2+ to activate downstream IRBIT (He et al., 2010). IRBIT is also able to activate
NBCe1 via its N-terminus and the combined effects on both NHE3 and NBCe1 may, therefore,
increase transcellular HCO−3 transport (Yang et al., 2011). Kinetically, most Na
+/H+ exchangers
also have an internal H+-modifier site to regulate transport activity in response to an acid load (Tse
et al., 1992; Fan et al., 1999). The overall effect of this is to decrease HCO−3 re-absorption and thus
allow excess Ci to be excreted.
Regulation of Phosphate Excretion and NaPi-IIa Activity
Phosphate is predominantly stored in the body as the ion PO4
2− with 85% of systemic phosphate
found in bone and teeth as a component of the crystal hydroxyapatite (Hammerman, 1986). The
principal organs involved in excretion and absorption are the kidneys and intestine respectively,
both through the use of sodium-phosphate co-transporters. In the kidney, phosphate excretion is
regulated by PTH, which stimulates cAMP production (Chase & Aurbach, 1967; Agus et al., 1971).
This cAMP decreases the activity of apical membrane (Friedlander & Amiel, 1994) Na+/PO−4 co-
transporters involved in the reabsorption of PO3−4 ions from the glomerular filtrate, resulting in
increased phosphaturia (Agus et al., 1973; Caverzasio et al., 1986). PTH signalling has an inhibitory
effect on both type II and III phosphate transporters, but most regulation is via the NaPi-IIa co-
transporter. In fact, in mice lacking the NaPi-IIa co-transporter, PTH injections do not cause
phosphaturia, emphasising its importance in phosphate homeostasis (Zhao & Tenenhouse, 2000).
PTH signalling decreases NaPi-IIa expression (Kempson et al., 1995; Picard et al., 2010), in addition
to causing transporter internalisation (Malmstrom & Murer, 1986) and targeting to lysosomes for
degradation (Keusch et al., 1998; Pfister et al., 1998; Picard et al., 2010). NaPi-IIa forms part of a
multiprotein complex, interacting via its PDZ-binding motif with the scaffolding proteins NHERF-1
and actin, which hold it in place at the apical membrane. NHERF1 is phosphorylated as a result of
PTH signalling, leading to dissociation of the NaPi-IIa-NHERF1 complex. This dissociation allows
NaPi-IIa to be routed via clathrin coated pits to be degraded by lysosomes (Picard et al., 2010).
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2 Chapter 2: Materials and Methods
2.1 Chemicals, Reagents and Equipment
All consumable plasticware was purchased through Thermo-Fisher Scientific R©, STARLAB R© and
Starstedt R© with the exception of Poly-prep chromatography columns (Bio-Rad - 731-1550). Cell
cultures were received from various sources as detailed in Section 2.3.1. All other chemicals used are
listed in the table below.
Chemicals Company Code
Acetazolamine Sigma A6011
Acetic acid Sigma 242853
Acetonitrile Sigma 34967
Acrylamide Sigma A9926
2, 8-[3H] Adenine Perkin Elmer NET063005MC
Adenosine Sigma A9251
Adenosine 3, 5 cyclic mono-phosphate (cAMP) Sigma A9501
Adenosine diphosphate (ADP) Sigma A2754
Adenosine monophosphate (AMP) Sigma A1752
Aluminium oxide (Activity Grade 1, WN-3:
neutral)
Sigma A9003
Ammonium persulphate Sigma A3678
2-Aminoethyl diphenylborinate (2-APB) Ascent Scientific Asc-124
Autocamtide II Calbiochem 189475
Bafilomycin A1 Enzo Life Sciences BML-CM110-0100
1, 2-bis (o-Aminophenoxy) ethane-N, N, N’,
N’-tetraacetic Acid Tetra (-acetoxymethyl) ester
(BAPTA-AM)
Calbiochem 196419
2’, 7’-bis (Carboxyethyl)-5(6)-Carboxyfluorescein
(-acetoxymethyl) ester (BCECF-AM)
Sigma C3411
Bovine serum albumin (BSA) Sigma A7906
Bradford Reagent Biorad 500-0006
Bromophenol Blue Sigma B0126
Calcium chloride Sigma C1016
Carbon dioxide (2.5, 5, 10% [v/v] in air) BOC Special order
Carbon dioxide mix (5% CO2, 18% O2, 77% N2 [v/v]) BOC Special order
cAMP Biotrak EnzymeImmunoAssay Kit GE Healthcare RPN2251
Chicken serum Biosera CH-515
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Chemicals Company Code
3-[(3-Cholamidopropyl) dimethylammonio] -1-
propanesulfonate hydrate (CHAPS)
Sigma C9426
Choline chloride Sigma C7017
Collagen Sigma C8919
Coomassie G-250 Sigma 201391
Dantrolene (sodium salt) Sigma 9175
5-(N,N-Dimethyl)-amiloride (DMA) Sigma A5462
Dimethyl sulfoxide (DMSO) Sigma D2650
Dithiothreitol (DTT) Simga 43817
Dulbecco’s Modified Eagle Medium Sigma D1152
DMEM/F12 (1:1) Sigma D8900
Dowex AG 50W-X4 resin Biorad 142-1341
EcoScint XR
National
Diagnostics
LS-272
Ethylenediaminetetraacetic acid (EDTA) Sigma E6758
Ethylene glycol-bis (2-aminoethylether)-N, N, N′,
N′ -tetraacetic acid (EGTA) Sigma E0396
Ethanol Dept. Stores -
Fibrinogen Sigma F1141
Fetal Bovine Serum Sigma F6178
Forskolin Sigma F6886
Fura-2 Calcium Imaging Calibration Kit Molecular Probes R© F-6774
Fura-2 pentakis(acetoxymethyl) ester (Fura 2-AM) Sigma F0888
Glucose Sigma 158968
L-Glutamine Sigma G6392
Glycerol Sigma G5516
Glycine Sigma 241261
Go¨6983 Calbiochem 365251
G-418 Sigma A1720
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES)
Sigma H3375
Hydrochloric acid Sigma H1758
H89 Sigma B1427
Imidazole Sigma I5513
Instant Blue Triple Red -
Isobutylmethylxanthine (IBMX) Sigma I5879
Isopropanol Dept. Stores -
Isopropyl β-D-thiogalactoside (IPTG) Sigma I5502
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Chemicals Company Code
iTRAQ Reagent
Applied
Biosystems
-
KH7 Enamine Ltd. Special order
Lithium chloride Sigma L4408
Magnesium chloride Sigma M8266
Manganese chloride Sigma 244589
Methyl methanethiosulfonate Sigma 64306
32P-Monopotassium phosphate Perkin Elmer NEX 060002MC
β-mercaptoethanol Sigma M6250
Methanol Sigma M1775
Nifedipene Sigma N7634
Nigericin Sigma N7143
N-Methyl-D-glucamine Sigma 66930
Non-Essential Amino Acids (NEAA) Sigma M7145
OptiPhase HiSafe 2 Perkin Elmer 1200-436
PagerulerTMpre-stained protein ladder Fermentas SM0671
Parathyroid Hormone Fragment (bovine, 1-34) Sigma P3671
Penicillin/Streptomycin Sigma P0781
Phenol Red Sigma P3532
Phosphate buffered saline Sigma 79382
Phosphoric acid Sigma P5811
Poly-D-Lysine Sigma P6407
Potassium bicarbonate Sigma P9144
Potassium chloride Sigma P9333
Potassium phosphate monobasic Sigma 60221
Propanoic acid Sigma 402907
Rotenone Sigma R8875
RPM1 1640 Media Biosera LM-R1641
Ryanodine Inhibitor Ascent Scientific Asc-083
Skimmed Milk Powder Co-op -
Ski/ROMe (sphingosine kinase antagonists)
Kind gift from Prof. Nigel Pyne,
University of Strathclyde
Sodium bicarbonate Sigma S6297
Sodium chloride Sigma S7653
Sodium dodecyl sulphate (SDS) Sigma L3771
Sodium hydroxide Sigma 221465
Sodium phosphate dibasic dihydrate Sigma 71643
SQ 22536 Calbiochem 568500
Staurosporine Calbiochem 569397
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Chemicals Company Code
STO-609 Enzo Life Sciences BML-EI389-0001
Tetramethylethylenediamine (TEMED) Sigma T9281
Thapsigargin Sigma T9033
Thiourea Sigma 88810
Trichloroacetic acid (TCA) Sigma T9159
Triethylammonium bicarbonate Sigma T7408
Tris-HCl Sigma 93363
Tris(2-carboxyethyl)phosphine Sigma C4706
Triton X-100 Sigma T8787
Trizma Base Sigma T4661
Trypsin-EDTA Sigma 594180
Urea Sigma U5378
U-73122 Enzo Life Sciences BML-ST391-0005
Xestospongin C Enzo Life Sciences BML-CA409-0050
Table 4: List of reagents used and purchasing details
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2.2 Computer Software and Statistical Analysis
The text for presentation of this thesis was written and formatted in LaTeX using TeXnicCenter
or TeXworks and viewed via Adobe Reader R©. Numerical manipulations were carried out in either
Microsoft ExcelTMsor GraphPad Prism 4 R©, the latter also used to produce all graphical repre-
sentations and statistical analysis of data. All error bars included in the thesis are the standard
error of the mean.
BCECF fluorescence measurements for intracellular pH were measured via a Life Sciences R© micro-
spectrofluorimeter system and computer software PhoCAL PRO 1.6b. Fura-2 measurements for
intracellular Ca2+ were measured via a Perkin Elmer R© LS-55 Luminescence Spectrometer and
computer software Perkin Elmer R© FL Winlab. Measurement of cAMP accumulation data was
carried out via a Perkin Elmer R© Liquid Scintillation Analyser Tri-Carb 2900TR and program
QuantSmartTM. Proteomics iTRAQTMldata was identified and quantitated using Applied Bio-
systemsTMs ProteinPilotTMs2.0.1 and the analysis program displayed in Section 8.3.1 was written
using PythonTMsand displayed using TextWranglerTM.
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2.3 Mammalian Cell Culture
2.3.1 General Cell Culture
All cells were cultured at 37 ◦C and 5% (v/v) CO2 in air with media changes every two to three
days. With adherant cell lines, sub-culturing was carried out at 80 - 100% confluence, with three
PBS washes preceding the addition of 1 mL of 0.1% (v/v) aqueous trypsin. Cells were incubated
with trypsin until cells were visibly lifting from the surface and the enzyme arrested by dilution with
10 mL of required media. A centrifugation step at 160 x g for 3 minutes was employed to remove
any residual enzyme from the cell suspension. Alterations to the culturing method and details of
media required for each cell type are listed in the subsections below.
Suspension cell lines were maintained at cell concentrations between 2 x 105 mL−1 and 4 x 106
mL−1, as measured using a haemocytometer. Passage was carried out at 2 x 106 mL−1 cells and
required centrifugation of cells, at 160 x g for 3 minutes, aspiration of old media, and re-suspension
in the required volume of fresh, pre-warmed media.
A549 cells (Human carcinomic alveolar basal epithelial cells)
Obtained from Dr. Paul Yeo, Biophysical Sciences Institute, Durham University
Media consisted of Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F12 (1:1 volume)
containing 15 mM HEPES (Sigma R© D8900) and 14 mM sodium bicarbonate, supplemented with
10% (v/v) fetal bovine serum, 1% (v/v) antibiotic penicillin-streptomycin, 2% (v/v) non-essential
amino acids, pH 7.4. Sub-culturing was carried out between 1:2 and 1:6 dilutions.
DT40 (Gallus gallus, avian leukosis virus induced B lymphoblasts)
Obtained from Prof. Colin Taylor, Pharmacology Department, University of Cambridge
Two DT40 cell lines were used, both stabily transfected and therefore requiring the same media
constituents. Strains used were either referred to as ‘DT40-K/O’ for cells where both alleles of
all three genes for the IP3 receptor have been disrupted (Sugawara et al., 1997), or ‘DT40-IP3R1’
where the gene for IP3 receptor 1 has been re-introduced by transfection (Laude et al., 2005). DT40
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cells were cultured in accordance to published work (Tovey et al., 2006) in RPMI 1640 medium
supplemented with 10% (v/v) fetal bovine serum, 1% (v/v) heat-inactivated chicken serum, 1%
(v/v) antibiotic penicillin-streptomycin, 2 mM glutamine and 50 µM 2-mercaptoethanol. 15 mM
HEPES and 14 mM sodium bicarbonate were also added for assay medium. Passaging was carried
out as detailed above.
HEK 293 (Human Embryonic Kidney) cells
Obtained from Dr. Michael Gray, Institute for Cell and Molecular Biosciences, University of Newcastle
HEK293 cells, immortalised through transformation with sheared fragments of adenovirus type 5
DNA (Graham et al., 1977), were cultured in Dulbecco’s Modified Eagle’s Medium (Sigma R© D777),
supplemented with 10% (v/v) newborn calf serum, 1% (v/v) antibiotic penicillin-streptomycin, 2%
(v/v) non-essential amino acids, pH 7.4. Sub-culturing was carried out between 1:3 and 1:6.
HEKPR1 cells
Obtained from Prof. Colin Taylor, Pharmacology Department, University of Cambridge
HEKPR1 (HEK 293 cells stably expressing human parathyroid hormone receptor 1 (Short & Taylor,
2000)) were cultured in Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F12 (1:1
volume) containing 15 mM HEPES (Sigma R© D8900) and 14 mM sodium bicarbonate supplemented
with 10% (v/v) fetal bovine serum, 1% (v/v) antibiotic penicillin-streptomycin, 2% (v/v) non-
essential amino acids, 1% (v/v) L-glutamine, 500 µg mL−1 G418 (to retain transfected phenotype),
pH 7.4. Sub-culturing was carried out at 1:3 or 1:6.
OK (Didelphis virginiana, Opossum Kidney) cells
Three independent lines were obtained from: Dr. Michael Gray, Institute for Cell and Molecular
Biosciences, University of Newcastle; LGC/ATCC R©; and Dr. H Murer, Institute of Physiology and
Zurich Center for Integrative Human Physiology, University of Zurich
Media consisted of Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F12 (1:1 volume)
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containing 15 mM HEPES (Sigma R© D8900) and 14 mM sodium bicarbonate, supplemented with
10% (v/v) fetal bovine serum, 1% (v/v) antibiotic penicillin-streptomycin, 2% (v/v) non-essential
amino acids, 1% (v/v) L-glutamine, pH 7.4. OK cells were sub-cultured at one day post-confluence
and required frequent media change; every 24 hours where possible (Koyama et al., 1978). Sub-
culturing was between 1:2 and 1:6 dilutions and trypsinisation often involved a 5 minute incubation
step at 37◦C to encourage cells to detach from one another (Koyama et al., 1978).
UMR-106 (Rattus norvegicus, 32P induced osteosarcoma) cells
Obtained from Prof. J.A. Gallagher, Department of Human Anatomy and Cell Biology, University
of Liverpool
Cells were cultured in Dulbecco’s Modified Eagle’s Medium (Sigma R© D777) supplemented to contain
15 mM HEPES, 14 mM sodium bicarbonate, 10% (v/v) fetal bovine serum, 1% (v/v) antibiotic
penicillin-streptomycin, 2% (v/v) non-essential amino acids, 1% (v/v) L-glutamine, pH 7.4. Sub-
culture was carried out between 1:2 and 1:6.
2.3.2 Preparation of -140 ◦C Freezer Stocks
To produce a permanent cell stock, cryo-vials of cells were frozen and stored at -140 ◦C. To prepare
for freezing, cells were centrifuged after trypsining and re-suspended in 0.5 mL normal media, to
which 0.5 mL media with 20% DMSO (v/v) was added drop-wise, with constant but gentle agitation.
Cell suspensions were then transferred to appropriate cryo-vials and cooled slowly for 2 to 3 hours
at -20 ◦C and overnight at -70 ◦C before transfer to -140 ◦C.
When reviving cells from frozen, cells were thawed as quickly as possible, using a pre-heated water-
bath at 37◦C. DMSO was removed through a wash in pre-warmed media with centrifugation at
160 x g for 3 minutes prior to transfer to a flask for growth. Whenever cells were in or had been
recently in media containing DMSO care was taken when pipetting to reduce damage and cell lysis
as a result of sheer stresses.
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2.3.3 Coating Tissue Culture Plates with Poly-D-Lysine
To improve HEKPR1 cell adherence to tissue culture plastic sterile 5 mg/ml poly-D-lysine solution
was added to cover the base of well and incubated for 10 minutes at room temperature, with constant
agitation. The poly-D-lysine solution was then aspirated off, wells washed with sterile water and
plates left to dry for either 1 hour in the microbiological safety hood or overnight in the incubator
before use.
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2.4 In cellulo Biochemical Assays
2.4.1 Measurement of Intracellular pH
Cells were grown to confluence on 25 mm diameter glass coverslips, with HEKPR1 coverslips pre-
coated with 5 mg/mL poly-D-lysine (as in Section 2.3.3), and serum starved overnight in the
presence of 0.2% (w/v) bovine serum albumin (BSA) prior to assay. 5 µM of the pH sensitive
fluorescent dye 2’,7’-bis(carboxyethyl)-5(6)-carboxyfluorescein (BCECF) was added in pre-warmed
and gassed phosphate buffered solution (PBS) supplemented with 25 mM glucose and 14 mM sodium
bicarbonate and incubated for 20 minutes at 37◦C, 5% (v/v) CO2 in air. Loading of this dye was
via its non-fluorescent membrane permeable acetoxymethyl ester (-AM) derivative enabling better
cell penetration. The -AM group is removed within the cell through cleavage of its adjoining ester
bond by endogenous non-specific esterases to give the active, hydrophilic compound (Thomas et al.,
1979; Hegyi et al., 2004). BCECF-AM (Rink et al., 1982) is a highly useful dye not only due the
aforementioned qualities but also has a pKa of pH 7.0, well within the normal cytoplasmic range
and at these pH values, once cleaved from its -AM group, it leaks out from cells far more slowly
than the parent compound, using key negative charges to aid cell retention (Invitrogen, 2006).
Figure 14: The pH-dependent fluorescence excitation spectra of BCECF (Invitrogen, 2006)
Coverslips were mounted in a perfusion chamber suspended over an inverted microscope, attached
to a photomultiplier tube enabling intracellular pH to be measured by exciting the cells at both 490
and 440 nm, whilst measuring emission at 535 nm. This enabled ratiometric monitoring of BCECF
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excitation and pHi to be measured due to the pH-dependent fluorescence spectra of this dye (Figure
14), where lowering the pH decreases the absorbance at 490 nm (Thomas et al., 1979) therefore
decreasing the ratio (Hegyi et al., 2004). Using a ratio instead of absolute values also eliminates
a number of potential artifacts: photobleaching, excessive dye leakage, non-uniform cell loading,
cell thickness and instrument stability (Invitrogen, 2006). Solution change and CO2 concentration
was altered through a heated microperfusion system, enabling the flow of 37◦C pre-gassed cell
media across cells at a variable rate (most commonly at 3smL/min). Media used for perfusion
was identical to the cell growth media but lacking serum (for details see Section 2.3.1). Where
propanoic acid concentrations were required these were added after medium constitution and pH
normalisation. Intracellular pH calibration was carried out using potassium nigericin solutions (130
mM KCl, 25 mM Glucose, 20 mM HEPES, 14 mM NaHCO3, 1 mM CaCl2, 1 mM MgSO4 and 10
µg/mL nigericin) at a range of pH values. Through this method nigericin, a K+/H+ antiporter,
equilibrates the intracellular pH to that of the surrounding solution due to the high K+ of this
solution (Thomas et al., 1979; Hegyi et al., 2004). Specific detail into this calibration method is
provided in Appendix 7.1. Compensation for ‘drift’, the continuous and unavoidable leakage of dye,
shown by a steady decrease in emission intensity, was calculated using the method outlined by Hegyi
et al. (Hegyi et al., 2004) (see Appendix 7.1 for more detail). An identical method was used with
OK cells with the exception that loading used 7.5 µM BCECF-AM for 30 minutes.
2.4.2 Measurement of Intracellular Ca2+
DT40 cells were grown to a concentration of 2 x 106 mL−1 and the required volume loaded with
10 µM of the Ca2+ sensitive fluorescent dye Fura-2 pentakis(acetoxymethyl) ester (Fura 2-AM) in
serum free media and incubated for 30 minutes at 37◦C, 5% (v/v) CO2 in air. As a lipid-soluble
acetoxymethyl ester (-AM) derivative, loading of this dye is similar to the BCECF-AM outlined in
Section 2.4.1. To enable complete cleavage of the ester, cells were then centrifuged at 160 x g for
3 minutes and re-suspended in pre-warmed Krebs-Ringer-HEPES solution (130 mM NaCl, 25 mM
glucose, 20 mM HEPES, 14 mM NaHCO3, 5 mM KCl, 1 mM CaCl2 and 1 mM MgSO4, pH 7.4)
for 30 minutes at 37◦C, 5% (v/v) CO2. Where required, antagonists were added at this stage and
maintained in the media for the duration of the experiment. Cells were then transferred to fresh
Krebs-Ringer-HEPES pre-gassed with the desired CO2 concentration and allowed to equilibrate,
with gassing, prior to experimentation. Where required, 2 mM propanoic acid was added at this
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stage. For repeats within experiments cells were labelled with dye en mass and separated to take
readings.
Measurement of dye emission was carried out using 1 mL of cells transferred to a quartz cuvette
within a spectrofluorometer able to excite the cells at 340 and 380 nm, whilst measuring emission
at 510 nm. As Fura 2-AM emits with excitation at 340 when bound to Ca2+ ions and 380 nm in
their absence (Figure 15), these measurements enable a ratio to be calculated, giving comparative
concentrations of the intracellular Ca2+ available. Similar to BCECF-AM, generation of such a
ratio removes certain aspects of data variability, such as the effects of photobleaching, leakage, dye
concentration and cell thickness (Hayashi & Miyata, 1994; Invitrogen, 2012). Using this ratio, the
intracellular Ca2+ concentration can be calculated using the calibration methods outlined by Bouyer
et al. (Bouyer et al., 2003) and Grynkiewicz et al. (Grynkiewicz et al., 1985), as detailed in Appendix
7.3.
Figure 15: The Ca2+-dependent fluorescence excitation spectra of Fura-2 (Invitrogen, 2012)
2.4.3 Cellular Equilibration with CO2, Pharmacological Inhibitors and Agonists
For adherant cell lines (A549, HEK 293, HEKPR1, OK and UMR-106), cells were cultured in 12
well plates and were allowed to reach 90% confluence over 3-4 days (OK cell assays grown to 1 day
post-confluence) and then serum starved overnight in the presence of 0.2% (w/v) BSA in serum
free media (Section 2.3.1). Cells were then washed 3 times with PBS, pre-warmed in a water bath
to 37◦C, and incubated for 30 minutes at 37◦C at the desired CO2 concentration in 990 µL pre-
incubation medium using a , environment-controlled Galaxy 14S incubator. This pre-incubation
media contained: DMEM/F12 1:1 or DMEM depending on cell type, 15smM HEPES, 1% (v/v)
penicillin-streptomycin, 1 mM IBMX and, where required, 2smM propanoic acid and was pre-gassed
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for 20 minutes with the desired CO2 concentration and the pH adjusted accordingly prior to addition
to cells. Assays were initiated by the addition of 10sµL agonist or H2O/DMSO control. Lysis buffers
and conditions were dependant on the experiment performed and are detailed in the appropriate
sections.
Experimentation in DT40 suspension cell lines followed a similar protocol, with minor adjustments.
Cells were allowed to grow to a concentration of 2 x 106 mL−1 for assay. PBS washes and addition
of pre-incubation medium were identical except that centrifugation steps at 160 x g for 3 minutes
and resuspension pipetting were employed with each medium change. After pre-incubation medium
was added, the cells were separated into 990sµL volumes in open eppendorf tubes and returned to
the appropriate incubator. Lysis also followed a similar centrifugation and aspiration step.
2.4.4 In cellulo cAMP Accumulation
Cells were prepared as detailed in Section 2.4.3 except that prior to PBS washing cells were labelled
for at least 2 hours with 0.75 µCi mL−1 (37 kBq) [3H]-adenine, allowing it to be incorporated into
the intracellular ATP pool for subsequent use by adenylyl cyclases (Alvarez & Daniels, 1992). After
incubation with agonist for 10 minutes at 37◦C, media was aspirated from wells and 1 mL ice cold
5% (w/v) trichloroacetic acid (TCA) containing 1 mM ATP and 1 mM cAMP added and cells left to
lyse at 4 ◦C for at least an hour before a twin column chromatography step (Section 2.4.6). An acid
such as TCA is preferable to stop the AC reaction and lyse cells as it has been shown that cAMP can
be made non-enzymmatically under alkaline conditions (Johnson et al., 1994), and also avoids false
results due to alkaline proton exchange from tritium labelled nucleotides to water (Johnson et al.,
1994). Additionally, a low pH promotes increased cAMP binding to the alumina for subsequent
chromatography (Johnson et al., 1994) and the additional ATP and cAMP limits sample loss on
irreversible binding sites on this alumina column.
2.4.5 Antagonist Assays
Cells were prepared as detailed in Sections 2.4.3 and 2.4.4 with the required antagonist added as part
of the pre-incubation medium. Cells were therefore exposed to the antagonist for 30 minutes prior
to agonist addition, with the exception of Ski/ROMe, which were added to the starvation media
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Inhibitor Details Conc. Used
Acetozolamide Carbonic anhydrase inhibitor 100 µM
2-APB Modulator of IP3-induced calcium release 100 µM
Autocamtide II CamKII inhibitor 100 nM
Bafilomycin A1 Inhibits vacuolar H+ATPases 100 nM
BAPTA-AM Intra-cellular Ca2+ chelator 1 mM
Dantrolene Inhibitor of ryanodine receptors 10 µM
EGTA Inter-cellular Ca2+ chelator 1 mM
Go¨6983 PKC inhibitor 1 mM
H89 PKA inhibitor 10 µM
IBMX PDE inhibitor 1 mM
KH7 Non-competitive sAC inhibitor 10 µM
Nifedipene L-type calcium channel blocker 100 µM
Rotenone Inhibitor of mitochondrial electron transport 5 µM
Ryanodine Modulator of ryanodine receptors 5/100 µM
SKi/ROMe Sphingosine kinase inhibitors 10/10 µM
SQ 22,536 Adenylyl cyclase inhibitor 200 µM
Staurosporine Non-specific kinase inhibitor (PKA/C/G, CamK, MLCK) 1 µM
Sto-609 Calmodulin-dependent protein kinase kinase inhibitor 5 µM
Thapsigargin IP3 independent intracellular calcium releaser 10 µM
U-73122 Phospholipase C inhibitor 5 µM
Xestospongin C Inhibitor of IP3 receptor 500 nM
Table 5: List of inhibitors and concentrations used
and thus exposed to cells overnight. Concentrations of each inhibitor used are detailed in Table 5.
Wherever possible the antagonist was dissolved into aqueous solution, with DMSO employed if not.
2.4.6 Radio-labelled cAMP Measurement
Cell lysates obtained by method 2.4.4 were quantified via modification of a twin column chromatogra-
phy approach (Salomon et al., 1974; Wincek & Sweat, 1975; Johnson et al., 1994). This method
works on the basis that negatively charged ions, such as nucleotides, can be easily separated from
solutions through the use of strong anionic-exchange resins (Kaczorowski et al., 1994). 1 mL TCA
samples were added directly to poly-prep (Bio-Rad R©) columns containing 1 g of pre-acidified AG
50W-X4 Dowex (Salomon et al., 1974; Wincek & Sweat, 1975) cation exchange resin and washed
through with 2 mL water into scintillation vials positioned beneath. The Dowex elutions contained
[3H]-adenosine and [3H]-AMP/ADP/ATP but limited amount of [3H]-cAMP (Johnson et al., 1994),
and were defined as total adenine nucleotide values. These were used later to normalise data as
an indication of total cell adenine pool labelling. Dowex columns were then placed over a second
set of columns containing 1 g of neutral aluminium oxide (alumina - Activity grade 1, Type WN-3
(White & Zenser, 1971; Salomon et al., 1974; Johnson et al., 1994)) and contents washed through
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using 5 mL of water (Wincek & Sweat, 1975). As this eluate is slightly acidic, cAMP becomes
adsorbed onto the alumina (Alvarez & Daniels, 1992; Johnson et al., 1994), requiring an increase in
pH and ionic strength for elution (Johnson et al., 1994). Two elutions of 3 mL (White & Zenser,
1971) 100 mM Tris-HCl, pH 7.5, followed (White & Zenser, 1971; Salomon et al., 1974; Wincek &
Sweat, 1975; Alvarez & Daniels, 1992; Johnson et al., 1994) to remove this cAMP and were collected
in scintillation vials as before. Using this method cAMP can be separated from other polyvalent
nucleotides (AMP/ATP etc), which are retained on the alumina (White & Zenser, 1971; Alvarez &
Daniels, 1992) due to their anionic character at this pH (White & Zenser, 1971). All elutions had
2.5 mL of scintillation fluid (EcoScint XR or Optiphase HiSafe 2 depending on availability) added
and tritium disintergrations-per-minute measured via scintillation counter; Perkin Elmer R© Liquid
Scintillation Analyzer Tri-Carb 2900TR. This liquid scintillation process is based on the conversion
of the energy of a radioactive decay event to a release of light from the scintillant, which can be
recorded. In order to compare results from different sample sets, values were normalised to produce
the following ratio:
Ratio = [Alumina elution counts / Dowex flow-through counts] = [3H]-cAMP/ Total [3H] nucleotides
Chromatography columns were retained and regenerated between experiments (Johnson et al., 1994)
using 2 sets of alternating 5 mL washes of 1 M hydrochloric acid and de-ionised water for Dowex
columns (Salomon et al., 1974) and 10 mL 100 mM Tris-HCl at pH 7.5 for the alumina. This was
often carried out prior to experimentation as columns performed better when moist.
2.4.7 Amersham Biotrak cAMP EnzymeImmunoAssay (EIA) System
For some experiments a greater level of sensitivity for cAMP was required than could be provided
by the the radio-labelled method outlined in Sections 2.4.4 and 2.4.6. To achieve this an ELISA
assay was employed (GE Healthcare R©, RPN2251). Cells were assayed as detailed in Section 2.4.3
and after incubation with agonist for 10 minutes at 37◦C media was aspirated from wells and 200
(adherant cell lines)/300 (suspension cells) µL of lysis buffer 1B, provided with the kit, was added.
Cells were then left on a shaker for at least 30 minutes to ensure complete lysis. In most cases, 10
µL of this lysate was further diluted to 100 µL with lysis buffer 1B for use in the ELISA itself. After
this stage, experimentation followed manufacturer’s recommendations where results are measured
quantitatively via a change in optical density and compared to a simultaneously produced cAMP
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Figure 16: Biotrak cAMP enzyme-linked immunosorbent assay (ELISA) principle. Adapted from
manufacturer’s product booklet (Healthcare, 2007)
standard curve. Briefly, the ELISA is based on competition between unlabelled sample derived
cAMP and a fixed quantity of peroxidase-labelled cAMP conjugate; for a limited number of binding
sites on a cAMP specific antibody added directly to the sample prior to the conjugate. A visual
representation of how the ELISA works is shown in Figure 16.
As DT40 samples may have contained cAMP from marginally different numbers of cells, ELISA
evaluated cAMP concentrations were normalised to sample protein content. Protein concentration
was calculated through use of a Bradford assay, as detailed in Section 2.6.2. Further information on
this method is appended in Section 7.2.
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2.5 Physiology Methodology
2.5.1 Sodium-Phosphate Co-transporter Radioassay
Sodium-phosphate co-transporter activity was monitored by measuring the uptake of 32P-labelled
phosphate into cells from a surrounding solution. The method used was developed from protocols
published by Cole et al. (Cole et al., 1989), and Mahon et al. (Mahon et al., 2003b). OK cells
were grown to 100% confluence in a 12 well plate and serum starved overnight in the presence of
0.2% (w/v) BSA in serum free media (Section 2.3.1). Similar to the cAMP accumulation assay
detailed in Section 2.4.4, cells were washed once with pre-warmed PBS and then 990 µL of a pre-
warmed, gassed and pH normalised pre-incubation media added (DMEM/F12 1:1, 100 mM HEPES,
1% (v/v) penicillin-streptomycin and appropriate inhibitors at concentrations shown in Table 5).
After 30 minutes incubation at 37◦C and the desired CO2 concentration, assays were initiated by
the addition of 10 µL agonist or H2O/DMSO control.
After further incubation under the same conditions for 4 hours, ample time for cells to reach maximal
phosphate transport (Cole et al., 1989), cells were washed twice in pre-warmed and gassed phosphate
uptake solution (150 mM NaCl, 20 mM glucose, 10 mM HEPES pH 7.4, 1.8 mM MgSO4, 1 mM
CaCl2) followed by incubated treatment with 500 µL phosphate uptake buffer containing 1 µCi mL
−1
KH32PO4. A 5 minute incubation period was chosen in accordance with previous publications to
represent an estimation of the initial rate of phosphate transport (Cole et al., 1989). Phosphate
uptake was then stopped by washing with 3 x 1 mL volumes of ice-cold stop solution (150 mM
choline chloride, 20 mM glucose, 10 mM HEPES pH 7.4, 1.8 mM MgSO4 and 1 mM CaCl2) and
cells lysed using 1 mL 1% (v/v) Triton X-100 solution. Samples were transfered to scintillation
vials, 2.5 mL of scintillation fluid (EcoScint XR or Optiphase HiSafe 2 depending on availability)
added and 32P disintergrations-per-minute measured via scintillation counter; Perkin Elmer R© Liquid
Scintillation Analyzer Tri-Carb 2900TR.
2.5.2 Ammonium Chloride Pulse pH Recoveries - NHE3 Activity
Sodium-proton exchange was monitored by measuring the intracellular pH recovery after an NH4Cl
pulse, using the pH sensitive fluorescent dye BCECF-AM and a microspectrofluorometer. The
method used was developed from protocols published by Cunningham et al. (Cunningham et al.,
2004), and Hegyi et al. 2004 (Hegyi et al., 2004). OK cells were grown to 100% confluence on 25
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mm diameter glass coverslips in a 6 well plate and serum starved overnight in the presence of 0.2%
(w/v) BSA in serum free media (Section 2.3.1). Following a similar methodology as outlined in
Section 2.4.1, cells were loaded with 7.5 µM BCECF-AM for 30 minutes at 37◦C and 5% (v/v) CO2,
using pre-warmed and gassed Krebs-Ringer-HEPES solution (130 mM NaCl, 25 mM Glucose, 20
mM HEPES, 14 mM NaHCO3, 5 mM KCl, 1 mM CaCl2 and 1 mM MgSO4, pH 7.4). Coverslips
were mounted on a microspectrofluorometric system and dye emission collected at 535 nm when
excited at 440 nm and 490 nm. Cells were perfused during experiments with Krebs-Ringer-HEPES
solutions bubbled to the desired CO2 concentration and containing any agonists and/or inhibitors
(concentrations provided in Table 5). NH4Cl pulses (110 mM NaCl, 25 mM Glucose, 20 mM NH4Cl,
20 mM HEPES, 14 mM NaHCO3, 5 mM KCl, 1 mM CaCl2, mM MgSO4, pH 7.4) were for 3 minutes
and were followed by at least 5 minutes perfused exposure to Krebs-Ringer-HEPES solution. When
recovery in the absence of sodium was required, N-methyl-D-glucamine was used to replace the
NaCl in the Krebs-Ringer-HEPES solution without affecting solution osmolarity. In order to follow
sodium-free recovery, NH4Cl pulses were carried out as per norm and cells returned directly to an
N-methyl-D-glucamine solution and recovery monitored prior to return to normal Krebs-Ringer-
HEPES.
pH calibration was performed using high potassium nigericin solutions as published (Thomas et al.,
1979; Hegyi et al., 2004) and compensation for ‘drift’ calculated using the method outlined by Hegyi
et al. (Hegyi et al., 2004). Post NH4Cl pulse recoveries were calculated by either linear regressions
over 45 second periods immediately when pHi began to recover, or by direct comparison of change
in pHi (∆pHi) between treatments over the same timeframes, represented as ∆pHi/s. Further
information on these methods are provided in Appendix 7.4.
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2.6 Molecular Biology and Proteomics
2.6.1 Generation of iTRAQ Proteomics Samples
HEK 293 cells were grown to 90-100% confluence in 10 cm diameter tissue culture petri dishes. Cells
were then washed with pre-warmed PBS and incubated for 30 minutes at 37◦C at the desired CO2
concentration in 10 mL of pre-incubation medium (DMEM, 100 mM HEPES, 1% (v/v) penicillin-
streptomycin and, where required, 1 mM BAPTA-AM or 2 mM propanoic acid). Assays were
initiated by the addition of 10 µM forskolin agonist or the equivalent volume of negative control;
agonist solvent DMSO. These cells were then incubated at 37◦C and the desired CO2 concentration
for 8 hours, sufficient time for translation to occur. To lyse cells, media was aspirated and 500 µL
urea lysis buffer (9 M urea, 2 M thiourea, 4% (w/v) CHAPS) added and cells collected from the
plasticware using a cell scraper. The protein concentration of these samples was then calculated
through the use of a Bradford assay (Section 2.6.2) and once checked for equal loading by SDS-
PAGE (Section 2.6.3) these were then acetone precipitated (Section 2.6.4) and prepared for iTRAQ
labelling (Section 2.6.5).
2.6.2 Bradford Assay
Bradford reagent is a dye which binds to protein and changes colour according to the amount of
protein available. For DT40 ELISA samples (Section 2.4.7 ), 1 mL solutions were made up with
200 µL Bradford Reagent (Biorad R© - 500-0006), 790 µL deionised water and 10 µL ELISA sample,
left to stand at room temperature for 10-15 minutes and the optical density measured at 595 nm.
The resultant value was then compared to a standard curve, created using known concentrations of
BSA. Slight modifications were made to measure samples for iTRAQ (carried out in collaboration
with Joanne Robson, Proteomics Facility, Biological and Biomedical Sciences, Durham University),
using a mix of 900 µL, 98 µL H2O and 2 µL sample and compared to a modified standard curve,
made to the specifications presented in Table 6:
Standards 0 1 2 5 10 15 20
1mg/ml BSA (µL) 0 1 2 5 10 15 20
0.1mM HCl (µL) 10 10 10 10 10 10 10
Urea Lysis Buffer (µL) 2 2 2 2 2 2 2
H2O (µL) 88 87 86 83 78 73 68
Bradford Reagent 20% (µL) 900 900 900 900 900 900 900
Table 6: Modified Bradford standard curve - for samples in urea lysis buffer
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2.6.3 Sodium Dodecyl Sulphate Poly-Acrylamide Gel Electrophoresis (SDS-PAGE)
0.75 mm thick gels were used, varying the resolving gel acrylamide content to best resolve the desired
protein (Table 7), with 375 mM Tris-HCl pH 8.8, 0.1% SDS (w/v), 0.1% (w/v) APS and 0.1% (v/v)
TEMED. Stacking gels were made to a standard of 5% (v/v) acrylamide with 130 mM Tris-HCl pH
6.8, 0.1% SDS (w/v), 0.1% (w/v) APS and 0.1% (v/v) TEMED. For whole cell lysates 12% (v/v)
resolving acrylamide gels were used.
Samples were mixed for loading 1:1 with SDS loading buffer (50 mM Tris-HCl pH 6.8, 2 % (w/v)
SDS, 0.1 % (w/v) bromophenol blue, 10 % (w/v) glycerol, 100 mM DTT) to a maximum volume
of 20 µL and incubated for 3 minutes at 95 ◦C to enable complete protein denaturation. Gels
were then loaded (usually with 10-15 µL sample/buffer per well), along with 10 µL protein ladder
(PagerulerTMlpre- stained protein ladder - Fermentas SM0671) in order to monitor gel progress and
enable estimation of protein size. Gels were run in running buffer (25mM Tris-HCl pH 7.5, 192
mM glycine, 0.1 % (w/v) SDS) at 150-200 V for approximately 50 minutes or until the loading dye
had reached the bottom of the gel. Gels were then stained overnight in Coomassie dye (0.1% (w/v)
Coomassie G-250 dye, 10% (v/v) acetic acid, 50% (v/v) methanol) and de-stained in 10% (v/v)
acetic acid, 50% (v/v) methanol.
Acrylamide Percentage of Gel Protein Size
4% 100-400 kDa
6% 60-300 kDa
8% 40-250 kDa
10% 30-200 kDa
12% 15-120 kDa
14% 6-80 kDa
16% 5-60 kDa
18% 2-50 kDa
Table 7: SDS-PAGE resolving gel acrylamide concentrations
2.6.4 Acetone Precipitation
Undertaken in collaboration with Miss Joanne Robson, Proteomics Facility, School of Biological and
Biomedical Sciences, Durham University
Using samples generated for iTRAQ (Section 2.6.1), 250 µg of each sample (as calculated using
a modified Bradford; Section 2.6.2, and checked using SDS-PAGE; Section 2.6.3) were acetone
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precipitated to remove non-protein contaminating molecules, such as salts, lipids and nucleic acids.
The relevant volume of protein for 250 µg was placed in an acetone-compatible tube with 4 sample
volumes of acetone at -20 ◦C, vortexed and incubated at -20 ◦C for at least 60 minutes. These
tubes were then centrifuged (15,000 x g, 10 minutes), the supernatant removed and the residual
acetone allowed to evaporate by incubating uncapped tubes for 30 minutes at room temperature.
Precipitated protein was then resuspended in 10 µl of 2% (w/v) SDS and incubated at 60 ◦C for
approximately 1 hour, sonicated 2-3 times for 5 minutes and subsequently 90 µL of dissolution
buffer (500 mM triethylammonium bicarbonate) was added. These protein samples were then in the
correct buffer for trypsin digest and preparation of labelling with iTRAQ reagents (Section 2.6.5).
2.6.5 Trypsin Digests and Preparation of Samples for iTRAQ
Undertaken in collaboration with Dr. William Simon and Miss Joanne Robson, Proteomics Facility,
School of Biological and Biomedical Sciences, Durham University
Using samples generated by previous steps (Sections 2.6.1), 2.6.2 and 2.6.4, a second precautionary
Bradford assay (Section 2.6.2) and SDS-PAGE gel (Section 2.6.3) were run and once satisified that
all samples had the same protein concentration, trypsin digests were carried out on 50 µg of each
sample, using 5 µg of trypsin in each. In order to trypsin digest, samples were incubated with 2
µL of the reducing reagent tris(2-carboxyethyl)phosphine for 1 hour at 60◦C, 10 minutes at room
temperature with the addition of 1 µL cysteine blocking reagent methyl methanethiosulfonate and
50 µL of 10 mM calcium chloride, followed by the trypsin. Digests were incubated at 37 ◦C overnight
and then vacuum centrifuged until dry.
Samples were then ready for iTRAQ labelling, through the direct addition of the relevant iTRAQ
reagent resuspended in 50 µL isopropanol. Labelling then proceeded via a 2 hour incubation step
at room temperature with occasional vortexing. Once fully labelled, samples were pooled together
and vacuum dried.
Pooled iTRAQ labelled protein samples were resuspended in 1 mL of ‘cation exchange buffer A’
(10mM KH2PO4, 25% acetonitrile (v/v)) and the pH adjusted to between 2.8 and 3.0 using 1 M
phosphoric acid. This solution could then be injected directly onto GE Healthcare R© EttanTMsMicro
Liquid Chromatography HPLC system for cation exchange fractionation producing 40 fractions
before passing into the Dionex Ultimate R© 3000 RSLC nano system for further fractionation and
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finally into the Applied BiosystemsTMsAPI QSTARTMsPulsar I LC/MS/MS system. Once data was
generated, using the Applied BiosystemsTMsProteinPilotTMs Software 2.0.1, the peptide sequences
were searched against the NCBI library for Homo sapiens to give the data presented in Appendix
8.4.
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3 Chapter 3: In cellulo cAMP Accumulation Under Different
Capnic States
3.1 Introduction
The study of ACs and their regulation by inorganic carbon is a developing field. Whilst in vitro
assays have identified that CO2 interacts with the AC apo-protein to increase metal co-factor affinity
(Townsend et al., 2009), in cellulo evidence is limited. Townsend et al. demonstrated in HEK 293
cells stimulated by isoproterenol that CO2 activates AC at 5% (v/v) compared to ambient CO2 (v/v).
This chapter aims to investigate this in cellulo CO2 activation of AC further at the pathophysiological
CO2 concentrations of 2.5% and 10% (v/v) representing hypo- and hypercapnia respectively.
To establish this aim, cell lines responsive to the hormone PTH were chosen. This hormonal response
not only acts through AC and cAMP (Agus et al., 1971, 1973) but is a particularly useful model as
is physiologically involved in systemic inorganic carbon homeostasis (Section 1.7.3). As PTH has its
most notable effect at the kidney and bone, two renal derived cell lines OK and HEKPR1, in addition
to the osteoblast UMR-106 cell line, have been utilised to identify patterns in cAMP accumulation
across hypo-, normo- and hypercapnic CO2 concentrations (2.5%, 5% and 10% [v/v] respectively).
Additionally, pHi measurements and the use of the weak acid propanoic acid to mimic CO2 induced
pHi changes have been utilised to ensure that any CO2 effects on cAMP are pH independent.
This chapter presents evidence for a hypercapnic reduction in cAMP levels that is independent of
activating stimulus, cell line, partial hypoxia, and both extra- and intracellular pH.
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3.2 Cell Lines Used in Experimentation
Three different cell lines were used to measure PTH activated cAMP production under different
capnic conditions: OK (Opossum Kidney), HEKPR1 (Human Embryonic Kidney cells expressing
human Parathyroid hormone Receptor one) and UMR-106 (rat osteoblast cells). These lines will
form the focus of this chapter and are decribed in the following sections.
3.2.1 OK cells
The response to PTH is well documented in OK cells after its first description by Teitelbaum and
Strewler in 1984 (Teitelbaum & Strewler, 1984). First established in 1978 by Koyama et al. (Koyama
et al., 1978), these cells exhibit numerous renal epithelial properties, including polarised distribution
of plasma membrane proteins, expression of apical microvilli, and active renal transport systems
characteristic of the proximal tubule (Cole et al., 1989), especially endogenous expression of high
affinity PTH receptors (numbering some 300,000 per cell (Teitelbaum & Strewler, 1984)) coupled
to both AC activation (Teitelbaum & Strewler, 1984; Malmstrom & Murer, 1986; Caverzasio et al.,
1986; Cole et al., 1987), NHE3 inhibition, and sodium dependent phosphate transport (Cole et al.,
1989). This PTH response is stable for 35 passages and the receptor affinity is similar to that found
in renal plasma membranes (Teitelbaum & Strewler, 1984). As the only renal epithelial cell line
to reliably respond to PTH (Cole et al., 1989) and with the complete signalling machinery for this
response intact, these cells provide a useful system to test the CO2 effect on cAMP accumulation,
providing a physiologically relevant model.
Optimisation of cAMP Accumulation Assay Using OK Cells
In total three independent sources of OK cells (Section 2.3.1) were tested in order to detect a cAMP
response to PTH. This response could not be detected in commercially available cells or those sent
from one collaborator but was finally demonstrated using cells received from another collaborator.
As experiments with HEKPR1 cells under identical conditions demonstrated a response to PTH
(Figure 18), the problem lay with the OK cells themselves, not the assay conditions. It is possible
that if the cells obtained from the first collaborator (passage number unknown) were cultured for
a long period of time without PTH challenge that they no longer expressed the PTH receptor or
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Figure 17: Failure to obtain parathyroid
hormone response.
Cells assayed at one day post-confluence
after overnight starvation (in absence of
BSA, unlike most experimentation) and two
hour labelling with 1.5 µCi (55.5 kBq) [3H]-
adenine per well. Agonist concentrations
used were 100 nM PTH and 1 µM forskolin.
A Pooled results, n = 3. T-test p-
values compared to DMSO control: PTH
7.88 x 10−2, FSK 3.22 x 10−3
B Same results as A with y-axis altered
to draw attention to PTH results; having
a similar level of cAMP accumulation as
DMSO (basal cellular cAMP), n = 24
C cAMP measurement using an enzyme
immunoassay (ELISA) kit to ensure results
were independent of method of cAMP
measurement used, n = 4. T-test p-
values compared to DMSO control: PTH
3.40 x 10−1, FSK 9.92 x 10−4
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an unknown part of signalling machinery. This is in accordance with previous papers which have
shown that these cells required additions to the culture media in order to maintain OK cell hormone
sensitivity (Armston & Wood, 1994). Further negative results with cells bought from ATCC R© are
less easy to explain. One possibility is that trypsinising cells between passages may have damaged
the hormone receptor, although this is unlikely as HEKPR1 PTH receptors would be expected to be
similarly affected. A repeated assay was carried out on cells reaching confluence in 7 days opposed
to 3-4 to increase cell recovery and mirror the growth times documented in several papers (Pollock
et al., 1986; Caverzasio et al., 1986; Cole et al., 1987, 1989; Armston & Wood, 1994). Results from
this were again negative, with no cAMP accumulated in response to PTH, as were results using the
increased sensitivity provided by the Biotrak ELISA and from samples of the media itself, ruling
out the possibility that these cells were secreting any cAMP produced.
Further experimentation to establish why these cells did not respond to PTH could have included
immunofluorescence or western blots to establish whether the PTH receptor was being expressed
in each batch of cells, but with no downstream appearance of cAMP this was deemed too time
consuming. It is possible that cells from each source exhibited different sensitivities to the hormone
or that the PTH receptor was being internalised via receptor-mediated endocytosis (Teitelbaum &
Strewler, 1984). It has previously been shown by Cole et al. that OK cell subline populations
can exhibit different PTH and forskolin effects on phosphate transport, with the OK cell line
‘morphologically and functionally heterogeneous’ (Cole et al., 1989). In fact, within the same Cole
et al. paper 125I-PTH receptor binding experiments show non-uniform receptor affinity across these
different clonal lines. In further agreement, Armston and Wood also had difficulty maintaining the
OK cell PTH response, which they claim to be ‘variable’ from batch to batch, despite attempts to
control it through constant feeding, sub-culturing, seeding cells at a constant density and altering
growth media constituents (Armston & Wood, 1994). The long term nature of the OK cell culture
is likely to be responsible for some of the heterogeneity due to the accumulation of spontaneous
transformants (Cole et al., 1989), particularly as it has been noted that ‘the inablility to maintain
hormone-sensitive trans-epithelial transport activity in cultured cells is the major obstacle to the
detailed analysis of epithelial transport function in vitro’ (Valentich, 1986). Despite these initial
obstacles, once a PTH responsive cell line was obtained, these cells provided a useful physiological
model for the desired thesis aims.
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Experimental repetition proved useful in determining optimal assay conditions. OK cells produce
optimal cAMP responses at one-day post confluence and after overnight starvation in the presence
of serum-free media supplemented with 0.2% BSA. This starvation step alone lead to a 35% increase
in total cell adenine labelling. Through numerous experiments, radio-labelling conditions were set
to contain 0.75 µCi (27.75 kBq) [3H]-adenine per well, with 2 hours labelling time, in preference to
longer exposure or higher tritium concentrations. Labelling also required the use of serum free media
to both enable media gassing without excess bubble formation and to prevent serum inhibition of
the PTH response as noted by Goldring et al. (Goldring et al., 1978). In addition, 10 minute agonist
exposure proved best, opposed to longer assay incubations, a time-frame that matches the amount
of time for cAMP levels to increase in rat urine following PTH injection (Chase & Aurbach, 1967)
and follows observations by Teitelbaum et al. and Malmstrom et al. that intracelluar cAMP reached
maximum 2-5 minutes after agonist addition, (Teitelbaum & Strewler, 1984; Malmstrom & Murer,
1986) and remained elevated as long as PTH was in contact with cells (Malmstrom & Murer, 1986).
Finally, care was further taken to optimise the pre-incubation step for these assays, which was set
to 30 minutes allowing both inhibitor penetration and transient pHi change and recovery to occur,
in accordance with results presented in Section 3.3.
3.2.2 HEKPR1 cells
Both OK and HEK 293 renal cell lines are purportedly derived from the proximal tubule of the
kidney; the area naturally responsive to PTH, and were therefore used in combination to demonstrate
that any findings were not species specific. According to most publications (except Jobert et al.
(Jobert et al., 1997)) parent HEK 293 cells have lost their natural ability to respond to PTH resulting
from their time in culture. This is due to an absence of the PTH receptor (Behar et al., 1996; Jobert
et al., 1997). Wild type HEK 293 were thus transfected to contain the complete coding sequence
for human parathyroid hormone receptor one (-PR1) using expression vector pRezex-2, enabling the
desired hormonal response to PTH for at least 40 passages (Short & Taylor, 2000). However, due to
this transfection requirement, although useful as a comparision, HEKPR1 cells could not be used to
produce physiologically relevant data. In addition to this, the HEKPR1 parent line, HEK 293, is now
under increasing scrutiny as to its true origin, especially as it is has proven difficult to characterise
these cells post adenovirus transformation (Graham et al., 1977). This difficulty occurs not only as a
result of viral transformation itself (Graham et al., 1977), but also due to the developing embryonic
102
nature of the tissue originally sampled, which would have contained cells of numerous lineages, as
well as the variable polypeptide expression already noted in the original paper creating the line
(Graham et al., 1977). In addition, due to the segmental heterogeneity of the kidney, isolating cells
and creating any renal cell line of a specific lineage at all is a major problem in the field (Armston
& Wood, 1994). In fact, there is convincing evidence to suggest that HEK 293 cells are of neuronal
origin, expressing a number of neuronal specific mRNA and gene products (Shaw et al., 2002);
further reason for repetition of results in OK cells.
3.2.3 UMR-106 cells
To provide confirmation of a general CO2 elicited response, UMR-106 cells (Partridge et al., 1980),
also responsive to PTH, were used to show that results were neither species nor tissue specific, as
UMR-106 are of osteoblast lineage opposed to kidney. Bone is an important PTH responsive organ,
where osteoblasts (fully differentiated bone cells embedded in the extra-cellular matrix) react to
the hormone through a variety of different mechanisms. These include cAMP production (Chase &
Aurbach, 1970) which results in the release of minerals from the bone, causing another bone cell type,
osteoclasts, to be indirectly stimulated to destroy and re-absorb osteoblasts (Forrest et al., 1985).
UMR-106 cells (Partridge et al., 1980) are rat derived osteosarcoma cells which have been repeatedly
proven as valuable model systems for studying the effects of PTH on bone cells (Forrest et al., 1985)
via ACs and cAMP (Partridge et al., 1981, 1980) and therefore provide a useful comparative tool.
3.2.4 cAMP Agonist Responses in Experimental Cell Lines
A primary objective was to ensure that all cell lines were responsive to the agonists PTH and FSK.
Figure 18 displays cAMP accumulation in response to negative control DMSO, PTH, and a FSK
positive control in OK, HEKPR1 and UMR-106 cells. Data is presented as normalised values of
[3H]-cAMP compared to total cell labelling, as explained in Section 2.4.6.
103
Figure 18: cAMP accumulation agonist
responses in OK, HEKPR1 and UMR-106
cell lines.
Agonist response at 5% CO2 (v/v), pH 7.0,
concentrations of agonist used were 100 nM
PTH and 10 µM FSK. DMSO used as a
negative control.
A: OK cells, n = 8, T-test p-values:
1.33 x 10−10 and 1.37 x 10−6 for PTH and
FSK compared to the control respectively;
B: HEKPR1 cells, n = 8, T-test p-values:
1.31 x 10−8 and 6.43 x 10−5 for PTH and
FSK compared to the control respectively;
C: UMR-106 cells, n = 4, T-test p-values:
4.76 x 10−7 and 5.61 x 10−5 for PTH and FSK
compared to the control respectively;
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3.3 Intracellular pH Control Experiments
3.3.1 Transient Intracellular pH Changes with Different Capnic States
Prior to any cAMP accumulation assays with varying CO2, it was important to ensure that assaying
cells in the presence of different CO2 concentrations had an effect on solely the intracellular pCO2
and not pH. This is particularly important as pH has a pronounced effect on adenylyl cyclase activity
(Hammes & Rodbell, 1976) and therefore, if not tightly controlled, could lead to erroneous results.
Previously published data by Townsend et al. showed that HEK 293 cells undergo a transient
pHi change on exposure to different CO2 concentrations. To establish whether OK and HEKPR1
cells would respond similarly, a microspectrofluorometric device was employed to measure pHi with
alteration of pCO2 in a perfused media. The premise of this experiment is that if pHi were to
recover from a change in pCO2 within a suitable time-frame, any cAMP measurements taken after
this period could be inferred to be influenced solely by the CO2 and not pH.
Intracellular pH measurement followed the method in Section 2.4.1, after optimisation. Each cell
line required different labelling conditions, 7.5 µM BCECF-AM (Rink et al., 1982) for OK cells and
5 µM for HEKPR1. Also, to enable cells to adequately recover from the different CO2 concentrations,
loading required the use of a pre-warmed, pre-gassed solution maintained at 37 ◦C and 5% CO2 (v/v).
If cells were left to load on the bench CO2 was lost from the loading medium and thus its pH allowed
to increase, the cells ability to recover from further changes was compromised. As a result of this
observation, the initial loading solution of PBS and glucose was supplemented with 14 mM NaHCO3
to facilitate solution gassing. Through these experiments and frequent measurements of the bubbled
perfusate, it was deemed that concentrations of 14 mM NaHCO3 and 15 mM HEPES were sufficient
to buffer the media for these periods of CO2 gassing, although an increase to 20 mM HEPES was
implemented in the Krebs-Ringer-HEPES solutions used in ammonium pulse experiments detailed
in Chapter 5 due to the extended time period of experimentation.
Both cell lines experience transient pHi changes on exposure to different CO2 concentrations, with
an acidification occuring as CO2 is increased, as shown in Figure 19. These graphs demonstrate that
cells recover to a resting pH of 7.05 for OK cells and 7.21 for HEKPR1 cells, as calculated by nigericin
calibration (Appendix 7.1). For example, with HEKPR1 cells when moving from a normocapnic (5%
CO2 [v/v]) to a hypercapnic (10% CO2 [v/v]) solution at time point 3583 s an initial acidification
event of 0.25 pH units occurs which recovers in under 10 minutes (here around 8 minutes 40 seconds).
Recovery time, on average, is around 10 minutes for both cell lines, with a maximum recovery period
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Figure 19: Intracellular pH in response to different CO2 concentrations. Experimentation using PBS
solution at pH 7.35 and DMEM CO2 containing solutions adjusted to pH 7.0 Dashed vertical lines
represent solution changes. Top: OK cells; Bottom: HEKPR1 cells.
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of 15 minutes. This fact was implemented when designing cAMP accumulation assays where a pre-
incubation step of 30 minutes was employed, allowing cells to respond to the influx of CO2 and
recover their pH before agonist addition, in addition to facilitating inhibitor cell permeation.
3.3.2 Mimicking CO2 Induced pHi Changes with Propanoic Acid
As shown in Section 3.3.1 both cell lines recover from a change in pCO2, with average recovery
around 10 minutes. However, their pHi does change, with average ∆pHi values of 0.65 ± 3.50 x10−2
and 0.28 ± 4.79 x10−2 for OK and HEKPR1 cells respectively when considering the 5% to 10%
CO2 (v/v) shift. Although this change recovers in a matter of minutes, in the physiological time-
frame this could still be long enough for the cells, or a cellular constituent, to respond. In order
to eliminate pH as a experimental factor, the weak acid propanoic acid (PA) was implemented to
mimic the transient pHi acid change experienced from 5% to 10% CO2 (v/v), without altering CO2
in any way, as previously published by Willoughby et al. (Willoughby et al., 2005).
In order to calculate the correct concentration of PA to use, cells were perfused (and then left to
recover) with normal 5% CO2 media containing different PA concentrations, ranging from 1 mM
to 10 mM, as shown in Figure 20. From these experiments 2 mM was chosen as the correct PA
concentration to mimic both cell lines 5% to 10% (v/v) CO2 induced pHi change, giving average
∆pHi values of 0.64 ± 2.42 x10−2 and 0.36 ± 3.29 x10−2 OK and HEKPR1 cells respectively.
Representative graphs of these pHi changes for both the CO2 and PA experiments are presented in
Figure 21.
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Figure 20: Intracellular pH in response to propanoic acid concentrations. Experimentation using
DMEM CO2 containing solutions adjusted to pH 7.4. Dashed vertical lines represent solution
changes. Top: OK cells; Bottom: HEKPR1 cells.
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Figure 21: Transient pHi changes relevant for future experimentation. A: OK cells, 5% (v/v) to
10% (v/v) CO2 B: OK cells, 5% (v/v) CO2 to 5% (v/v) CO2 and 2 mM PA. C: HEKPR1 cells,
5% (v/v) to 10% (v/v) CO2 D: HEKPR1 cells, 5% (v/v) CO2 to 5% (v/v) CO2 and 2 mM PA
Figure 22: OK and HEKPR1 cells PTH dose responses. PTH sigmoidal dose-response at 5% CO2
and defined pH, PTH in aqueous solution. A: OK cells, pH 7.0 (physiological acidosis), n = 7/8,
EC50 = 1.09 x 10
−8, R2 value = 0.7498 B: OK cells, pH 7.5 (physiological alkalosis), n = 7/8, EC50
= 9.83 x 10−9, R2 value = 0.8205 C: HEKPR1 cells, pH 7.0, n = 7/8, EC50 = 2.55 x 10−9, R2 value
= 0.7537 D: HEKPR1 cells, pH 7.5, n = 7/8, EC50 = 2.60 x 10
−9, R2 value = 0.8785
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3.4 PTH Dose-Response at pH levels 7.0 and 7.5
Dose responses for PTH stimulated cAMP production were characterised at both pH 7.0 and 7.5 to
model the physiological acidotic and alkalotic conditions typical of systemic hyper- and hypocapnia
respectively (Marshall & Bangert, 2008), to determine whether pH had an effect of the efficacy of
the hormone (Figure 22). PTH concentrations between 10 pM and 1 µM were implemented with
the lowest recordable response at 100 pM. Although these values are higher than the circulating
serum concentration of 1 pM (Chambers et al., 1978; Allgrove et al., 1983) the dose responses for
OK cells match those published (Teitelbaum & Strewler, 1984; Malmstrom & Murer, 1986; Armston
& Wood, 1994) and this repeatable difference between experimentally determined EC50 values and
the much lower serum concentrations has been noted previously by Cole et al. (Cole et al., 1987).
Within each cell line there were no significant EC50 differences between the two pH values. Extra-
cellular pH therefore does not have an effect on PTH efficacy and downstream AC activation and
cAMP production. As CO2 concentration and pH are intrinsically linked this result demonstrates
that any alterations in PTH stimulated cAMP production with varied CO2 will not result from any
pH fluctuations on the PTH signalling response. From the dose responses it was decided to use 5 nM
PTH in future cAMP accumulation experiments for both cell lines. This concentration was deemed
appropriate as it should give a clear and measurable result with lower cAMP concentrations still
detectable, whilst still allowing the system to be stimulated further if required.
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3.5 cAMP Accumulation with Differing CO2 Concentrations
Accumulated cAMP levels were measured in cells exposed to different capnic conditions using 2.5%,
5% and 10% (v/v) CO2 in air to model hypo-, normo- and hypercapnia respectively (Marshall
& Bangert, 2008). Methodology was altered accordingly to ensure that any pHi changes induced
in cells with exposure to a different level of CO2 to that of their culture (5% [v/v] CO2) would
experience the transient pHi change shown in Section 3.3.1 and recover before cAMP levels were
measured. Experiments used both the agonists PTH and FSK to answer whether the method of AC
stimulation affected the result. In addition, both extracellular pH values of 7.0 and 7.5 were tested,
to mimic the typical pH levels experienced by the cells during acidosis or alkalosis respectively and
repeated across both OK and HEKPR1 cells.
As can be seen in Figures 23 and 24 for both PTH and FSK, 2.5% and 5% (v/v) CO2 solutions elicit
similar responses, whilst there is a drop in cAMP production at 10% (v/v) CO2. For comparison
between data sets tritiated adenine derived ratios ([3H]-cAMP/ Total [3H] adenine nucleotides) are
displayed as percentages of the normocapnic (5%) agonist induced value. Negative control data has
also been included for comparison, using the agonist solvents H2O or DMSO for PTH and FSK
respectively. Table 8 displays statistical two-way ANOVA (with post hoc Bonferroni) testing of
these data sets to show that this trend is statistically significant. Tabulated results are calculated as
a percentage of the normocapnic (5%) agonist induced values to match graphically presented data.
Similar statistical analysis for raw data also show the same trend (not shown). Importantly, negative
control data does not follow this trend, implying the effect of CO2 is solely on the agonist activated
AC, although it is possible that the experimental method employed was not sensitive enough to
distinguish between these basal cAMP levels.
This trend is independent of the mode of AC activation with both PTH and FSK giving identical
results, suggesting that the CO2 sensor is either directly at the AC or interacting closely with the
enzyme and is not part of the upstream signalling pathway from the PTH receptor. Additionally,
it is not species/cell line specific as appears across OK and HEKPR1 cell lines and, crucially, is
pH independent. This latter conclusion is drawn from that fact that changing the extracellular pH
from pH 7.0 to 7.5 maintained the drop in cAMP levels at 10% (v/v) CO2, in conjunction with
the established fact that these cell lines will experience a transient pH change with exposure to
the different CO2 levels which quickly recovers before the time at which cAMP measurements are
made. Nevertheless, as mentioned in Section 3.3.2, despite this speedy recovery it is possible that
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Figure 23: OK PTH and FSK responses at 2.5%, 5% and 10% (v/v) CO2. Agonist concentrations
of 5 nM PTH and 10 µM FSK, agonist solvents H2O and DMSO respectively as negative controls.
Results shown as a percentage of the 5% CO2 value. A: PTH activation at pH 7.0, n = 8 B: FSK
activation at pH 7.0, n = 8 C: PTH at pH 7.5, n = 8 D: FSK at pH 7.5, n = 8
Figure 24: HEKPR1 PTH and FSK responses at 2.5%, 5% and 10% (v/v) CO2. Agonist
concentrations of 5 nM PTH and 10 µM FSK, agonist solvents H2O and DMSO respectively as
negative controls. Results shown as a percentage of the 5% CO2 value. A: PTH activation at pH
7.0, n = 5/6 B: FSK activation at pH 7.0, n = 6 C: PTH at pH 7.5, n = 5/6 D: FSK at pH 7.5, n
= 6
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Comparison
Negative Control (H2O/DMSO) Agonist(PTH/FSK)
Difference P value Difference P value
OK pH 7.0 PTH
2.5% vs 5% 0.978 P ≥ 0.05 19.56 P ≤ 0.05
2.5% vs 10% 4.645 P ≥ 0.05 -19.32 P ≤ 0.05
5% vs 10% 3.667 P ≥ 0.05 -38.88 P ≤ 0.001
OK pH 7.0 FSK
2.5% vs 5% -6.218 P ≥ 0.05 -11.92 P ≥ 0.05
2.5% vs 10% -11.92 P ≥ 0.05 -42.29 P ≤ 0.001
5% vs 10% -5.699 P ≥ 0.05 -30.57 P ≤ 0.001
OK pH 7.5 PTH
2.5% vs 5% 0.054 P ≥ 0.05 1.163 P ≥ 0.05
2.5% vs 10% 1.163 P ≥ 0.05 -18.60 P ≤ 0.001
5% vs 10% 1.109 P ≥ 0.05 -19.77 P ≤ 0.001
OK pH 7.5 FSK
2.5% vs 5% -0.4566 P ≥ 0.05 6.589 P ≥ 0.05
2.5% vs 10% -0.4500 P ≥ 0.05 -20.81 P ≤ 0.001
5% vs 10% 0.0066 P ≥ 0.05 -27.40 P ≤ 0.001
HEKPR1 pH 7.0 PTH
2.5% vs 5% 0.3636 P ≥ 0.05 12.55 P ≥ 0.05
2.5% vs 10% 0.3546 P ≥ 0.05 -25.09 P ≤ 0.001
5% vs 10% -0.0121 P ≥ 0.05 -37.64 P ≤ 0.001
HEKPR1 pH 7.0 FSK
2.5% vs 5% -2.946 P ≥ 0.05 -5.260 P ≥ 0.05
2.5% vs 10% 2.820 P ≥ 0.05 -58.99 P ≤ 0.001
5% vs 10% 0.1260 P ≥ 0.05 -53.73 P ≤ 0.001
HEKPR1 pH 7.5 PTH
2.5% vs 5% -4.768 P ≥ 0.05 9.407 P ≥ 0.05
2.5% vs 10% -5.799 P ≥ 0.05 -36.98 P ≤ 0.001
5% vs 10% -1.031 P ≥ 0.05 -46.39 P ≤ 0.001
HEKPR1 pH 7.5 FSK
2.5% vs 5% -5.195 P ≥ 0.05 5.195 P ≥ 0.05
2.5% vs 10% -3.896 P ≥ 0.05 -29.22 P ≤ 0.001
5% vs 10% 1.299 P ≥ 0.05 -34.42 P ≤ 0.001
Table 8: Statistical analysis of cAMP capnic response: Two-way ANOVA analysis with post hoc
Boniferroni testing
this change in pH may have been long enough for the cells, or a cellular constituent, to respond in
some way. This problem is addressed in Section 3.7.
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3.6 UMR-106 Cell cAMP Accumulation at Differing CO2 Concentrations
Section 3.5 demonstrated an in cellulo inhibitory effect of hypercapnia (modelled using 10% (v/v)
CO2) on cAMP accumulation, unreliant on species origin, method of AC activation or extracellular
pH. Whilst the data presented using OK and HEKPR1 cells suggests that the effect is true for
both Didelphis virginiana and Homo sapiens, both cell lines are of renal origin. PTH is not only
active in the kidney; it also causes bone breakdown and re-absorption to release stored calcium and
phosphate ions (Forrest et al., 1985). This section demonstrates the inhibiton of cAMP accumulation
at elevated CO2 in another species (Rattus norvegicus) using UMR-106 cells (Partridge et al., 1980),
a rat osteosarcoma cell line known to respond to PTH through the production of cAMP (Partridge
et al., 1980, 1981) and thus demonstrates similar responses across both organ lineages. As shown in
Figure 25 hypo- and normocapnic levels of CO2 (2.5% (v/v) and 5% (v/v)) exhibit similar cAMP
levels with a decrease across the board at hypercapnic 10% (v/v) CO2. Again this trend is present for
both extracellular media pH levels of 7.0 and 7.5, indicating that extracelluar pH is not a determining
factor, and independent of mode of AC stimulation with identical trends with both PTH and FSK.
Statistical ANOVA evidence is presented in Table 9, again showing that only the agonist activated
AC is affected by CO2, as noted in Section 3.5.
Comparison
Negative Control (H2O/DMSO) Agonist(PTH/FSK)
Difference P value Difference P value
UMR-106 pH 7.0 PTH
2.5% vs 5% 0.1104 P ≥ 0.05 -9.713 P ≥ 0.05
2.5% vs 10% 1.656 P ≥ 0.05 -61.26 P ≤ 0.001
5% vs 10% 1.545 P ≥ 0.05 -51.55 P ≤ 0.001
UMR-106 pH 7.0 FSK
2.5% vs 5% -3.430 P ≥ 0.05 -9.675 P ≥ 0.05
2.5% vs 10% -3.782 P ≥ 0.05 -54.62 P ≤ 0.001
5% vs 10% -0.351 P ≥ 0.05 -44.94 P ≤ 0.001
UMR-106 pH 7.5 PTH
2.5% vs 5% -1.846 P ≥ 0.05 8.795 P ≥ 0.05
2.5% vs 10% -5.103 P ≥ 0.05 -37.68 P ≤ 0.001
5% vs 10% -3.257 P ≥ 0.05 -46.47 P ≤ 0.001
UMR-106 pH 7.5 FSK
2.5% vs 5% -0.1992 P ≥ 0.05 -16.33 P ≤ 0.05
2.5% vs 10% -0.3984 P ≥ 0.05 -55.68 P ≤ 0.001
5% vs 10% -0.1992 P ≥ 0.05 -39.34 P ≤ 0.001
Table 9: Statistical analysis of UMR-106 cAMP capnic response: ANOVA analysis with post hoc
Bonferroni testing
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Figure 25: UMR-106 PTH and FSK responses at 2.5%, 5% and 10% (v/v) CO2. Agonist
concentrations of 5 nM PTH and 10 µM FSK, agonist solvents H2O and DMSO respectively as
negative controls. Results shown as a percentage of the 5% (v/v) CO2 value. A: PTH activation at
pH 7.0, n = 8 B: FSK activation at pH 7.0, n = 8 C: PTH at pH 7.5, n = 8 D: FSK at pH 7.5, n
= 8
Figure 26: Effect of acidosis on cAMP accumulation. 10 µM FSK agonist with 2 mM propanoic
acid (PA) used to mimic the transient pH change associated with 10% (v/v) CO2. Results shown
as a percentage of the 5% (v/v) CO2 FSK value, with error bars generated from across individual
experimental replicates. A: OK cells, pH 7.5, n = 6 B: HEKPR1 cells, pH 7.5, n = 7
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3.7 pH Independent Effect of Hypercapnia on cAMP Accumulation
Sections 3.5 and 3.6 demonstrate that hypercapnia induces a potentially pH-independent inhibition
in cAMP accumulation, based on the fact that alteration of extracellular pH from 7.0 to 7.5 had
no effect on the observed reduction in cAMP levels at 10% (v/v) CO2, and that increased CO2
administration causes only a transient intracellular pH change which should recover before cAMP
accumulation measurements are made (Section 3.3). In order to eliminate pH completely, the pHi
change associated with 5% (v/v) CO2 was mimicked using 2 mM propanoic acid (Section 3.3.2).
Propanoic acid was also introduced to cells at 10% (v/v) CO2 to establish whether the propanoate
ion or its related intracellular pH change, in addition to that ellicited by the higher concentration
of CO2, would affect the observed hypercapnic effect on cAMP accumulation. As extracellular pH
had no effect on previous cAMP accumulation experiments, these experiments were carried out at
pH 7.5.
It should be noted that a similar weak base was not introduced to mimic the pHi change experienced
with 2.5% (v/v) CO2 as this hypocapnic CO2 concentration was dropped from later experiments
in order to focus on the effects on cAMP accumulation observed at 10% (v/v) CO2. Hypercapnic
acidosis is of arguably greater clinical interest, having contrasting positive and negative implications
on pathophysiological prognosis (Section 1.7), further justifying this focus.
Results displayed in Figure 26 show that 5% (v/v) CO2 with 2 mM propanoic acid did not cause
the drop in cAMP associated with 10% (v/v) CO2, with no statistical difference between 5% (v/v)
CO2 and 5% with the acid (Table 10). This was found for both renal cell lines, HEKPR1 and OK,
and the inhibition of cAMP accumulation with hypercapnia can therefore be viewed reliably as a
pH independent phenomena. In addition to this, it is also worth noting that it has previously been
demonstrated that G-protein regulated ACs are offered some protection from changes in pHi through
the action of Na+/H+ antiporters (Willoughby et al., 2005), further justifying this conclusion. The
introduction of PA to cells at 10% (v/v) CO2 also had no statistical effect on the observed decrease
in cAMP levels, further validating the usage of this acid as a control (Figure 26 and Table 10).
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Comparison
FSK Agonist
Difference P value
OK pH 7.5
5% vs 5% + 2mM PA 3.078 P ≥ 0.05
5% vs 10% -16.77 P ≤ 0.05
5% + 2 mM PA vs 10% + 2mM PA -17.75 P ≤ 0.05
10% vs 10% + 2mM PA 2.097 P ≥ 0.05
HEKPR1 pH 7.5
5% vs 5% + 2mM PA 3.952 P ≥ 0.05
5% vs 10% -19.91 P ≤ 0.05
5% + 2 mM PA vs 10% + 2mM PA -24.70 P ≤ 0.01
10% vs 10% + 2mM PA -0.831 P ≥ 0.05
Table 10: Statistical analysis of the effect of PA: ANOVA analysis with post hoc Bonferroni testing.
CO2 percentages presented as v/v.
Figure 27: Effect of O2 on cAMP accumulation in HEKPR1 cells at pH 7.5. 10 µM FSK used
with FSK solvent DMSO used as a negative control. 5% CO2, 18% O2, 77% N2 (v/v) used to
mimic the alteration of O2 experienced by cells exposed to 10% compared to 5% (v/v) CO2 in air.
Results shown as a percentage of the 5% CO2 value, with error bars generated from across individual
experimental replicates, n =4
Comparison
Negative Control - DMSO FSK Agonist
Difference P value Difference P value
HEKPR1 pH 7.5
5% CO2 vs 5% CO2, 18% O2, 77% N2 0.005 P ≥ 0.05 7.733 P ≥ 0.05
5% CO2 vs 10% CO2 0.4225 P ≥ 0.05 -11.340 P ≤ 0.05
5% CO2, 18% O2, 77% N2 vs 10% CO2 0.417 P ≥ 0.05 -19.07 P ≤ 0.001
Table 11: Statistical analysis of the effect of O2: ANOVA analysis with post hoc Bonferroni testing.
CO2 percentages presented as v/v.
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3.8 Hypercapnic Effect on cAMP Accumulation Independent of Hypoxia
In order to expose cells to different capnic conditions, solutions have been gased using mixtures of
CO2 in air (2.5, 5, 10% (v/v)). As the percentage of CO2 is altered between mixtures, so too must be
the relative percentage of air present and thus the oxygen content. Therefore, based on the premise
that air contains 20.95% (v/v) O2, under these conditions cells at 5% (v/v) CO2 will experience
19.90% (v/v) O2 and cells at 10% (v/v) CO2, 18.85% (v/v) O2. This discrepancy, although minor,
could explain the observed differences between 5% and 10% CO2 (v/v), especially due to evidence in
the literature that down-regulation of the cAMP signalling systems may be a mechanism by which
cells adapt to long-term hypoxia (Beitner-Johnson et al., 1998). To test for this, HEKPR1 cells were
exposed to a gaseous mixture of 5% CO2, 18% O2, 77% N2 (v/v) and compared to cells exposed to
5% and 10% CO2 (v/v) in air. The results displayed in Figure 27 and Table 11 demonstrate that
under these conditions, whilst the expected drop in cAMP accumulation from 5% to 10% CO2 in
air is present, this phenomenon does not occur with the 5% CO2, 18% O2, 77% N2 (v/v) mixture.
Thus it can be inferred that the effect of 10% (v/v) CO2 on cAMP accumulation occurs as a result
of CO2 and not O2.
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3.9 Chapter Conclusions
This chapter provides evidence for a pH independent inhibition of cAMP production by AC during
hypercapnia (Figure 28). Alteration of extracellular pH had no effect on this blunted response
or on normocapnic PTH induced cAMP production, with no change in EC50 values. Thus, any
potential media pH changes associated with altering the CO2 concentration are not responsible
for the observed trends. In addition, transient pHi changes experienced by cells with exposure to
elevated CO2 were measured and mimicked using weak acid 2 mM propanoic acid. Use of this acid
in the absence of simultaneously elevated CO2 had no effect on cAMP production, suggesting that
the blunted cAMP levels observed are due to CO2 and not any changes in pHi. Together these
results infer a pH independent effect on AC mediated cAMP production.
This inhibition of AC with elevated CO2 was also true regardless of the agonist employed, with the
same trend present for both PTH and FSK, indicating that the inhibitory effect of CO2 does not
occur upstream of AC and is independent of the AC isoform (PTH couples specifically to AC VI in
HEKPR1 cells (Tovey et al., 2008) whilst FSK activates all tmAC isoforms (Zhang et al., 1997)).
Results displayed include evidence from three cell lines: HEKPR1, OK and UMR-106; suggesting a
species and tissue independent effect.
Hypocapnia, modelled by 2.5% (v/v) CO2 in air, did not inhibit AC and cAMP production but
instead resulted in cAMP levels statistically similar to that of normocapnia (5% (v/v) CO2 in
air). This hypocapnic CO2 concentration has been henceforth abandoned in order to focus on the
effects of elevated CO2, which both gave a clear effect on cAMP accumulation and is of arguably
more clinical interest, having contrasting postive and negative implications on pathophysiological
prognosis (Section 1.7). The benefits of therapeutically administed permissive hypercapnia have in
part been attributed to inhibition of alveolar fluid reabsorption via a cAMP mediated mechanism
(Vada´sz et al., 2008b). Thus, the hypercapnic attenuation of cAMP signalling demonstrated in this
chapter could provide a link to the physiological effects observed with elevated CO2. Further work to
delinearise the contributing signalling pathways in this hypercapnic effect on AC, as well as evidence
for its physiological implications, are presented in the following chapters.
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Figure 28: Chapter 3 overview of signalling events at normal and elevated CO2. Normal CO2: PTH
activation of the AC signalling complex increases cAMP levels. Elevated CO2: CO2 blunts the PTH
activation of AC leading to a reduction in cAMP production.
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4 Chapter 4: Ca2+ Ion Requirement in the Inhibition of
cAMP Production at Elevated CO2
4.1 Introduction
Chapter 3 presented evidence for a pH independent inhibition of cAMP production under hyper-
capnic conditions. This trend is true for multiple cell lines (HEKPR1, OK and UMR-106), making
it potentially common across species and tissue types, and is independent of the mechanism of AC
activation: present with both PTH and FSK agonists. This latter fact not only suggests that the
hypercapnic mechanism is independent of the AC isoform (PTH couples specifically to AC VI in
HEKPR1 cells (Tovey et al., 2008) whilst FSK activates all tmAC isoforms (Zhang et al., 1997)),
but also that CO2 is not interacting with a protein upstream from the AC.
This chapter is concerned with investigating the hypercapnic phenomena in more depth, elucidating
whether any of the known AC interacting signalling pathways are involved in generating the observed
inhibition of cAMP generation. To do this, cAMP accumulation assays were repeated with a range
of pharmacological antagonists (including inhibitors and chelators) to eliminate possible intervening
pathways. Verification of a component’s involvement was based on the assumption that its inhibition
would remove the CO2 constraint on AC, i.e. giving similar cAMP levels at 10% CO2 (v/v) to that
at 5% CO2 (v/v). As will be shown in Section 4.3, this assumption held true for BAPTA-AM,
implying that intracellular calcium ions are required to inhibit AC at elevated CO2.
Futher antagonist assays led to the conclusion that these calcium ions were released from the ER via
the IP3 receptor. Due to the relative non-specificity of pharmacological antagonists, this conclusion
was further examined using a genetic approach with two DT40 cell lines (chicken B lymphoblasts).
These cells were also used to demonstrate CO2 dependent Ca
2+ release, independent of intracellular
pH. Together these results demonstrate a blunted cAMP response to agonist activation at elevated
CO2, which is both pH independent and reliant on Ca
2+ release from IP3 receptors.
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4.2 Cell Lines Used in Experimentation
Throughout this chapter the renal derived lines OK and HEKPR1 (Section 3.2) are primarily used.
Three further lines are implemented, A549 (human alveolar epithelial cells (Giard et al., 1973))
and two DT40 lineages: DT40-K/O (Sugawara et al., 1997) and DT40-IP3 R1 (Laude et al., 2005).
Descriptions of these cells and information regarding their usage can be found in the following
sections.
4.2.1 A549 cells
The A549 cell line (Giard et al., 1973) was initiated from a human alveolar adenocarcinoma and has
been identified as a type II alveolar epithelial cell line (Lieber et al., 1976). Culture of these cells is
straightforward and their growth rate high, therefore they were implemented as a useful non-PTH
sensitive cell to confirm the capnic effect on AC/cAMP and its requirement for Ca2+ ions. The
data from these cells infers the presence of a more general hypercapnic trend across cell lineages,
independent of the PTH signalling pathway.
4.2.2 DT40 cells
DT40 cells are B lymphoblasts harvested from a Hyline SC chicken bursal lymphoma induced by
the avian leukosis virus (Baba et al., 1985). These cells were used to provide genetic evidence for a
role for calcium release from IP3 receptors in the AC response to elevated CO2 (Section 4.6). Two
lineages were used: DT40-K/O (Sugawara et al., 1997) and DT40-IP3R1 (Laude et al., 2005), both
cell lines manipulated with respect to their IP3 receptors. DT40-K/O cells have both alleles for all
three of the IP3 receptor genes disrupted by sequential homologous recombination within the region
that encodes the transmembrane domain and thus produce no detectable transcripts or translation
products from the IP3R genes, nor do they exhibit any IP3 sensitive stores (Sugawara et al., 1997).
Using these cells to investigate a contribition of Ca2+ ions from an IP3 receptor controlled store is
particularly useful as the absence of any IP3R genes provides a null background for IP3 production
(Tovey et al., 2006). DT40-IP3R1 cells are DT40-K/O cells with the rat gene for IP3 receptor 1
re-introduced by transfection (Laude et al., 2005). Due to the functional redundancy of the IP3
receptor isoforms, even if only one isoform is present the cells behave as normal with all IP3 related
signalling events returning (Sugawara et al., 1997), thus giving these cells their value. As will be
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explained in Section 4.6, CO2 induced inhibition of cAMP production was abolished with DT40-K/O
cells and returned with DT40-IP3R1 cells. This result provides genetic proof for the requirement of
IP3R derived Ca
2+ ions in this phenomenon.
4.2.3 cAMP Agonist Responses in A549 and DT40 Cell Lines
All cell lines were tested for a cAMP response to agonist. As all of these lines are insensitive to
PTH, only 10 µM FSK was implemented. Figure 29 displays cAMP accumulation in each line in
response to both a DMSO negative control and FSK. Data for A549 cells is presented as normalised
values of [3H]-cAMP compared to total cell labelling (Section 2.4.6). DT40 cells required use of
an ELISA due to complications with suspension cells clogging the chromatography columns usually
used. Thus, values are presented as the sample cAMP concentration normalised to protein content
(as calculated through use of a Bradford assay, see Section 2.6.2 and Appendix 7.2). P-values were
calculated via a two-sample T-test. All three cell lines respond to FSK and therefore are suitable
for use in further experiments.
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Figure 29: cAMP accumulation agonist
responses in A549, DT40-K/O and DT40-
IP3R1 cell lines.
Agonist response at 5% CO2 (v/v) and
pH 7.5. Agonist concentration of 10 µM
FSK with DMSO negative control.
A: A549 cells, n = 4/8, P-value 3.19 x 10−9
B: DT40-K/O, n = 6, P-value 1.09 x 10−2
C: DT40-IP3 R1, n = 6, P-value 3.19 x 10
−5
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4.3 The Role of Ca2+ Ions in AC Inhibition at Elevated CO2
4.3.1 HEKPR1 cells
In order to characterise the capnic response, it is important to ascertain whether AC is the site of
CO2 action. Through cAMP accumulation experiments in the presence of various antagonists, other
signalling pathways can be ruled out based on the assumption that if the same trends are found
whist a pathway is inhibited (i.e. a significant reduction in cAMP at 10% [v/v] CO2) then it is
unlikely to be involved. Conversely, production of cAMP levels with 10% (v/v) CO2 similar to the
normocapnic values, would implicate the disrupted cell signalling pathway.
Section 3.5 demonstrated that the mechanism of AC stimulation, by PTH or FSK, made no difference
to the resultant trend. Therefore, all inhibitor assays used 10 µM FSK. This decision simplified
the assayed system as FSK activates the AC enzyme directly, binding via hydrophobic pockets
on its second catalytic domain (Zhang et al., 1997). Use of PTH, known to also stimulate IP3
generation leading to Ca2+ release (Hruska et al., 1987; Pines et al., 1996) would potentially offer
more complicated results. Similarly, as extracellular pH was also unimportant, all experiments were
carried out at pH 7.5. HEKPR1 cells were uniformly used, taking advantage of their fast growth
cycle.
Results for a range of antagonists with HEKPR1 cells are shown in Figure 30 with statistical ANOVA
analysis presented in Table 12. All data is presented as a percentage of the normocapnic (5% [v/v]
CO2) value for each inhibitor. Negative control data, using DMSO addition instead of agonist, has
been omitted for clarity.
Through the retained hypercapnic trends displayed, it can be concluded that the effect of elevated
CO2 on cAMP does not require the activity of cAMP phosphodiesterases (IBMX (Beavo et al.,
1970)), soluble adenylyl cyclase (KH7 (Hess et al., 2005)), cAMP dependent protein kinase A (H-89
(Chijiwa et al., 1990)), carbonic anhydrase (acetazolamide (Maren, 1952)), sphingosine kinases 1
and 2 (SKi (French et al., 2003, 2006)/ROMe (Lim et al., 2011) respectively), calmodulin-dependent
protein kinase II (autocamtide-II (Hanson et al., 1989)) or protein kinase C (staurosporine (Omura
et al., 1977; Tamaoki et al., 1986)/Go¨6983 (Gschwendt et al., 1996)). Finally, through the relative
non-specificity of staurosporine, other kinases might potentially be ruled out, including protein
kinase G, CaM kinase, CDK2-5, GSK-3β, Pim-1 kinase and MLCK (Enzo-Life-Sciences, 2010; Gani
& Engh, 2010) but further experiments would be needed to confirm this.
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Comparison
Agonist(PTH/FSK)
Difference P value
IBMX
2.5% vs 5% -5.260 P ≥ 0.05
2.5% vs 10% -58.99 P ≤ 0.001
5% vs 10% -53.73 P ≤ 0.001
SQ 22, 536
2.5% vs 5% -10.77 P ≥ 0.05
2.5% vs 10% -13.85 P ≥ 0.05
5% vs 10% -3.077 P ≥ 0.05
KH7
2.5% vs 5% –10.50 P ≥ 0.05
2.5% vs 10% -37.02 P ≤ 0.01
5% vs 10% -26.52 P ≤ 0.05
H89
2.5% vs 5% -12.81 P ≥ 0.05
2.5% vs 10% -33.28 P ≤ 0.01
5% vs 10% -20.00 P ≤ 0.05
Acetazolamide
2.5% vs 5% 7.570 P ≥ 0.05
2.5% vs 10% -39.81 P ≤ 0.001
5% vs 10% -27.00 P ≤ 0.05
SKi/ROMe
2.5% vs 5% - -
2.5% vs 10% - -
5% vs 10% -25.14 P ≤ 0.01
Comparison
Agonist(PTH/FSK)
Difference P value
BAPTA-AM
2.5% vs 5% -17.10 P ≥ 0.05
2.5% vs 10% 11.40 P ≥ 0.05
5% vs 10% 28.50 P ≤ 0.05
EGTA
2.5% vs 5% -1.794 P ≥ 0.05
2.5% vs 10% -43.95 P ≤ 0.001
5% vs 10% -42.15 P ≤ 0.001
Autocamtide II
2.5% vs 5% -8.995 P ≥ 0.05
2.5% vs 10% -38.10 P ≤ 0.01
5% vs 10% -29.10 P ≤ 0.01
Staurosporine
2.5% vs 5% -14.72 P ≥ 0.05
2.5% vs 10% -43.19 P ≤ 0.001
5% vs 10% -28.47 P ≤ 0.05
Go¨6983
2.5% vs 5% 6.962 P ≥ 0.05
2.5% vs 10% -35.44 P ≤ 0.01
5% vs 10% -42.41 P ≤ 0.001
Table 12: Statistical analysis of HEKPR1 inhibitor data: two-way ANOVA analysis with post hoc
Boniferroni testing. Percentages of CO2 concentration given as v/v.
Within these conclusions, there are some interesting points to note. First, despite overwhelming
evidence in the literature for Ci stimulation of sAC, this AC isoform did not appear to contribute to
the hypercapnic inhibition observed, whilst the lack of CO2 effect with tmAC inhibitor SQ 22, 536
(Harris et al., 1979) demonstrated the requirement for G-protein activated tmAC. This reflects
growing evidence towards a regulatory role for Ci with tmACs. Use of SQ 22, 536 reduced cAMP
levels, as expected, though this result is deceptive when viewed as a percentage of the 5% (v/v) CO2
value as presented in Figure 30 and can be seen clearly in Figure 31 where each value is normalised
to a 5% (v/v) CO2 IBMX containing control, run simultaneously. SQ 22, 536 addition halved the
level of cAMP accumulated across all CO2 concentrations but did not completely ablate cAMP
production due to incomplete inhibition by the antagonist.
Second, the carbonic anhydrase inhibitor acetazolamide had no effect, demonstrating that there is
no requirement for the CO2 present in the media to be converted to HCO3
− to inhibit the AC (Guo
et al., 2009; Huckstepp et al., 2010a).
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Figure 31: True values for SQ 22, 536 assay. Agonist concentration of 10 µM FSK, pH 7.5, n = 8.
Results shown as a percentage of the 5% (v/v) CO2 IBMX containing sample.
Figure 32: Usage of PDE inhibitor IBMX. Agonist concentration of 10 µM FSK with DMSO negative
control, pH 7.5. A: OK cells, n = 6, B: HEKPR1 cells, n = 6, C: HEKPR1 cells exposed to 5%
and 10% (v/v) CO2 in the presence or absence of IBMX, n = 6. T-tests for cAMP accumulation in
response to different capnic states: No IBMX = 0.0221, IBMX = 0.0385, D: Data presented in C
with y-axis enlarged to highlight cAMP levels in the absence of IBMX.
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Of note are the data from the two Ca2+ chelators EGTA and BAPTA-AM. Whilst the extracellular
calcium chelator EGTA (Christian et al., 1965) had no effect on the cAMP trend, it was abolished by
the membrane permeable intracellular calcium chelator BAPTA-AM (Lew et al., 1982). Although
statistical analysis comparing 5% and 10% (v/v) CO2 for BAPTA-AM showed a significant difference
this represented an increase in cAMP accumulation at elevated CO2 opposed to the expected
decrease. Therefore, the CO2 dependent inhibition of cAMP production is reliant on calcium ions
that are provided from an intracellular source. It is important to note that chelator affinity for Ca2+
is often altered by pH (Christensen et al., 2002), although both EGTA and BAPTA-AM maintain
suitable affinities within the pH range required: the calcium affinity of BAPTA-AM has been shown
to remain relatively constant between pH levels of 6.0 and 7.5 (Tsien, 1980). Chelators of this type
will also bind other divalent cations such as Mg2+ which, as the co-factor metal required by AC,
could inhibit cAMP production. However, this is unlikely to be a problem as BAPTA-AM has a
selectivity for Ca2+ of more than 105 higher than that for Mg2+, giving a Ca2+ dissociation constant
of 1.1 x 10−7 M (Tsien, 1980).
As noted in Chapter 3, the hypocapnic CO2 concentration of 2.5% (v/v) was abandoned in later
experimentation, however, this pCO2 was included in these experiments (with the exception of
SKi/ROMe) to identify whether any of the interacting signalling pathways could alter cAMP accum-
ulation at this concentration. As all values were statistically similar to 5% (v/v) CO2, none of the
tested signalling components had an impact on cAMP levels at reduced CO2.
All cAMP accumulation assays are carried out in the presence of the non-selective phosphodiesterase
antagonist IBMX (Acin-Perez et al., 2011). Inhibition of these enzymes is necessary to enable
comparision of cAMP levels under different conditions and without it the cAMP turnover is too
high and resultant levels too low to measure accurately by this method (Figure 32). Figure 32
also demonstrates blunted cAMP levels at 10% (v/v) CO2 in both the presence and absence of
IBMX, suggesting that this antagonist is not the causitive agent of this hypercapnic effect. Use of
this antagonist is accepted widely as cAMP levels are not easily measured without it, due to the
aforementioned high phosphodiesterase turnover (Caverzasio et al., 1986).
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4.3.2 OK cells
Section 4.3.1 demonstrated that the reduction in cAMP levels with elevated CO2 required an
availability of intracellular calcium in HEKPR1 cells. This conclusion was drawn from the observation
that intracellular calcium chelator BAPTA-AM removed the cAMP decrease at 10% (v/v) CO2,
whilst extracellular chelator EGTA did not. Further cAMP accumulation assays with both EGTA
and BAPTA-AM were then repeated using OK cells. Experiments were carried out under identical
conditions to HEKPR1 cells for comparison and only 5% (v/v) and 10% (v/v) CO2 concentrations
were employed. Results are presented in Figure 33 as percentages of the normocapnic value for each
inhibitor. DMSO negative controls have been omitted for clarity. Statistical analysis was via a two
sample t-test with values presented in the figure caption.
These results confirm conclusions drawn from HEKPR1 data, that the reduction in cAMP levels at
elevated CO2 requires intracellular calcium. This conclusion can be drawn from the evidence that
both control IBMX and EGTA values have statistically different cAMP production at 5% (v/v)
compared to 10% (v/v) CO2, with both p-values below 0.05. Inclusion of intracellular calcium
chelator BAPTA-AM, however, resulted in statistically similar cAMP production at both CO2
concentrations, with a p-value of 0.097. This indicates that Ca2+ release from an intracellular source
is required for elevated CO2 to blunt the production of cAMP and that this Ca
2+ requirement is
neither cell line nor species specific.
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Figure 33: OK cell inhibitor assays at 5% and 10% (v/v) CO2. Agonist concentration of 10 µM
FSK, pH 7.5, n ≥ 4. Results shown as a percentage of the 5% (v/v) CO2 value. T-test p-values as
follows: IBMX, 8.75 x 10−3; EGTA, 1.00 x 10−3; BAPTA-AM, 9.70 x 10−2
Figure 34: A549 inhibitor assay. Agonist concentration of 10 µM FSK, pH 7.5, n ≤ 7. Results
shown as a percentage of the 5% (v/v) CO2 value. T-test p-values as follows: IBMX, 1.37 x 10
−3 ;
EGTA, 2.15 x 10−4; BAPTA-AM, 7.97 x 10−1.
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4.3.3 A549 cells
Experiments so far have taken place in cell lines responsive to PTH and containing at least part of
the signalling machinery to sense this hormone and bring about the correct physiological outcome.
Results presented in this chapter suggest the possibility that the effects of elevated CO2 on cAMP
and Ca2+ signalling might be a general effect, especially as results from Chapter 3 demonstrated that
the mechanism of AC activation did not alter the outcome. To test this hypothesis, key inhibitor
assays were repeated using A549 cells (Giard et al., 1973), an alveolar epithelial cell line unresponsive
to PTH. Figure 34 displays these results with values shown as percentages of the normocapnic cAMP
level and DMSO negative control data has been omitted for clarity.
These data sets confirm the trends shown previously, that 10% (v/v) CO2 causes a reduction in
cAMP compared to 5% (v/v), a trend unaffected by chelation of extracellular calcium by EGTA,
but abolished by intracellular calcium chelator BAPTA-AM, which gave a p-value of 0.797. This
result suggests that the effect of hypercapnia on the cell is a general cellular phenomenon, although
it must be noted that all of the cell lines tested are of epithelial nature and lineage.
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4.4 CO2 Sensitive Calcium Store Identified as the ER
As shown in Section 4.3, the CO2 induced decrease in cAMP levels is dependent on intracellular
calcium as the cell permeable calcium chelator BAPTA-AM ablated the expected inhibition of AC
activity. As an important signalling molecule in its own right, Ca2+ levels are tightly controlled
throughout the cell. In metazoans cytosolic calcium is maintained at nanomolar concentrations,
with the bulk of the Ca2+ ions stored in discrete subcellular organelles, in addition to being available
from outside the cells where the concentrations are in the millimolar range (Christensen et al., 2002).
More detail on this storage and release of Ca2+ can be found in Section 1.4.
In order to establish which source was providing these calcium ions, pharmacological antagonists
were used to inhibit calcium release from each intracellular compartment: bafiliomycin A1 (Werner
et al., 1984) inhibiting release from NAADP sensitive lysosomal granules (Christensen et al., 2002),
thapsigargin (Rasmussen et al., 1978) for the ER, nifedipene (Fleckenstein et al., 1972; Vater et al.,
1972) inhibiting L-type calcium channels in the plasma membrane, and rotenone (Geoffroy, 1895) for
the mitochondria. These experiments were repeated for both HEKPR1 and OK cells and results are
presented in Figures 35 and 36. Data is displayed as a percentage comparison of the normocapnic
5% (v/v) CO2 value with negative control DMSO values omitted for clarity. Statistical analysis was
by two sample t-tests and values are presented within the figure captions. Bafilomycin A1 results
are only presented for OK cells.
Based on the assumption that inhibition of a source required to provide the calcium ions would
remove the expected drop in cAMP production at 10% (v/v) CO2, these data sets indicate that
the calcium ions are likely to be released from the ER, as thapsigargin abolishes this trend in
both cell lines (in fact significantly reversing it in OK cells). Thapsigargin is an antagonist of
sarcoplasmic/endoplasmic reticulum Ca2+-ATPases (SERCAs) (Thastrup et al., 1990; Lytton et al.,
1991), disruption of which unmasks a constitutive leak of Ca2+ from the ER by blocking calcium
uptake (Mason et al., 1991; Thastrup et al., 1990). Thus, the ER store is emptied of Ca2+ and
cannot be rejuvenated, rendering it unable to respond to any further stimulus for the controlled
release of Ca2+ ions. Based on this, abolition of the cAMP inhibition by CO2 can be reasonably
inferred to require ER derived calcium ions.
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Figure 35: HEKPR1 cell calcium store inhibitor assays. Agonist concentration of 10 µM FSK,
pH 7.5, n ≥ 8. Results shown as a percentage of the 5% (v/v) CO2 value for each inhibitor. T-test
p-values as follows: IBMX, 2.01 x 10−3 ; Thapsigargin, 0.36; Nifedipene, 7.10 x 10−3, Rotenone,
1.93 x 10−3
Figure 36: OK cell calcium store inhibitor assays. Agonist concentration of 10 µM FSK, pH 7.5,
n ≥ 6. Results shown as a percentage of the 5% (v/v) CO2 value for each inhibitor. T-test p-values
as follows: IBMX, 1.54 x 10−4 ; Bafilomycin A1, 2.28 x 10−2 ; Thapsigargin, 5.012.28 x 10−3;
Nifedipene, 1.27 x 10−2, Rotenone, 9.20 x 10−3
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The use of nifedipene, a dihydropyridine antagonist exclusive to L-type calcium channels (Hayashi
et al., 2007) in these cells is controversial in that their expression in HEK 293 parent cells is dubious
due to the fact that the calcium channels present cannot be attributed to any particular class
(Berjukow et al., 1996). Although most of the calcium channels show more similarities to the low-
voltage activated E- and T-type channels (Berjukow et al., 1996), an endogenous L-type signal can be
detected (Zong et al., 1995), especially if the cells have been serum starved prior to experimentation,
which leads to an increase in endogenous calcium channel density (Berjukow et al., 1996). As
these cAMP accumulation experiments occur after a similar overnight starvation, this detail may
be relevant. In fact, the α subunit of L-type channels has been detected all over the rat kidney,
including cells of the proximal tubules (Zhao et al., 2002), where both HEKPR1 and OK cells are
purported to originate. Therefore, use of nifedipene is a valid experiment, especially as antisense
oligonucleotides to the α1D subunit inhibit PTH induced calcium influx (Barry et al., 1998) and
PTH stimulated cAMP can phosphorylate the α1C receptor subunit enhancing channel opening
(Zhao et al., 2002). As presented in Figures 35 and 36, L-type channels are not the source of Ca2+
ions required to inhibit cAMP production with elevated CO2, a result further supported by trends
gained using the non membrane permeable calcium chelator EGTA as both antagonists imply that
an extracellular source of Ca2+ ions is not required.
Most results presented so far have been confirmed through the usage of two cell lines. Here, however,
there is discrepancy between the rotenone results for HEKPR1 and OK cells. Whilst the results
from OK cells implicate mitochondrial calcium in the CO2 effect, HEKPR1 cell results do not.
Calcium is stored in the mitochondria and whilst the organelle does have Na+/Ca2+ or H+/Ca2+
exchangers for the release of Ca2+ ions into the cytosol, it predominantly acts as a calcium sink
via its Ca2+ uniporter (Walsh et al., 2009). In fact, as described in Section 1.4, mitochondria have
more of an indirect influence on Ca2+ signalling through changing the cellular concentrations of
ATP, NAD(P)H, pyruvate and reactive oxygen species (Walsh et al., 2009). Therefore rotenone,
which primarily disrupts the electron transport chain, is a useful antagonist, shown previously to
abolish calcium signals and cellular oscillations in many cell types (Walsh et al., 2009). However, as
rotenone primarily interferes with the electron transport chain preventing ATP formation coupled to
respiration, it will have multiple effects on the cell, thus leading to this discrepancy between results.
Nevertheless, based on this knowledge and the HEKPR1 pattern, it is unlikely that mitochondrial
calcium is involved in the cAMP capnic effect or at most it is a minor contributor compared to the
ER.
135
Finally, ER calcium store depletion is known to trigger Ca2+ influx through the plasma membrane
via ‘capacitative Ca2+ entry’ (Putney, 1986; Kwan et al., 1990), noted previously with use of
thapsigargin (Gouy et al., 1990; Takemura et al., 1989; Mason et al., 1991). Although this Ca2+
entry may be being inhibited with the concentration of thapsigargin implemented (Mason et al.,
1991), capacitative entry may still be occuring. To eliminate the possibility that this source of Ca2+
ions were activating the AC at elevated CO2 with thapsigargin, leading to erroneous conclusions, an
additional set of experiments was undertaken with OK cells, using thapsigargin in combination with
intracellular calcium chelator BAPTA-AM. The premise of these experiments was that BAPTA-
AM should chelate any Ca2+ ions which enter the cell via this method. This data, provided as
a percentage of the 5% control (Figure 37), shows a lack of cAMP reduction at 10% (v/v) CO2,
implying that Ca2+ activation from this source is not required. In addition, this result also proves
that the transient eﬄux of Ca2+ from the ER with application of thapsigargin is also not stimulating
any AC isoforms.
Figure 37: Thapsigargin and BAPTA-AM assay. Agonist concentration of 10 µM FSK, pH 7.5,
n = 9. Results shown as a percentage of the 5% (v/v) CO2 value for each inhibitor. T-test p-values
as follows: IBMX, 1.53 x 10−3; Thapsigargin/BAPTA-AM, 8.30 x 10−1
Together the results displayed in Figures 35, 36 and 37 give evidence that the capnic effect of
inhibiting cAMP production requires Ca2+ release from the endoplasmic reticulum in both OK and
HEKPR1 cell lines.
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4.5 Pharmacological Determination of the ER Calcium Source
Sections 4.3 and 4.4 display evidence that the blunted cAMP production at elevated CO2 levels
required intracellular Ca2+ ion release from the ER, based upon cAMP accumulation assays in
the presence of BAPTA-AM and thapsigargin. The ER, being the principal cellular calcium store,
provides Ca2+ ion release via a number of mechanisms, namely via IP3 receptors (Ross et al., 1989) or
ryanodine receptors, RyRs (Pessah et al., 1985). By emptying this store of calcium using thapsigarin,
these routes will both be abolished (Galione, 2006), necessitating further experiments to determine
which route was involved in the capnic response. To achieve this, further pharmacological antagonists
were implemented in cAMP accumulation assays. In addition to the IP3 receptor inhibitors 2-
APB (Maruyama et al., 1997) and Xestospongin C (Gafni et al., 1997) and the RyR inhibitor
dantrolene (Snyder et al., 1967), two further inhibitors U-73122 (Bleasdale et al., 1989) and Sto-
609 (Tokumitsu et al., 2002) were also used. These chemicals inhibit phospholipase (PLC) and
Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK) respectively, enzymes of potential
interest. PLC catalyses an important Ca2+ signalling reaction, the production of IP3 and DAG
from PIP2 (Section 1.4) and CaM-KK has recently been implicated in the transduction of a CO2
induced Ca2+ ion release in alveolar epithelial cells to Na+/K+-ATPase, causing endocytosis of this
pump and thus impaired alveolar fluid reabsorption (Vada´sz et al., 2008b). While the most obvious
regulator of RyRs is the plant alkaloid ryanodine itself, this chemical has a biphasic effect. Ryanodine
activates the channel at low concentrations (≤ 10 µM) by stabilising it in a subconductance state,
and an inhibits only at higher levels (≥ 100 µM) by locking the channel closed (Querfurth et al.,
1998). Use of this regulator could potentially lead to erroneous conclusions due to its biphasic effect.
Dantrolene was therefore employed, which is known to inhibit both RyRs and their effects on Ca2+
induced Ca2+ release (Ohta et al., 1990).
As prior conclusions have been found to be true for both HEKPR1 and OK cell lines, here assays
only used OK cells, as the most physiologically relevant line. Data collected from these experiments
is presented in Figure 38. Results are presented as percentages of the 5% (v/v) value for each
antagonist, with DMSO negative controls omitted for clarity. Two sample T-test p-values are
presented in the figure caption.
From these data sets, it can be concluded that RyRs, CaMKK-α, CaMKK-β and PLC activity are
not required to inhibit AC at elevated CO2. The latter two inferences are significant as they imply
that the effect of elevated CO2 on cells is not via the same CaMKK-β dependent route identified
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recently by Vadasz et al. (Vada´sz et al., 2008b) and also that any potential Ca2+ release from IP3
receptors is unlikely to be a result of PLC derived IP3 production, the most likely route. However,
the efficacy of U-73122 has since been questioned by Klein et al. who have demonstrated both
inhibition and activation of PLC isoforms by the chemical, as well as a host of other unspecific
interactions with signalling molecules (Klein et al., 2011), thus further experimentation into the
contribution from this signalling component may be of interest.
Results using IP3 receptor antagonists are a little more complex. When normalised across experiments,
2-APB implicated IP3 receptor mediated Ca
2+ release in the cAMP drop at 10% (v/v) CO2 whilst
Xestospongin C did not. 2-APB occasionally caused cells to lift from the plasticware and it is
possible that this may altered results, but as [3H]-cAMP level are normalised to total cell [3H]-adenine
nucleotide labelling this variable should not have altered the final values. Despite repetition, this
discrepancy between antagonists could not be remedied, nor could a definitive trend be established
using Xestospongin C in A549 cells. Therefore, although these data sets do potentially implicate
Ca2+ release from IP3 receptors causing the reduction in cAMP production at elevated CO2, this
interpretation could not be unambiguously proven. Further experiments were designed to test this
hypothesis, using DT40 cells lines (Section 4.6).
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Figure 38: OK cell determination of the ER sensitive store. Agonist concentration of 10 µM FSK,
pH 7.5, n ≤ 6. Results shown as a percentage of the 5% (v/v) CO2 value for each inhibitor. T-test
p-values as follows: IBMX, 1.01 x 10−2 ; 2-APB, 0.81 ; Xestospongin C, 4.37 x 10−3; Dantrolene,
3.38 x 10−4; Sto-609, 1.25 x 10−3; U-73122, 1.95 x 10−4
Figure 39: DT40 IP3 receptor assays. Agonist concentration of 10 µM FSK, DMSO negative control,
pH 7.5. Results shown as a percentage of the 5% (v/v) CO2 value, with error bars generated from
across individual experimental replicates. A: DT40 K/O, n = 4, B: DT40 IP3R1, n = 6
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4.6 Genetic Proof of IP3R Involvement using DT40 cell line
As presented in Section 4.5, results from pharmacological antagonists in OK cells implied that the
hypercapnic effect on cAMP required calcium release via IP3 receptors in the ER. However, this was
not entirely conclusive, due not only to the contradictions presented using the two IP3R inhibitors
2-APB and Xestospongin C, but also to the inherent fallibility of pharmacological antagonists. To
catagorically prove this hypothesis, a genetic approach was employed. Using DT40 cell lines (Section
4.2.2), cAMP accumulation assays were carried out at varying CO2 concentrations in a cellular
environment where IP3 receptor expression was controlled. Two DT40 cell lines were used: ‘DT40-
K/O’, where both alleles of all three genes for the IP3 receptor had been disrupted (Sugawara et al.,
1997), and ‘DT40-IP3 3R1’, which have the rat gene for IP3 receptor 1 reintroduced by transfection
(Laude et al., 2005).
In contrast to all other cell lines used in this thesis, DT40 cells are not an adherant line and
instead grow in suspension. Despite effort to adhere these cells to the plasticware for use in cAMP
accumulation assays, mimimal adherance was acheived. This was attempted using 5 mg/ml poly-
D-lysine similar to the protocol used for HEKPR1 cells (Section 2.3.3) and the published DT40
methodology by Tovey et al. (Tovey et al., 2006). In addition, fibronectin (25sµg/ml) and collagen
(100 µg/ml) were also tested, although due to the lymphocyte origin of these cells again limited
adherance was observed. Therefore, substantial changes to methodology were required for cAMP
accumulation assays as detailed in Sections 2.4.3 and 2.6.2, especially as DT40 cAMP levels in
response to 10 µM FSK were too low to measure using tritium-labelled methods. DT40 assays instead
employed use of an ELISA and cAMP concentrations were normalised to Bradford determined sample
protein content.
Results are displayed in Figure 39 and Table 13. Data is presented as a percentage of the 5% (v/v)
CO2 normocapnic cAMP level and statistical analysis was via an ANOVA with post-hoc Boniferroni
testing, as displayed in the table.
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Comparison
Negative Control - DMSO FSK Agonist
Difference P value Difference P value
DT40-K/O
5% vs 10% 1.996 P ≥ 0.05 9.894 P ≥ 0.05
DT40-IP3 R1
5% vs 5% + 2mM PA -2.742 P ≥ 0.05 7.712 P ≥ 0.05
5% vs 10% -5.877 P ≥ 0.05 -53.02 P ≤ 0.001
Table 13: Statistical analysis of DT40 assays: ANOVA analysis with post hoc Bonferroni testing
These results categorically show that Ca2+ release from IP3 receptors is required to blunt the AC
response to FSK at elevated CO2 concentrations. In the absence of any IP3 receptors, this effect
of CO2 on cAMP was removed (DT40-K/O), whilst re-introduction of an isoform of this receptor
restored this response (DT40-IP3R1). Importantly, use of 5% (v/v) CO2 with 2 mM PA in DT40-
IP3R1 cells did not ellicit the same response as 10% (v/v) CO2 and instead gave high cAMP levels
similar to that at 5% (v/v), proving this CO2 effect to be pH-independent. This latter conclusion
agrees with the data presented in Chapter 3 for OK, HEKPR1 and UMR-106 cells. Overall these
data provide proof of a pH-independent inhibition of cAMP accumulation at elevated CO2 which
requires the release of Ca2+ ions from an IP3 sensitive store.
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4.7 Intracellular Ca2+ Measurement using Fura 2-AM
The results from the above sections led to the inference that the blunted cAMP response observed
at 10% (v/v) CO2 compared to 5% (v/v) requires the release of Ca
2+ ions from an intracellular
source (BAPTA-AM result from Section 4.3), in particular via IP3 receptors in the ER (Sections
4.4, 4.5 and 4.6). To test for this CO2 induced Ca
2+ release, DT40 cell Ca2+ levels were measured
under different conditions, using the ratiometric calcium dye Fura 2-AM. Introduced by Roger Tsien
in 1985 (Grynkiewicz et al., 1985), Fura 2 combines the tetracarboylate pattern of liganding groups
characterisic of Ca2+ specific chelators such as EGTA and BAPTA to enhance Ca2+ selectivity,
a bright stilbene flurophore and a cleavable membrane permeable acetoxymethyl ester group for
biological application (Grynkiewicz et al., 1985). This dye exhibits minimal compartmentalism
(Paredes et al., 2008), leakage or bleaching (Invitrogen, 2012) during the time-frame of these
experiments and the ratiometric element of its measurements limits data variability from the effects
of photobleaching, leakage, dye concentration and cell thickness (Hayashi & Miyata, 1994; Invitrogen,
2012). Further advantages of this dye include the fact that it is bright enough to enable measurements
of intracellular Ca2+ using concentrations unlikely to cause significant Ca2+ buffering or damping of
Ca2+ transients (Invitrogen, 2012), in addition to being relatively unaffected by pH changes within
the physiological range (Grynkiewicz et al., 1985), ideal where CO2 is acting as a variable.
4.7.1 Release of Calcium by Thapsigargin
Prior to exposure to CO2 concentrations both DT40 cell lines (DT40-IP3R1 and DT40-K/O)
were loaded with Fura-2 AM and intracellular calcium release induced using SERCA antagonist
thapsigargin to prove that the instrumentation employed worked correctly and that dye loading
conditions were sufficient. Figure 40 provides sample data for thapsigargin responses in both cell
lines, proving that experimentation could proceed.
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Figure 40: DT40 thapsigargin induced Ca2+ release. Agonist concentration of 5µM thapsigargin,
pH 7.5. A: DT40 K/O, B DT40 IP3R1
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4.7.2 Release of Calcium by Elevated CO2
DT40-IP3R1 and DT40-K/O cells were exposed to 5% (v/v) and 10% (v/v) CO2 in combination
with a number of antagonists of the elements of the Ca2+ signalling pathway (Figures 42, 41 and
Table 14). Elevated CO2 induced an increase in intracellular Ca
2+ concentration in DT4-IP3R1
cells, on average 116.63% ± 6.81 that of the resting 5% (v/v) CO2 level. As mentioned previously
(Sections 3.3 and 3.8) use of this elevated CO2 concentration may lead to changes in pHi or pO2.
These variables were eliminated using propanoic acid and gas mix 5% CO2, 18% O2, 77 % N2 (v/v)
repectively, both of which failed to increase [Ca2+].
Importantly this Ca2+ release appears to be generated via IP3 receptors as both disruption of IP3R
activity via antagonists 2-APB and Xestospongin C and genetic ablation (DT40-K/O) removed the
observed elevation in Ca2+ levels at 10% (v/v) CO2. This result agrees with the inferences made
previously in this chapter based on cAMP accummulation data (Sections 4.5 and 4.6).
Interestingly inhibition of PLC by U-73122 also removed the effect of CO2 on Ca
2+ release. As PLC
cleaves phosphatidylinositol 4,5-bisphosphate to yield diacylglycerol and IP3, the latter product
likely to then activate Ca2+ release from IP3 receptors, this result suggests that the CO2 sensor is
located within or upstream of this pathway. However, when U73-122 was used in cAMP accumulation
experiments (Section 4.5) there was no demonstrable effect. This discrepancy may be due to the
questionable effects of U73-122 on PLC as evidence in the literature suggests both inhibition and
activation of PLC isoforms by the chemical, as well as a host of other unspecific interactions with
signalling molecules (Klein et al., 2011). It is also possible that DT40s contain different PLC isoforms
to the OK cells employed for cAMP accumulation, with different sensitivities to U73-122 and/or CO2.
Finally, when extracellular calcium was chelated by EGTA, although the overall effect of CO2 on
Ca2+ release was unaffected, the magnitude of this response decreased. Under control conditions
with DT40-IP3R1 cells the percentage increase in Ca
2+ at 10% (v/v) CO2 was 116.63% ± 6.81 that
of the resting 5% CO2 level, whilst with EGTA this value was 109.29% ± 2.81. This may suggest
that whilst the Ca2+ release is from an intracellular source, replenishment of this store from outside
the cell is required to maintain signalling while pCO2 levels are elevated. Such interactions between
the ER and extracellular stores of Ca2+ are well recognised, supporting this inference (Rosado, 2006;
Kwan et al., 1990; Wu et al., 2007)
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Figure 41: DT40 Ca2+ imaging sample graphs, pH 7.5. A: DT40 IP3R1 5 - 10% (v/v) CO2,
Ttest: 1.79 x 10 −5 B: DT40 IP3R1 5 - 5% (v/v) CO2 + 2 mM PA, Ttest: 0.844 C: DT40 IP3R1
5 % CO2 - 5% CO2, 18% O2, 77 % N2 (v/v), Ttest: 0.882 D: DT40 K/O 5 - 10% (v/v) CO2,
Ttest: 0.565 E: DT40 IP3R1 no Ca
2+ and 500 µM EGTA; 5 -10% (v/v) CO2, Ttest: 1.19 x 10
−3
F: DT40 IP3R1 5 µM U73-122; 5 - 10% (v/v) CO2, Ttest: 0.120 G: DT40 IP3R1 100 µM 2-APB;
5 - 10% (v/v) CO2, Ttest: 0.354 H: DT40 IP3R1 500 nM Xestospongin C; 5 - 10% (v/v) CO2,
Ttest: 0.948
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Figure 42: Percentage comparison of Ca2+ released at 10% (v/v) CO2 compared to 5% (v/v) in
DT40 cells. Where relevant: 100 µM 2-APB, 500 µM EGTA, 5 µM U73-122, 500 nM Xestospongin
C. pH 7.5, n ≥ 4
Comparison Difference P value
IP3R1 5-10% CO2 vs IP3R1 5-5% PA 14.27 P ≤ 0.05
IP3R1 5-10% CO2 vs IP3R1 5-5% CO2 + 18% O2 13.13 P ≥ 0.05
IP3R1 5-10% CO2 vs K/O 5-10% 18.8 P ≤ 0.001
IP3R1 5-10% CO2 vs IP3R1 no Ca + EGTA 5.01 P ≥ 0.05
IP3R1 5-10% CO2 vs IP3P1 U73-122 17.18 P ≤ 0.05
IP3R1 5-10% CO2 vs IP3R1 2-APB 19.62 P ≤ 0.001
IP3R1 5-10% CO2 vs IP3R1 Xestospongin C 14.65 P ≥ 0.05
IP3R1 5-5% CO2 + 18% O2 vs IP3R1 5-5% PA 1.146 P ≥ 0.05
IP3R1 2-APB vs IP3R1 Xestospongin C -4.973 P ≥ 0.05
Table 14: Statistical analysis of DT40 calcium data presented in Figure 41: Two-way ANOVA
analysis with post hoc Boniferroni testing
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4.8 Chapter Conclusions
This chapter provides evidence that the inhibition of cAMP accumulation at 10% (v/v) CO2
compared to 5% (v/v) is controlled by Ca2+ ions released from IP3 receptors in the ER. Proof is
provided through use of both pharmacological and genetic approaches. Abolition of the CO2 induced
constraint on cAMP accumulation with the chelator BAPTA-AM and antagonists thapsigargin and
2-APB led to the conclusion that in HEKPR1 cells Ca2+ ion release was required to inhibit AC
and that the source of this calcium was the ER, specifically via IP3 receptors. This requirement for
calcium is true for HEKPR1, OK and A549 cells and is, therefore, not specific to cell line or species.
Further evidence is provided through the use of DT40 cells which have been genetically ablated
for IP3 receptors (DT40-K/O). In these cells the inhibition of AC at 10% (v/v) CO2 was ablated
with the re-introduction of IP3 receptors (DT40-IP3R1) which again resulted in a blunted cAMP
response. This latter result forms genetic evidence for an IP3 receptor mediated release of Ca
2+ ions
interacting with cAMP signalling. Furthermore, using DT40 cells, intracellular Ca2+ concentrations
were shown to increase with elevated CO2, independent of pHi or hypoxia. This increase in Ca
2+
was demonstrated to proceed via an IP3 dependent mechanism, established by pharmacological and
genetic methods. A pictorial representation of this hypothesised signalling pathway at normal and
elevated CO2 is displayed in Figure 43.
These findings are of particular interest in the clinical treatment of a number of pathological
conditions. Hypercapnia can occur as a complication of numerous disease states, with elevated CO2
often associated with a worse prognosis and elevated morbidity (Section 1.7). Inconsistent with
this detrimental effect of CO2, permissive hypercapnia is often used as a treatment, particularly
when mechanical ventilation is required to support patients with respiratory complications, and this
use of CO2 is here related to an improved outcome. Whilst this protective effect has been largely
attributed to the anti-inflammatory influence of CO2, futher understanding into the mechanisms
involved in these hypercapnic effects is required. The effects of CO2 on both cAMP and Ca
2+
signalling pathways presented in this chapter may provide further insight into understanding the
clinical effects of hypercapnia and aid clinicians’ attempts to better patient prognosis. Further work
is required, however, to prove that these biochemical phenomena presented have physiologically
relevant outcomes and this will be provided in Chapter 5.
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Figure 43: Chapter 4 overview of signalling events at normal and elevated CO2. Normal CO2: PTH
activation of the AC signalling complex increases cAMP levels. Elevated CO2: CO2 induces a Ca
2+
ion release from the ER via the IP3 receptor, blunting AC’s response to PTH resulting in reduced
cAMP production.
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5 Chapter 5: Physiological Experiments to Determine the
Effect of Hypercapnia on Renal Cell Function
5.1 Introduction
Chapter 3 presented evidence for a pH independent inhibition of cAMP production with elevated
CO2 (from normocapnic 5% [v/v] to hypercapnic 10% [v/v]) that is true for multiple cell lines and
independent of the mechanism of AC activation. This signalling phenomenon was demonstrated
in Chapter 4 to require the release of Ca2+ ions from IP3 receptors in the ER. This finding was
confirmed using both pharmacological and genetic methods.
The majority of data presented so far has involved biochemical analysis of cAMP levels under
different experimental conditions. This chapter focuses on whether the observed alterations to
the cell signalling patterns have a physiological outcome. To achieve this the activity of two
luminal membrane transporters was investigated; the sodium-phosphate co-transporter NaPi-IIa
and sodium-hydrogen exchanger 3 (NHE3). Both these transporters are downstream of AC and
are inhibited in response to PTH in order to control the levels of phosphaturia and bicarbonaturia
respectively (Section 1.7.3). To monitor the activity of NaPi-IIa, cellular re-absorption of radio-
labelled phosphate was measured (Section 5.2), whilst measurement of NHE3 activity employed
measurement of pHi in response to an ammonium chloride pulse (Section 5.3). For all physiological
experiments OK cells were used as a representative model of a proximal tubule cell responsive to
PTH, in which the complete signalling machinery is present to regulate the desired transporters
(Cole et al., 1989). Numerous publications exist supporting use of these cells for these physiological
experiments, studying both phosphate (Caverzasio et al., 1986; Malmstrom & Murer, 1986; Cole
et al., 1987; Jehle et al., 1999) and NHE activity (Pollock et al., 1986; Azarani et al., 1995).
This chapter demonstrates that the effects of elevated CO2 and IP3 receptor mediated Ca
2+ release
have downstream physiological implications, particularly on the activity of NHE3 and its ability to
rescue pHi after an ammonium chloride pulse. The effects on phosphate transport with CO2 are
more complicated and no definitive effect of CO2 was identified.
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5.2 Activation of Downstream Sodium-Phosphate Co-transporters
PTH causes marked phosphaturia in vivo (Chase & Aurbach, 1967), an effect mediated by cAMP
(Chase & Aurbach, 1967; Agus et al., 1971). This cAMP causes both inactivating phosphorylation
of the sodium-dependent phosphate co-transporter NaPi-IIa in addition to a decrease in its number
at the plasma membrane (Malmstrom & Murer, 1986) due to both decreased expression (Kempson
et al., 1995; Picard et al., 2010) and targetted internalisation for lysosomal degradation (Keusch et al.,
1998; Pfister et al., 1998; Picard et al., 2010). Together these effects decrease phosphate re-absorption
in the renal proximal tubule (Agus et al., 1971, 1973) thus leading to the observed phosphaturia
(Section 1.7.3). As a physiologically relevant process downstream of cAMP accumulation, this system
was used to demonstrate whether the observed effects of elevated CO2 on in cellulo cAMP levels
could have a physiological outcome.
Several published works have shown that PTH causes time and concentration dependent decreases
in sodium-dependent phosphate transport in OK cells (Cole et al., 1987; Malmstrom & Murer, 1986;
Caverzasio et al., 1986) with significant inhibition in phosphate transport at PTH concentrations
stimulating relatively low concentrations of cAMP (Caverzasio et al., 1986). In fact, Malmstrom et
al. commented that in all the renal cell lines studied by the authors, including porcine LLC-PK1
(Hull et al., 1976) and monkey derived JTC-12.P3 (Katsuta et al., 1960) cells, OK cell lines are
the only line to retain the complete phosphate transport regulatory cascade (Malmstrom & Murer,
1986). OK cells were thus deemed a reliable model for further experimental purposes.
Experiments detailed in the sections below monitored the re-absorption of radio-labelled phosphate
molecules under a variety of conditions. These assays were used to assess whether elevated CO2,
demonstrated to influence cAMP levels in Chapters 3 and 4, would have an effect on phosphate
transport across the apical membrane.
5.2.1 Optimisation of Phosphate Transport Assay
The methodology used for the phosphate transport assays (Section 2.5.1) required a 4 hour incubation
step at the appropriate pCO2 and agonist/antagonist concentration. This step was required to allow
cells to reach maximal phosphate transport levels (Cole et al., 1989), taking into account the time
required for initial alterations to cAMP signalling (Caverzasio et al., 1986; Malmstrom & Murer,
1986) followed by their effects on NaPi-IIa expression (Kempson et al., 1995; Picard et al., 2010),
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internalisation and degradation (Keusch et al., 1998; Pfister et al., 1998; Picard et al., 2010). The
efficacy of this extended incubation period was demonstrated using PTH activation in OK cells,
where phosphate transport was observed to decrease progressively over time with a 30% reduction
of phosphate transport after 1 hour and 60% after 4 hours (Malmstrom & Murer, 1986).
This incubation period was significantly longer than cAMP accumulation assays, which required
only 30 minutes. As CO2 decreases the pH of solutions, preliminary experiments were carried out
to monitor extracellular pH over the whole 4 hour period in an attempt to keep medium pH as
controlled as possible between experiments requiring different CO2 concentrations to eliminate pH
as a determining factor. With cAMP and pHi measurements (Chapters 3 and 4), 15 mM HEPES
was used to effectively buffer any CO2 changes; therefore, different concentrations of this buffer were
tested to establish optimal assay conditions.
Incubation experiments were carried out with cells with a starting pre-gassed medium pH of 7.5.
Assays were performed by taking 500 µL samples of each medium every hour and measuring pH using
a Hamilton Biotrode pH probe, specially designed to measure pH of small volumes, requiring only
a 7 mm immersion depth (Hamilton, 2011). These samples were then returned to their respective
bulk medium and the process repeated to cover the whole 4 hour period. Through repetition
with different HEPES concentrations it was possible to identify optimal experimental conditions;
foremostly maintaining similar pH levels for the longest period in those experiments with different
CO2 exposure levels, thereby eliminating pH as a variable as far as possible (Figure 44A). Phosphate
uptake assays under basal conditions (no PTH or FSK agonists) using each HEPES concentration
were also performed to establish the effect this buffer would have on phosphate uptake (Figure 44B).
From these experiments 100 mM HEPES was chosen for use in future experiments as use of this
concentration resulted in minimal pH changes between samples exposed to each CO2 concentration.
However, this increased HEPES concentration increased phosphate uptake (Figure 44B). It is probable
that this observed effect of HEPES was due to the fact that this buffer was applied to the media
as a sodium-salt. As phosphate transport requires the activity of a Na+/PO4
3− co-transporter,
this process must be sodium dependent (Baumann et al., 1975) and thus application of Na-HEPES
in this way could have partially altered transport dynamics. As all experiments were carried out
under the same conditions and the cAMP activated system of interest causes inhibition of phosphate
transport with no requirement for further activation of the transporter, this HEPES concentration
was deemed acceptable for use.
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Figure 44: pH optimisation of phosphate transport assay across independent repetitions, pCO2
percentage concentrations presented as v/v. A: Effect of HEPES concentration on cell medium pH
at each pCO2, all experiments started at pH 7.5, n = 5 B: Effect of HEPES on basal (no agonist)
phosphate uptake, pH 7.5, n = 4 C: Medium pH changes with each pCO2 and different starting pH
values (detailed in the legend), 100mM HEPES
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With 100 mM HEPES the pH difference between samples exposed to 5% (v/v) CO2 and 10% (v/v)
was 0.34 ± 0.07 pH units after 4 hours. It was also observed that the pH of the medium dropped
rapidly within the first hour and then remained relatively constant. Data presented in Figure 44A
was from experiments with the same starting pH. To maintain extracellular pH as close as possible
across experiments with different CO2 concentrations, the effect of different starting pH levels was
tested. Figure 44C shows that with 100 mM HEPES, implementation of a starting pH of 7.5 for
10% (v/v) CO2 and 7.4 for 5% (v/v) allowed the medium to remain at similar pH values for the
greatest portion of the incubation period. Use of these conditions resulted in a pH value difference
between samples from each CO2 concentration of only 0.01 ± 0.04 pH units after 4 hours.
Assays to test whether the PDE antagonist IBMX should be included in the incubation media were
also performed. IBMX had no effect on phosphate uptake at normocapnic 5% CO2 in the absence
of any agonist (Figure 45). Evidence in the literature, however, noted that IBMX greatly increased
the observed agonist inhibition of phosphate transport (Caverzasio et al., 1986) while under basal
conditions OK cells with 4 hours of 1 mM IBMX experienced a 50% reduction in phosphate transport
(Malmstrom & Murer, 1986), indicating that basal AC activity was enough to inhibit NaPi-IIa if
cAMP was not broken down by PDEs. It was decided not to include this PDE inhibitor so that
the effects of cAMP turnover would also impact on the resultant phosphate uptake trends and the
effects of endogenous basal AC activity would not lead to erroneous conclusions.
5.2.2 Phosphate Uptake In Response to PTH and FSK Agonists
A primary objective was to ensure that OK cells were responsive to the agonists PTH and FSK,
causing measurable inhibition of phosphate uptake. FSK has been shown to mimic PTH inhibition
of phosphate transport in OK cells (Caverzasio et al., 1986; Malmstrom & Murer, 1986) and
should, therefore, have a similar effect. Results presented in Figure 46A demonstrate that in these
OK cells both PTH and FSK inhibit phosphate uptake, most likely via their ability to generate
cAMP. Inclusion of the PKA inhibitor H89 abolished this inhibition, giving phosphate uptake values
statistically similar to the basal value (Figure 46B) . This demonstrated that both PTH and FSK
inhibition of phosphate transport is via cAMP responsive PKA. Based on these results, these cells
and this method can be used to monitor phosphate uptake in response to agonist with elevated CO2.
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Figure 45: Effect of IBMX on phosphate uptake. Experimental conditions were 5% (v/v) CO2, pH
7.5, 1mM IBMX added as indicated. T-test compared to control: 3.42 x 10−1, n = 4
Figure 46: Phosphate uptake positive agonist responses. Agonist concentrations of 100 nM PTH
and 10 µM forskolin with agonist solvent DMSO used as a negative control. Experimental conditions
were 5% (v/v) CO2, pH 7.5, antagonist added as indicated. Bar chart results shown as a percentage
of phosphate uptake of the DMSO control averaged across independent experiments. A: n = 4,
T-test compared to control: PTH, 2.91 x 10−5; FSK, 7.37 x 10−5 B: H89, n = 4, T-test compared
to control: PTH, 5.00 x 10−1; FSK, 7.70 x 10−2
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5.2.3 Phosphate Uptake at Different Capnic Conditions
Section 5.2.2 demonstrated that PTH and FSK cause inhibition of phosphate uptake reliant on PKA
activation in OK cells. These cells could thus be employed to monitor whether elevated CO2 had
an effect on this transport mechanism and if the effects of CO2 on decreased cAMP accumulation
would have a physiological effect. Figure 47 presents data from across independently performed
experiments, with results presented as a percentage of phosphate uptake at 5% CO2 with the DMSO
control.
These results demonstrate an inhibition in total phosphate uptake with both PTH and FSK agonists
as expected (Section 5.2.2), although the difference in their efficacy can only be explained as a
consequence of the concentrations used. Regarding the effect of CO2, however, these results do
not match those found previously with cAMP accumulation. The decrease in cAMP observed with
elevated CO2 would be expected to relieve agonist induced inhibition of phosphate transport at
this CO2 concentration, demonstrable by an increase in phosphate uptake compared to the values
at normocapnic 5% (v/v) CO2. Instead there is a marked decrease in phosphate uptake. This
observation is true for both control DMSO samples and agonist induced phosphate uptake. This
inhibition of phosphate uptake at elevated CO2 can not be attributed to cAMP and PKA activity
as explained. The reduction in phosphate reabsorption with hypercapnia has been demonstrated
previously in the literature (Lotspeich & Malvin, 1956; Webb et al., 1977; Haramati & Nienhuis,
1984; Guntupalli et al., 1987; Krapf et al., 1992; Jehle et al., 1999) and may be attributable to Ca2+
release at elevated CO2 (Section 4.7.2) inhibiting phosphate uptake via PKC (Malmstrom & Murer,
1986; Cole et al., 1987; Martin et al., 1994).
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Figure 47: Phosphate uptake at 5% (v/v) and 10% (v/v) CO2. Agonist concentrations of 100 nM
PTH and 10 µM forskolin with agonist solvent DMSO used as a negative control. Bar chart
results shown as a percentage of phosphate uptake of the 5% CO2 DMSO control averaged across
independent experiments, n = 7. T-test between CO2 concentrations: DMSO, 9.96 x 10
−5; PTH,
6.16 x 10−1; FSK, 3.08 x 10−1
Figure 48: Typical ammonium chloride pulse: ‘NaCl’ refers to a Krebs-Ringer-HEPES solution
(130mM NaCl, 25mM Glucose, 20mM HEPES, 14mM NaHCO3, 5mM KCl, 1mM CaCl2 and 1mM
MgSO4, pH 7.4, 5% [v/v] CO2) and ‘NH4Cl’ to the ammonium chloride pulse solution (110mM
NaCl, 25mM Glucose, 20mM NH4Cl, 20mM HEPES, 14mM NaHCO3, 5mM KCl, 1mM CaCl2 and
1mM MgSO4, pH 7.4, 5% [v/v] CO2). Cells are typically exposed to the NH4Cl pulse solution for
3 minutes before return to Krebs-Ringer-HEPES.
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5.3 Sodium-Hydrogen Exchangers and Intracellular pH recovery
Section 5.2 demonstrated that whilst agonist inhibition of phosphate uptake could be measured, a
definitive effect linking elevated CO2 and cAMP levels in this system could not be identified. It
is possible that the effects of CO2 are relatively short lived and thus, instead of concentrating on
a chronic effect such as phosphate re-absorption, experiments were carried out on the more acute
physiological effect provided by the regulation of sodium-proton exchangers, principally NHE3 (Tse
et al., 1992). Here the inhibitory effects of PTH on Na+-H+ transport in OK cells can be observed
after 2 minutes and are maximal after 4 minutes (Pollock et al., 1986). As a physiologically relevant
acute response downstream of cAMP accumulation, this system was used to demonstrate whether the
observed effects of elevated CO2 on in cellulo cAMP levels could have a physiological outcome. This
system is particularly relevant as NHE activity is involved in controlling PTH induced bicarbonaturia
via cAMP inhibition of the exchanger (Section 1.7). OK cells have been used in numerous studies
to investigate the effect of PTH on NHE3 activity (Pollock et al., 1986; Azarani et al., 1995) and
therefore provide a useful model system on which to study the effects of CO2 on NHE3 activity,
particularly as they are noted to have a PTH NHE3 response similar to that recorded in isolated
renal proximal tubules (Pollock et al., 1986).
In order to monitor the activity of NHE3, OK cells equilibrated at the desired CO2 level and
agonist/antagonist concentration were exposed to an ammonium chloride pulse. A typical pHi trace
is presented as Figure 48. NH4Cl causes an alkalinisation of pHi due to the rapid influx of NH3
into cells which buffers intracellular protons (Boyarsky et al., 1988; Hegyi et al., 2004). This rapid
alkalisation is then followed by a slower ‘plateau-phase’ acidification caused by the slower entry of
NH4
+ which is dissociated to NH3 and H
+ (Boyarsky et al., 1988; Weintraub & Machen, 1989).
When NH4Cl is washed off the cells the reverse occurs, with eﬄux of NH3 from the cells leaving
behind a large number of trapped H+ ions, which causes a rapid decrease in pHi (Boyarsky et al.,
1988). These changes in pHi activate sodium-proton exchangers, particularly NHE3, which pump
protons across the plasma membrane to return the cell to its resting pHi. It is this latter recovery
step after the NH4Cl pulse which is of most interest here. Comparsion of the rate at which this
recovery occurs under different conditions allows the effect on NHE3 to be measured. A number of
different methods of measuring this recovery have been used (Appendix 7.4). The initial recovery
rate is most relevant as is representative of the activity of NHEs prior to any buffering of protons by
cellular constituents. The majority of graphs presented display this period with the lowest measured
pHi point set as time 0 and change in pH units (∆pH) from this point displayed. In addition to
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this, recovery rates have been calculated either by measuring this ∆pHi or by performing a linear
regression on the first 45 seconds of recovery.
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5.3.1 Sodium Dependent pHi Recovery
Pollock et al. demonstrated that in OK cells, PTH induced pHi changes were due to an amiloride-
sensitive Na+-H+ antiporter and a cAMP response to the hormone (Pollock et al., 1986). The
authors also noted that in the absence of sodium in the media or use of amiloride to inhibit Na+-
H+ exchange via NHE3 there was a resultant decrease in pHi demonstrating an impairment in
proton extrusion (Boyarsky et al., 1988) in addition to abolishing the PTH effect on this system
(Pollock et al., 1986). To establish whether the pHi recoveries measured in response to NH4Cl pulse
involved this NHE3 dependent pHi recovery mechanism, experiments were performed using both a
sodium-free solution and the Na+-H+ exchange inhibitor 5’-(N,N-dimethyl)-amiloride, DMA (Vigne
et al., 1984; Kleyman & Cragoe, 1988). For sodium-free experiments, N-methyl-D-glucamine was
used to replace the sodium chloride in the Krebs-Ringer-HEPES solution without affecting solution
osmolarity. Potassium cations were not implemented as a substitute for sodium, even though the
NHE family are known to not be able to use this ion (Beltra´n et al., 2008), as they may have had
electrogenic effects on the cell or modulate HCO−3 uptake (Rakonczay et al., 2006). Thus, sodium-
free recoveries were performed using an ammonium chloride pulse and cells were then returned to
the N-methyl-D-glucamine solution for monitored recovery prior to return to normal Krebs-Ringer-
HEPES.
Figure 49 demonstrates that in the presence of both the sodium-free Krebs-Ringer-HEPES and
DMA containing solutions pHi recovery was compromised, giving initial recovery rates of 1.10 x
10−5 ± 2.69 x 10−5 pH units s−1 and 7.34 x 10−4 ± 4.41 x 10−5 pH units s−1 for the two conditions
respectively, compared to the control sodium containing recovery of 1.58 x 10−3 ± 7.96 x 10−5 pH
units s−1. When t-tested against the control, sodium-free conditions gave a value of 3.46 x 10−3 and
DMA; 3.58 x 10−3, providing statistical support for this blunted ability to recover. These results
indicate that under these experimental conditions the OK cells exhibit pHi recovery which is chiefly
dependent on NHE activity, agreeing with evidence from the literature (Pollock et al., 1986). The
results presented in Figure 49B demonstrate an inhibition in pHi recovery when cells were exposed
to 10 µM FSK, covered further in Section 5.3.3. Of note here, FSK inhibition of pHi recovery does
not reduce the rate to the same low levels as the exchanger inhibitor DMA, which indicates that at
this concentration of agonist the pHi recovery rate can still be both activated and inhibited further.
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Figure 49: Control experiments to monitor pHi recovery when NHE is compromised. A: Rate of
pHi recovery after NH4Cl pulse with and without Na
+ (N-methyl-D-glucamine substitute), pH 7.4,
B: Rate of pHi recovery after NH4Cl pulse with DMSO control, 10 µM FSK and 100 µM DMA, pH
7.4, C: Bar chart of pHi recovery rates when NHE is compromised compared to control, 100 µM
DMA, pH 7.4, n = 7.
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5.3.2 DMSO Control with Different Capnic Conditions
Having established that in OK cells pHi recovery in response to NH4Cl pulse occurs via the activity
of Na+-H+ antiporters (Section 5.3.1), pHi recovery was monitored in the presence of different
concentrations of CO2. As presented in Figures 50 and 51, under control conditions the rate of
pHi recovery after NH4Cl pulse was decreased in the presence of 10% (v/v) CO2 compared to 5%
(v/v), resulting in a slower return to resting pHi. Estimates of the initial rate of pHi recovery were
then calculated by applying linear regression to data points generated within the first 45 seconds of
recovery. Using these values, the mean pHi recovery at 10% (v/v) CO2 was calculated as 58.36% ±
5.57 of the rate at 5% (v/v). Possible explanations for this difference in pHi recovery rate are covered
in Section 5.3.5, which may implicate the involvement of CO2 induced Ca
2+ ions and subsequently
activated PKC modulation of NHE3 activity. At this stage it is sufficient to note the difference in
recovery found between conditions as a comparison point for future experiments.
As the majority of agonists and antagonists required for experimentation (Sections 5.3.3, 5.3.4 and
5.3.5) were dissolved as stock solutions in DMSO, equivalent concentrations of this solvent were
added to control experiments to determine whether it would have any effect on the observed trends
in pHi recovery. Figure 51 presents evidence that the inclusion of DMSO had no effect on the rates of
pHi recovery, displaying the same 5-10% trend established above. To remove this potential variable
further, all comparisons from this point were thus compared to control experiments containing
DMSO.
5.3.3 pHi Recovery with Agonist Activation at Different Capnic Levels
As outlined above, the principal aim of this Chapter was to identify whether the diminished cAMP
response to agonist at 10% (v/v) CO2 compared to 5% (v/v) presented in Chapters 3 and 4 could
have a physiological outcome. As cAMP and downstream PKA activation inhibit the Na+/H+
antiporter NHE3 (Tse et al., 1992) via phosphorylation (Fan et al., 1999) and eventually decreased
expression rate (Nogueira et al., 2008), monitoring pHi recovery after an NH4Cl pulse provided a
useful system in which to test for any physiological effect. This signalling network is predominantly
used in the context of a PTH response, with the whole pathway previously demonstrated in OK
cells (Pollock et al., 1986; Nogueira et al., 2008). Pollock et al. also demonstrated that direct
activation of ACs by FSK could reproduce the PTH inhibition on NHE activity in OK cells via the
same signalling mechanism, causing a decrease in 22Na+ uptake by up to 64% (Pollock et al., 1986).
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Figure 50: Control NHE experiment at different CO2 concentrations, overlay of NH4Cl pulses. CO2
percentages given as v/v in air.
Figure 51: Effect of DMSO on pHi recovery after NH4Cl pulse at different CO2 concentrations.
Percentages refer to CO2 concentration in air, given as v/v. Linear regression values calculated from
the first 45 seconds of recovery following NH4Cl pulse, n = 4.
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Thus, pHi recovery was measured after activation by both PTH and FSK agonists.
As shown in Figures 52B, 52C and 53 both agonists result in a decrease in pHi recovery rate.
Therefore, cAMP production initiated by both agonists is able to inhibit NHE3 activity, as demonstrated
by this alteration in pHi recovery. This inhibition is reduced in the presence of PKA inhibitor H89
(Figures 52D, 52E and 53), suggesting that PTH and FSK are both acting on NHE3 via PKA, in
accordance with the literature (Nogueira et al., 2008).
These results also demonstrate an effect of the CO2 concentration. Comparing panel A with B and C
in Figure 52, the 5-10% (v/v) CO2 trend is reversed in the presence of both agonists compared to the
control, with pHi recovery rate at 10% (v/v) CO2 faster than 5% (v/v). This result is seen clearly in
Figure 53 where mean linear regression values are presented as a percentage ratio of the recovery rates
between CO2 concentrations, with associated statistical ANOVA data displayed as Table 15. As an
increase in CO2 brings about a decrease in cAMP production in the presence of agonist (Chapters
3 and 4), at 10% (v/v) CO2 NHE3 would be expected to experience less inhibition and therefore be
more active compared to normocapnic conditions. Thus, as observed, the pHi recovery rate following
an NH4Cl pulse would be expected to be greater, removing the constraint on recovery observed at
10% (v/v) CO2 compared to 5% (v/v) under control conditions. This effect is not observed in the
presence of H89 with either agonist, further suggesting involvement of a PKA mediated mechanism.
In a physiological context this would mean that with hypercapnia bicarbonaturia would be expected
to increase. These results match those found in normal, PTH responsive men with increased CO2
inhalation where a decrease in bicarbonaturia was observed (Barker et al., 1957).
5.3.4 Physiological Evidence for the Requirement of IP3R Generated Ca
2+ Ions in the
Response to Elevated CO2
Section 5.3.3 demonstrated a CO2 dependent effect on NHE3 mediated pHi recovery in response to
AC agonists PTH and FSK, which was abolished in the presence of PKA inhibitor H89. This response
correlated with data generated in Chapters 3 and 4 whereby CO2 blunted the cAMP response to
agonist (Section 5.3.3). Results from both antagonist application to cAMP accumulation assays
in renal derived cells and cAMP measurements in genetically manipulated chicken lymphoblasts
provided evidence for an involvement of Ca2+ ion release from the ER via IP3 receptors in mediating
this cAMP effect (Chapter 4). It was, therefore, of interest to establish whether this Ca2+ ion release
was involved in the CO2 mediated cAMP effect on NHE3 demonstrated in the previous section.
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Figure 52: Effect of AC agonist on pHi recovery. Agonist concentrations of 5 nM PTH and 10 µM
forskolin with agonist solvent DMSO used as a negative control. Experiments at pH 7.4 and inhibitor
allowed time to enter cell prior to NH4Cl assault. CO2 percentages given as v/v in air. A: DMSO
B: PTH C: FSK D: PTH, 10 µM H89 E: FSK, 10 µM H89.
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Figure 53: Effect of AC agonist on pHi recovery. Percentage ratio of pHi recovery at 10% (v/v)
CO2 versus 5% (v/v) CO2 after an NH4Cl pulse, pH 7.4. Agonist concentrations of 5 nM PTH and
10 µM forskolin with agonist solvent DMSO used as a negative control. Inhibitor concentrations
detailed in Table 5 and these antagonists allowed time to enter cell prior to NH4Cl assault. CO2
percentages given as v/v in air. n ≥ 3
Comparison Diff. P value
DMSO vs FSK -82.35 P ≤ 0.001
DMSO vs PTH -61.82 P ≤ 0.05
DMSO vs FSK H-89 15.81 P ≥ 0.05
DMSO vs PTH H-89 11.89 P ≥ 0.05
DMSO vs BAPTA -28.66 P ≥0.05
DMSO vs Dantrolene -55.8 P ≤ 0.001
DMSO vs Xestospongin -25.89 P ≥ 0.05
DMSO vs 2-APB -22.36 P ≥ 0.05
DMSO vs Sto-609 -67.02 p ≤ 0.01
FSK vs PTH 20.53 P ≥ 0.05
FSK vs FSK H-89 98.16 P ≤ 0.001
Comparison Diff. P value
FSK vs BAPTA 53.69 P ≤ 0.05
FSK vs Dantrolene 26.55 P ≥ 0.05
FSK vs Xestospongin 56.47 P ≤ 0.05
FSK vs 2-APB 59.99 P ≤ 0.01
FSK vs Sto-609 15.33 p ≥ 0.05
PTH vs PTH H-89 73.71 P ≤ 0.05
FSK H-89 vs PTH H-89 -3.92 P ≥ 0.05
BAPTA vs Dantrolene -27.14 P ≥ 0.05
BAPTA vs Xestospongin 2.78 P ≥ 0.05
BAPTA vs 2-APB 6.3 P ≥ 0.05
Table 15: Statistical analysis of the effect of AC agonist on pHi recovery (Figure 53): ANOVA
analysis with post hoc Bonferroni testing. BAPTA-AM, Dantrolene, Xestospongin C, 2-APB and
Sto-609 experiments carried out in the presence of 10 µM FSK.
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Without any OK cell lines avaliable with the target receptor/enzyme genes ablated, pharmacological
antagonists and calcium chelators were employed to inhibit the desired element of the Ca2+ signalling
network. The pHi recovery after an NH4Cl pulse was thus monitored in the presence of an agonist
in addition to the desired antagonist. As both PTH and FSK elicited the same effects on NHE3
with CO2, FSK was used in these experiments as the AC agonist to avoid complications from PTH
activated IP3 release (Hruska et al., 1987; Pines et al., 1996; Abou-Samra et al., 1992).
Data provided in Figures 53, 54 and Table 15 illustrates that the CO2 dependent effect of FSK
is reliant on Ca2+ ion release from IP3 receptors. Agonist induced relief of the constraint on pHi
recovery at 10% (v/v) CO2 is reduced in the presence of intracellular Ca
2+ chelator BAPTA-AM.
With BAPTA-AM pHi recovery is faster with 5% (v/v) CO2 than 10% (v/v) CO2, similar to the
trend observed under control conditions. This result, in collaboration with the cAMP accumulation
data, implies that at elevated CO2 Ca
2+ ions are released which inhibit cAMP generation. The IP3
receptor inhibitors 2-APB and Xestospongin C gave similar results to BAPTA-AM, indicating that
the Ca2+ ion release is via these receptors, which agrees with the cAMP data from Chapter 4. Use
of the ryanodine receptor antagonist Dantrolene with FSK had no effect, with the 10%/5% (v/v)
CO2 ratio presented in Figure 53 statistically similar to values for FSK alone, thus proving that
Ca2+ ion release from this source is not required in this system.
Data is additionally provided with the Ca2+/calmodulin-dependent protein kinase kinase (CaM-
KK) antagonist Sto-609. As mentioned in Chapter 4, this enzyme has recently been implicated in
the transduction of a CO2 induced Ca
2+ ion release to Na+/K+-ATPase in alveolar epithelial cells
(Vada´sz et al., 2008b) and thus provided an interesting enzyme to test. Furthermore, Tokumitsu et
al. have provided evidence for the involvement of the CaM-KIV cascade, which includes CaM-KK,
in Ca2+ dependent gene expression by the phosphorylation of transcription factors such as CREB
(Tokumitsu et al., 2002). As cAMP is known to inhibit NHE3 via both phosphorylation (Fan et al.,
1999) and reduced expression (Nogueira et al., 2008), this information provides further justification
for the inclusion of Sto-609. However, as presented in Figures 53, 54 and Table 15, Sto-609 did not
remove the effect of FSK and therefore CaM-KK is not required to transduce the CO2 signal.
It is feasible that the Ca2+ ions released in response to elevated CO2 are acting directly on the
NHE3 antiporter to inhibit pHi recovery and this possibility is covered further in Section 5.3.5.
166
Figure 54: Effect of calcium signalling antagonists on agonist stimulated pHi recovery. Agonist
concentrations of 5 nM PTH and 10 µM forskolin with agonist solvent DMSO used as a negative
control. Experiments at pH 7.4 and inhibitor allowed time to enter cell prior to NH4Cl assault. CO2
percentages given as v/v in air. A: PTH, 1mM BAPTA-AM B: FSK, 1 mM BAPTA-AM C: FSK,
100 µM 2-APB D: FSK, 500 nM Xestospongin C E: FSK, 10 µM Dantrolene, F: FSK, 5 µM Sto-609.
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5.3.5 Involvement of PKC pHi Recovery at Different Capnic Levels
Section 5.3.4 demonstrates that the CO2 dependent effect of FSK (Section 5.3.3) requires Ca
2+ ion
release from IP3 receptors. Evidence in the literature suggests that NHE3 can be inhibited by both
PKA and PKC (Azarani et al., 1995), the latter of which is activated by Ca2+ ions. To test the
involvement of the PKC pathway, pHi recovery experiments were repeated, this time including the
PKC antagonist Go¨6983, in conjuction with FSK activation of AC (Figure 55, Table 16). Use of
Go¨6983 yielded similar trends to BAPTA-AM (explained in Section 5.3.4), removing the effect of
FSK on pHi recovery and yielding a trend similar to the control. This implies that PKC is involved
in inhibiting NHE3 with FSK activation. However, as inhibition of PKA with H89 (Section 5.3.3)
also removes the effect of FSK with elevated CO2, it can only be inferred that both pathways are
involved in this physiological effect of CO2.
Furthermore it is was interesting to test whether the disparity between control pHi recoveries at
5% (v/v) CO2 and 10% (v/v) CO2 (Section 5.3.2) was caused by the increase in intracellular Ca
2+
observed at elevated CO2 in the absence of any agonist stimulation (Chapter 4). NH4Cl pulse
experiments were repeated in the absence of any AC agonist with both Go¨6983 and Staurosporine,
another PKC antagonist. Results from Figure 56 and Table 16 demonstrate that with PKC inhibition
the constraint on pHi recovery at 10% (v/v) CO2 is removed, giving a 5%/10% percentage closer
to 100 than under control conditions. Data collected with Staurosporine is less statistically reliable,
however this is to be expected as Staurosporine is a non-specific kinase inhibitor, known have effects
on PKA, C, G, CaMK and MLCK. With such a range of targets it is therefore difficult to identify the
true target protein, however when used in conjuction with the Go¨6983 data they would suggest that
Ca2+ ions released in response to elevated CO2 inhibit NHE3 via PKC, resulting in the difference
in pHi recovery after NH4Cl pulse observed between 5% (v/v) CO2 and 10% (v/v) CO2.
PKC FSK ANOVA (Figure 55)
Comparison Diff. P value
DMSO vs FSK -82.35 P ≤ 0.001
DMSO vs BAPTA-AM -28.66 P ≥0.05
DMSO vs FSK Go¨6983 -27.94 P ≤ 0.05
FSK vs BAPTA-AM 53.69 P ≤ 0.05
FSK vs FSK Go¨6983 54.41 P ≤ 0.01
FSK BAPTA vs FSK Go¨6983 0.72 P≥ 0.05
PKC DMSO ANOVA (Figure 56)
Comparison Diff. P value
DMSO vs FSK Go¨6983 2.71 P ≤ 0.05
DMSO vs Staurosporine -18.53 P ≥ 0.05
Go¨6983 vs Staurosporine 13.59 P ≥ 0.05
Table 16: Statistical analysis of the effect of PKC antagonist on pHi recovery under different
conditions (Figures 55 and 56): ANOVA analysis with post hoc Bonferroni testing.
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Figure 55: Effect of PKC on FSK inhibited NHE3 activity. Agonist concentration of 10 µM forskolin
with agonist solvent DMSO used as a negative control. Experiments at pH 7.4 and inhibitors (1 mM
BAPTA-AM or Go¨6983) allowed time to enter cell prior to NH4Cl assault. CO2 percentages given
as v/v in air. n ≥ 6
Figure 56: Role of PKC on unstimulated pHi recovery under different capnic conditions. Experiments
at pH 7.4 and inhibitors (1 mM Go¨6983 or 1 µM Staurosporine) allowed time to enter cell prior to
NH4Cl assault. CO2 percentages given as v/v in air. n ≥ 3.
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5.4 Chapter Conclusions
Chapters 3 and 4 provided evidence for a pH independent inhibition of cAMP accumulation at
elevated CO2 reliant on Ca
2+ ion release from IP3 receptors in the ER. The aim of this chapter
was to identify whether this biochemical signalling effect could have a physiological outcome. To
investigate this, the activity of two downstream transporters; sodium-phosphate co-transporter
NaPi-IIa and sodium-hydrogen exchanger NHE3 were explored under a range of conditions. Whilst
results from NaPi-IIa did not support this signalling model, experiments on NHE3 activity were
more encouraging. By measuring pHi recovery following an NH4Cl pulse it was observed that under
control conditions recovery rate was faster in cells exposed to 5% (v/v) CO2 compared to those
at 10% (v/v) CO2. Activation of AC by both PTH and FSK both inhibited NHE3 activity as
expected and reversed this control trend, indicative of a reduction of cAMP generated at elevated
CO2 (explained fully in Section 5.3.3). Using pharmacological inhibitors this CO2 mediated effect
of cAMP was found to rely on intracellular Ca2+ ions realeased from IP3 receptors, agreeing with
the signalling data generated in Chapter 4. Pictoral representation of this effect of CO2 is provided
as Figure 57.
Inhibition of both PKA and PKC removed the effect of FSK on NHE3. This demonstrates that
under these conditions NHE3 activity is inhibited by both cAMP activated PKA and Ca2+ ion
stimulated PKC. Thus, it is possible that the CO2 generated Ca
2+ ions are involved in regulating
both control mechanisms. This duel mechanism is, however, unlikely to be the cause for the observed
decrease in phosphate uptake at 10% (v/v) CO2 compared to 5% (v/v) CO2 as PKC is known to
inhibit NaPi-IIa and phosphate transport (Malmstrom & Murer, 1986; Cole et al., 1987; Martin
et al., 1994). The effect of CO2 on phosphate transport can therefore not be explained but does
agree with findings from in vivo experiments in the literature, as mentioned in Section 5.2.3.
These findings may have profound implications, particularly when trying to understand the homeo-
static control mechanisms of systemic pH and inorganic carbon, in the context of metabolic acidosis
and hypercapnia. As sodium-hydrogen exchangers of the NHE family are present in most epithelial
cells (Schwark et al., 1998), understanding the control mechanisms behind their activity may be vital
in understanding the complications arising from hypercapnia in a range of contexts, from therapeutic
permissive hypercapnia through to cystic fibrosis and cardiovasular disease (Section 1.7).
Prolonged elevated CO2 may have an effect on multiple cellular proteins, both directly or indirectly.
One possible approach to defining targets to investigate further is through proteomic analysis of
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different cell samples after exposure to elevated CO2. Sample data from one such experiment is
provided in Appendix Chapter 8.
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Figure 57: Chapter 5 overview of signalling events at normal and elevated CO2. Normal CO2: PTH
activation of the AC signalling complex increases cAMP levels which in turn activate PKA and
inhibit NHE3 activity. Elevated CO2: CO2 induces a Ca
2+ ion release from the ER via the IP3
receptor. This Ca2+ blunts AC’s response to PTH resulting in reduced cAMP production, blunted
PKA activity and less inhbition of the NHE3 transporter.
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6 Chapter 6: Discussion
6.1 Introduction
This thesis demonstrates that elevated CO2 can alter physiological processes through IP3 mediated
Ca2+ release and an associated decrease in intracellular cAMP levels. Furthermore, these effects of
CO2 were independent of both intra- and extracellular pH. Results were obtained using the PTH
response of HEKPR1 and OK cell lines. OK cells were chosen because in vivo proximal tubule
cells are involved in inorganic carbon homeostasis through HCO−3 absorption from the glomerular
filtrate. Use of cultured cells enabled sufficient levels of control over incubation conditions and
CO2 associated acidoses and avoided any secondary interactions from the effects on the endocrine
and autonomic nervous systems. This discussion chapter will summarise the results presented in
Chapters 3, 4 and 5 and discuss their findings in relation to the literature currently available, and
present ideas for future studies arising from this work.
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6.2 Reduction in Agonist Induced cAMP with Elevated CO2
When stimulated by FSK or PTH, AC mediated cAMP production showed a consistent drop at
10% (v/v) CO2 compared to 2.5% and 5% (v/v) CO2. These pCO2 levels were chosen to represent
hyper-, normo- and hypocapnic conditions, spanning the extremes experienced in physiology and
pathophysiology (Marshall & Bangert, 2008). Sub-maximal concentrations of cAMP agonists were
used to enable the detection of either activation or down-regulation of the cAMP signalling pathway
under a given experimental condition. The observation that the inhibition of AC with elevated CO2
was present regardless of the AC agonist employed, indicated that the inhibitory effect of CO2 does
not occur upstream of AC and is independent of the AC isoform (PTH couples specifically to AC VI
in HEKPR1 cells (Tovey et al., 2008), whilst FSK activates all tmAC isoforms (Zhang et al., 1997)).
This response to CO2 is in direct contrast to the current paradigm where cyclic nucleotide levels
are observed to increase in response to increases in CO2 (Section 1.3.6). There is evidence in the
literature, however, that agrees with these findings. In Mucor racemosus, exposure to elevated
CO2 caused an immediate four-fold decrease in cAMP compared to control conditions, however this
effect may be due to the concomitant acidosis (Larsen & Sypherd, 1974). Townsend et al. previously
demonstrated a decrease in cAMP mediated CREB phosphylation at 10% (v/v) CO2 compared to
that at 5% (v/v) but no further details were given regarding this observation. In the light of
these results, it may be worth considering whether Ci may impart a biphasic effect on ACs with
stimulation in vivo at lower pCO2 levels from ambient to physiological levels and inhibition with
higher concentrations. Furthermore, whilst in isolation, inorganic carbon may have an activatory
role on an AC (Cann et al., 2003); in vivo other variables such as Ca2+ ions may modulate this
activity (Section 6.4).
As CO2 in solution reacts with water molecules to produce HCO
−
3 ions and protons, it was possible
that AC activity was being modulated by pH instead of CO2, especially as pH has been previously
shown to have a marked effect on AC activity in vitro (Hammes & Rodbell, 1976). The AC rate
dependence on pH is due to the fact that the enzyme requires its ATP substrate in two forms
for catalysis to proceed, with one ionisable group in its acid form and one in its basic form and
that the protonated form of the substrate alone has a strong inhibitory effect (Hammes & Rodbell,
1976). Some ACs are able to respond directly to changes in pH, such as the mycobacterial class III
AC, which has a pH sensing domain. When activated, this domain enables conformational changes
to occur, which allow the AC to orientate its two catalytic domains properly (Tews et al., 2005).
174
However, it has also been postulated that in some systems ACs are protected against pH change
through association with Na+/H+ exchangers, forming microdomains in which pH control on AC
activity is effectively eliminated (Willoughby et al., 2005).
The effect of experimental conditions on intracellular pH was determined using microspectrofluoro-
metric measurement of the cell-permeable pH sensitive dye BCECF-AM (Rink et al., 1982). Cells
transferred from normo- to hypercapnic media experienced an initial intracellular acidification, as
CO2 reaching the cells reacted in solution to produce protons. This acidification was followed by
a gradual return to resting pHas Na+/H+ antiporters are activated. Recovery time for pHi, on
average, was 10 minutes for both HEKPR1 and OK cells and a similar transient change in pHi could
be mimicked using 2 mM propanoic acid. BCECF dye was added to cells as an inactive acetoxyester
in order to permit penetration of the cell membrane. This slightly lowered the intracellular pH as
intracellular esterases cleave off the acetoxyester group, leaving an acidic functional dye less able
to cross the cell membrane (Hegyi et al., 2004). Although this is not ideal, the cells’ response to
fluctuations in CO2 concentration is still valid, as pH changes stemming from BECEF cleavage should
be minor (Hegyi et al., 2004). All pHi measurements were made after a BECEF-AM incubation step
with subsequent media perfusion. The pHi was stable prior to CO2 change and then recovered
afterward to the same pHi. Thus the effects of BCECF on pHi are unlikely to influence the central
findings of this thesis.
The timing of the transient pHi change was used to design cAMP accumulation experiments where
pHi was allowed to normalise after CO2 elevation and prior to any agonist application. Replication
of the pHi change associated with elevated CO2 using propanoic acid did not alter cAMP in the same
manner as hypercapnia. Therefore, the observations made concerning cAMP accumulation levels
are unlikely to be due to altered pHi, as any potential acid signal would need to persist long after pH
homeostasis. Extracellular pH is also unlikely to be responsible, as the potential mid-assay medium
acidification does not alter the EC50 for PTH for either HEKPR1 or OK cell lines. Additionally, the
blunted cAMP response at elevated CO2 can be reproduced when cells are exposed to both acidotic
or alkalotic extracellular pH, modelled by pH levels of 7.0 and 7.5 respectively (Marshall & Bangert,
2008). As mentioned, it has previously been demonstrated that G-protein regulated ACs are offered
some protection from changes in pHi through the action of Na+/H+ antiporters (Willoughby et al.,
2005) and this further justifies this conclusion.
The cAMP effects observed were also not due to any mild hypoxia that may have been induced
by the gas mixtures used in experimentation. This variable was important to disregard as a down-
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regulation of the cAMP signalling network has been reported as a mechanism by which cells adapt
to long-term hypoxia (Beitner-Johnson et al., 1998). This potential hypoxic difference was due to
the 5% (v/v) CO2 gas mixture containing 19.90% (v/v) O2 and the 10% (v/v) CO2: 18.85% (v/v)
O2. Experiments using a gaseous mixture of 5% CO2, 18% O2 and 77% N2 (v/v) to replicate
the hypoxic condition, in the absence of any additional hypercapnia, did not cause any inhibition of
cAMP production compared to a 5% (v/v) CO2 control. Thus hypoxia is unlikely to be a determining
factor in this blunted cAMP response.
The effect of CO2 on cAMP is demonstrated in five independent cell lines: HEKPR1, OK, UMR-
106, A549 and DT40 IP3R1. This suggests a species and tissue independent effect, at least at
the metazoan level. Whilst results from the renal and osteoblast cell lines are of interest as these
tissues are involved in Ci homeostasis, confirmation using the alveolar epithelial cell line, A549, is of
particular interest as a key tissue affected by the use of permissive hypercapnia in a clinical setting.
The use of permissive hypercapnia is of increasing interest as a treatment for a range of pathological
disorders where artificial hypoventilation is induced to avoid damage from overstretching the lungs.
The positive effects of this strategy are not only due to the mechanical ventilation, but have also
been attributed to the induced hypercapnia itself, largely due to the anti-inflammatory influence of
CO2 (Sections 1.7.1 and 1.7.2). The effects of CO2 on cAMP observed here may provide further
insight into the positive effects of permissive hypercapnia.
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6.3 Use of Pharmacological Inhibitors Suggests Ca2+ Ion Release from
IP3 Receptors in the Endoplasmic Reticulum
Based on the conclusions drawn in Section 6.2 it was not possible to determine whether the inhibitory
influence of CO2 on cAMP signalling was due to a direct interaction with AC or indirectly through
another signalling pathway affecting cAMP. Pharmacological inhibitors offered the best initial route
to investigate the impact of other signalling molecules, taking advantage of the broad spectrum of
targets antagonised under moderate inhibitor concentrations. Through studies on HEKPR1 cells,
it was possible to eliminate interactions from sAC, PDEs, PKA, CA, sphingosine kinases 1 and 2,
PKC and CAMKII. However, antagonism of tmACs did greatly reduce cAMP levels and remove
inhibiton at 10% (v/v) CO2, indicating that the majority of the cellular cAMP produced was from
tmACs and the effects of CO2 were on these isoforms and not the HCO
−
3 stimulated sAC (Section
1.3.6).
Interestingly, the blunted cAMP response with hypercapnia was not affected by the CA inhibitor
acetazolamide (Maren, 1952). This result may indicate that there is no requirement for CO2 from
the media to be converted to HCO−3 to cross the membrane (Huckstepp et al., 2010a) and inhibit
the AC either directly or indirectly. Missner et al. demonstrated that Ci movement across a
membrane is via passive diffusion of the CO2 species (Missner et al., 2008), opposed to through
previously hypothesised routes via membrane channels such as aquaporin 1 (Endeward et al., 2006)
or the Rhesus complex RhAG (Endeward et al., 2008). The authors demonstrate that movement
of Ci across a membrane physiological pH levels is restricted by the near-membrane unstirred layer,
which acts as a diffusional barrier to the membrane. Here, CAs convert any HCO−3 ions from the
extracellular bulk to CO2, allowing diffusion across to the intracellular compartment where the
reverse can occur, enabling both CO2 and HCO3
− to exist within the cell (Missner et al., 2008).
With CAs inhibited, CO2 within the cell will not be converted to HCO3
− as readily, supporting the
inference that there is no requirement for the CO2 within the media to be converted to HCO3
− to
inhibit the AC. Nevertheless, the possibility that the blunted cAMP response at 10% (v/v) CO2 is
due in part to HCO−3 cannot completely be excluded. Use of in vitro AC assays under conditions
of Ci disequilibrium where a single predominant carbon species, CO2 or HCO3
−, is present at a
defined pH (Hammer et al., 2006) would further identify this mechanism.
Use of pharmacological inhibitors also identified a role for intracellular Ca2+ in the response to CO2.
In the presence of the intracellular Ca2+ chelator BAPTA-AM, no reduction in cAMP accumulation
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was observed at 10% (v/v) CO2, whilst in the presence of non-membrane permeable EGTA, the
expected drop was obtained. This result suggested that the hypercapnic effect on cAMP signalling
involved Ca2+ and that the source was most likely derived from an intracellular store. It is possible
that by chelating Ca2+ ions, CO2 diffusion rates are affected through inhibition of CA activity (Botre
et al., 1991). However, as acetazolamide had no effect on the cAMP trend, this is unlikely.
Further experimentation with antagonists to individually inhibit each of the main intracellular
calcium stores led to the inference that Ca2+ release was occuring from the endoplasmic reticulum.
This inference was made from the observation that thapsigargin ablated the cAMP response to CO2
in both OK and HEKPR1 cells. Interestingly, this approach was also implemented by Bouyer et al.
in rabbit S2 PT cells to identify the source of a pH independent Ca2+ signal, generated following an
application of basolateral CO2, but in this case the authors were unable to locate the source (Bouyer
et al., 2003).
Further chemical antagonists were used to identify the Ca2+ source within the ER and whether
other potential elements of the Ca2+ signalling network could be involved in regulating AC activity.
From these studies it was inferred that in OK cells, whilst PLC and Ca2+ release from ryanodine
receptors were not involved, the Ca2+ responsible for blunting agonist induced cAMP production at
elevated CO2 was most likely from IP3 receptors. The use of IP3 receptor antagonist 2-APB in OK
cells removed the CO2 effect on cAMP levels, whilst Xestospongin C had no effect. The 2-APB data
thus implicated CO2 dependent release of Ca
2+ from IP3 receptors, whilst those from Xestospongin
C did not concur. 2-APB antagonises both IP3 receptors and transient receptor potential channels,
TPCs (Prakriya & Lewis, 2001; Venkatachalam et al., 2001; Martin et al., 2009). It is, therefore,
possible that Ca2+ entry was across the plasma membrane via TPCs, although the lack of a role for
extracellular Ca2+ (EGTA result) eliminated this possibility and supported a role for Ca2+ release
from the ER, via the IP3 receptor.
The involvement of CaM-KK in this response was also tested using antagonist Sto-609. A CaKK-β
dependent route was identified recently, by which alveolar epithelial cells respond to hypercapnia
(Vada´sz et al., 2008a). This response involved a rapid and transient increase in intracellular Ca2+,
which caused Na+, K+-ATPase endocytosis and may explain why hypercapnia impairs alveolar
fluid reabsorption, an important consideration with permissive hypercapnia. In the presence of Sto-
609, however, the cAMP response to CO2 was unaltered, demonstrating that this enzyme was not
required to inhibit AC activity under hypercapnic conditions in OK cells.
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6.4 Release of Calcium by Elevated CO2
The use of pharmacological inhibitors identified that in HEKPR1 and OK cells the inhibition of
cAMP accumulation at elevated CO2 involved an interaction with an intracellular Ca
2+ source and
that this source was most likely from IP3 receptors in the endoplasmic reticulum. A role for the
IP3 receptor was subsequently proven through the use of an independent cell line that had been
genetically ablated for all three IP3 receptor isoforms (Sugawara et al., 1997). When exposed to
hypercapnic CO2, this DT40 IP3 receptor knock-out ( DT40 K/O) exhibited no change in cAMP
accumulation levels between CO2 concentrations. However, in a DT40-IP3R1 cell line where the gene
for IP3 receptor 1 had been re-introduced (Laude et al., 2005), the reduction in cAMP accumulation
at elevated CO2 was observed once more, providing genetic proof that cAMP inhibition requires
Ca2+ release from IP3 receptors.
DT40 cells were also used to demonstrate CO2 induced Ca
2+ release, using the Ca2+ sensitive
ratiometric dye Fura-AM (Grynkiewicz et al., 1985). Through this method, an increase in intracellular
Ca2+ was observed on transition from 5% to 10% (v/v) CO2 that was independent of pH and any
hypoxic changes incurred. Ca2+ release was demonstrated both pharmacologically and genetically
to be via IP3 receptors and did not require extracellular Ca
2+. The lack of a role for extracellular
Ca2+ is particularly important as most Ca2+-sensitive ACs are regulated by capacitative calcium
entry (Cooper et al., 1994; Sunahara & Taussig, 2002; Willoughby et al., 2005). This Ca2+ release
did, however, require PLC activity, as demonstrated through the use of antagonist U73-122. As PLC
is responsible for generating the IP3 signal, this result would suggest that the CO2 sensor is located
within or upstream of this pathway. However, when this antagonist was used in cAMP accumulation,
there was no demonstrable effect. This discrepancy may be due to the questionable effects of U73-
122 on PLC, which may induce both inhibition and activation, as well as a host of other unspecific
interactions with signalling molecules (Klein et al., 2011). It is also possible that DT40s contain
different PLC isoforms to the OK cells employed for cAMP accumulation, with different sensitivities
to U73-122 and/or CO2. Future work to identify the CO2 receptor would require further attention
to this section of the Ca2+ signalling network. It is possible that the signalling response to CO2
in HEKPR1 and OK cells does not involve the IP3 receptor. This possibility is unlikely, however,
as the IP3 receptor antagonists used in this study were validated by demonstrating their effect on
CO2 mediated Ca
2+ release in DT40-IP3R1 cells. Future experiments, using siRNA or knock-outs
generated via zinc finger nucleases, would enable genetic conformation in these renal cells.
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This observed release of Ca2+ and the inferred effect on AC and cAMP production would suggest
that, at elevated CO2, AC is inhibited by Ca
2+ or a molecule regulated by Ca2+. All tmAC
isoforms are inhibited by high concentrations of calcium, due to competition between these divalent
ions and the Mg2+ co-factor (Guillou et al., 1999). Certain isoforms are also regulated at lower
concentrations e.g. tmACs V and VI (Ishikawa et al., 1992; Yoshimura & Cooper, 1992; Guillou et al.,
1999). IP3 receptor 2 and AC VI have been shown to interact in HEK cells after PTH stimulation
forming ‘cAMP junctions’ (Tovey et al., 2008). These interactions have been hypothesised to directly
provide supramaximal concentrations of cAMP to the IP3 receptor, in order to increase the receptor’s
sensitivity to IP3 (Tovey et al., 2008). It is plausible that this interaction may work in reverse under
hypercapnic conditions, with IP3 mediated Ca
2+ release inhibiting the AC VI and thus generating
the data obtained in this report. Cooper et al. presents a model whereby AC and Ca2+ create
a negative feedback control loop that results in oscillations of the two second messengers (Cooper
et al., 1995). It is possible that these observations follow a similar feedback loop. Although the
PKC antagonists staurosporine and Go¨6983 did not identify a role for PKC, the calcium chelator
BAPTA-AM is also known to inactivate this kinase (Dieter et al., 1993). As the use of BAPTA-
AM removed the CO2 restraint of cAMP accumulation, it is feasible that this regulation could be
mediated by PKC. Experimentation using a genetic model, for example, would be needed to further
identify the mechanism behind AC inhibition.
Some PDE isoforms are also regulated by Ca2+/CaM (Section 1.5.3). With hypercapnia, the CO2
induced Ca2+ ions could activate a Ca2+-sensitive PDE, increasing cAMP turnover. However, all
cAMP accumulation experiments were carried out in the presence of non-selective PDE inhibitor
IBMX and so PDE involvement is unlikely (Gray, 2006). Furthermore, the PDE isoforms PDE8A,
8B and 9, which show limited sensitivity to IBMX, exhibit no known sensitivity to Ca2+ (Omori &
Kotera, 2007; Wang et al., 2008).
A role for elevated Ca2+ signalling in the response to CO2 has been investigated previously. Vada´sz
et al. noted a transient increase in cytoplasmic Ca2+ in response to hypercapnia, whilst Bouyer et
al. identified a rise in intracellular Ca2+ in response to basolateral Ci application (Bouyer et al.,
2003; Vada´sz et al., 2008a). Further evidence of acidosis (Tsunoda et al., 1991; Dwyer et al., 1991;
Buckler & Vaughan-Jones, 1993; Slotki et al., 1993; Ziegelstein et al., 1993) and hypercapnic acidosis
(Rigual et al., 1991; Nishio et al., 2001) stimulating Ca2+ release is also available. Whilst pH has
been eliminated as the Ca2+ mobilising signal, particularly through the use of propanoic acid, which
had no effect on Ca2+ release, it is still plausible that pH could be contributing. Further monitoring
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of pHi with simultaneous measurement of intracellular Ca2+ may delinerate this interaction further.
It might also be interesting to follow the production of cAMP (Binkowski et al., 2011) and IP3
through real-time application of biosensors (Tanimura et al., 2009).
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6.5 Effect of CO2 on cAMP Dependent Physiological Processes
The effects of the hypercapnic alterations to cAMP and Ca2+ signalling on downstream physiological
responses were tested, focusing on the sodium-driven transporters NaPi-IIa and NHE3. These
luminal membrane transporters are both downstream of AC and are inhibited in response to PTH.
In vivo NaPi-IIa and NHE3 are particularly important as they are vitally responsible for controlling
the levels of phosphaturia and bicarbonaturia respectively (Section 1.7.3). Hypercapnia appears to
have divergent effects on the biochemical signalling network and downstream response from NaPi-IIa.
However, the effect of hypercapnia on NHE3 activity and its ability to rescue pHi after an ammonium
chloride pulse were more conclusive. When activated by an AC agonist, the pHi recovery rates
under control and elevated pCO2 were reversed, providing a link between the inhibition of cAMP
production and a physiological outcome.
6.5.1 Inhibition of Phosphate Uptake with Hypercapnia
As NaPi-IIa activity is inhibited by cAMP signalling, it was hypothesised that the inhibition of
agonist induced cAMP accumulation at elevated CO2 would result in a relative increase in phosphate
ion uptake at this CO2 concentration, compared to normocapnic control. This hypothesis was based
on the assumption that the reduction in cAMP would alleviate the inhibition on NaPi-IIa, enabling
a higher level of activity. Whilst application of both AC agonists PTH and FSK inhibited phosphate
uptake via PKA, the expected increased response with elevated CO2 was not observed. Instead,
there was a consistent decrease in phosphate uptake, independent of agonist presence, absence or
the agonist used.
This inhibition of phosphate uptake at elevated CO2 can not, therefore, be attributed to cAMP and
PKA activity. The reduction in phosphate reabsorption with hypercapnia has been demonstrated
previously in the literature (Lotspeich & Malvin, 1956; Webb et al., 1977; Guntupalli et al., 1987;
Jehle et al., 1999) and may instead be attributed to the observed Ca2+ release with elevated
CO2, especially as Ca
2+ ions are known to inhibit NaPi-IIa mediated phosphate uptake via PKC
(Malmstrom & Murer, 1986; Cole et al., 1987; Martin et al., 1994). Repetition of these experiments
in the presence of calcium chelators and PKC antagonists may begin to delinearate the observed
trend. Furthermore, the effects of hypercapnia may also be a result of alterations to NaPi-IIa
expression, which previously have been observed to increase with isohydric normocapnia, compared
to hypercapnia in OK cells (Jehle et al., 1999). It is even possible that the activity of the NHE3
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exchanger has an indirect effect on NaPi-IIa activity through alteration of the sodium gradient
(Hamm et al., 1984). As elevated CO2 increases AC agonist inhibited NHE3 activity compared to
a normocapnic control (Section 6.5.2), the availability of sodium ions would decrease. With fewer
sodium ions available for co-transport by NaPi-IIa, it is likely that phosphaturia would develop.
6.5.2 Decreased Inhibition of AC Agonist Induced NHE3 Activity with Hypercapnia
The effect of CO2 on the cAMP inhibited Na
+-H+ antiporter NHE3 is consistent with the observed
biochemistry of the influence of CO2 on cAMP. By measuring NHE3 mediated pHi recovery following
an NH4Cl pulse it was observed that under control conditions recovery rate was faster in cells
exposed to 5% (v/v) CO2 compared to those at 10% (v/v) CO2. Activation of AC by both PTH
and FSK both inhibited NHE3 activity as expected and reversed this control trend, indicative of a
reduction of cAMP generated at elevated CO2. Using pharmacological inhibitors, this CO2 mediated
effect of cAMP was observed to rely on intracellular Ca2+ ions released from IP3 receptors, further
agreeing with biochemical data. Ca2+ release has been documented to increase HCO−3 flux in PT
cells previously (Liu & Cogan, 1990), although this observation may involve either NHE3 or Na-
HCO−3 transporters. Additionally, modulation of proton secretion rates similar to those observed
here have been previously demonstrated with CO2 application. CO2 has been demonstrated to
not only increase cytosolic Ca2+ but also elevate proton secretion (Schwartz & Al-Awqati, 1985;
Van Adelsberg & Al-Awqati, 1986). However, these effects were attributed to the action of H+-
ATPases. It is unlikely that the observed pHi recovery rates were mediated by H+-ATPases as AC
agonists inhibited recovery and, under control conditions, both DMA and an absence of sodium ions
restricted pHi recovery. Confirmation of that the observed CO2 trend is due to the activity of NHE3
may be provided through use transporter siRNA or knock-outs generated via zinc finger nucleases,
in addition to the use of pharmacological inhibitors such as DMA or S3226 (Schwark et al., 1998).
Inhibition of both PKA and PKC removed the effects of FSK on NHE3. This demonstrates that
under these conditions NHE3 activity is inhibited by both cAMP activated PKA and Ca2+ ion
stimulated PKC. Thus, it is possible that the CO2 generated Ca
2+ ions are involved in regulating
both control mechanisms. It is possible that this duel regulation is due to the fact that the cells
used are not polarised, especially as the two systems are purported to be spatially separated (Section
1.7.3). This may be investigated through the use of primary cell cultures and transwells which enable
solution perfusion to both apical and basolateral sides of the cell (Rakonczay et al., 2006).
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6.6 Further Future Work
Throughout this chapter where relevant future experiments have been outlined. These largely involve
confirming the current conclusions using genetic models incorporating either siRNA or knock-outs
generated using zinc finger nucleases, particularly with IP3 receptors from epithelial cell lines and
the NHE3 transporter. These constructs are not currently commerically avaliable for the desired
targets and therefore were not implemented in this thesis.
From these results it is not possible to know whether the Ci and Ca2+ are interacting with the
AC directly or via another molecule or even definitively whether the active Ci species is CO2 or
HCO−3 ions. Use of in vitro AC assays on purified enzymes from these HEK and OK cell lines
under conditions of Ci disequilibrium (Hammer et al., 2006) would answer some of these questions.
Additionally, it is not known whether the observed effects on AC are a general mechanism on all
AC isoforms present or on an individual isoform. In vitro assays where possible and AC isoform
knock-outs using zinc finger nucleases could further help identify the Ci-regulated enzymes.
An important physiological experiment would be to use isolated proximal tubules for perfusion
and NHE studies. Whilst cell lines have numerous advantages, they can be heterogenous and
unpolarised, potentially leading to misleading results particularly in epithelial cells such as those
from the proximal tubule, which have different proteins associated with the apical and basolateral
membranes. Experiments to identify whether the observed CO2 effect is apical or basolateral
are particularly important due to spatial separation of the PKA and PKC mediated signalling
networks in response to PTH stimulus (Section 1.7.3). In addition, Chen et al. demonstrated a pHi
alkalinisation of proximal tubule cells in response to Ci which is not due to HCO−3 transport but
most likely from proton extrusion across the apical membrane (Chen & Boron, 1995a,b). However,
this effect depended on whether the cells were exposed to Ci on their apical or basolateral face
with the tubule lumen insensitive to Ci and the basolateral proposed to contain a Ci sensor (Chen &
Boron, 1995b). In continuation of this work, Bouyer et al. demonstrated that this basolateral sensor
acted by increasing intracellular Ca2+ (Bouyer et al., 2003). These results potentially agree with the
work presented in this thesis, although Bouyer et al. were unable to locate the Ca2+ source (Bouyer
et al., 2003). It would, therefore, be of interest to ascertain whether the two signalling observations
match up. Futhermore, use of polarised cells would also confirm the physiological involvement of
the apical NHE proton transporter compared to the basolateral Na+/HCO−3 co-transporters in pHi
maintenance and recovery after NH4Cl pulse.
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Further work is also required to identify the CO2 sensor and the mechanism by which the IP3
receptor is activated. Due to the involvement of this receptor it is resonable to assume that IP3
is being generated. Therefore, one of the first experiments of interest would be to measure IP3
generation in response to elevated CO2 by with commercially avaliable tritium-labelling kits or a
FRET biosensor (Remus et al., 2006), in addition to inhibiting the IP3 generating enzyme PLC
with siRNA. Whilst PLC was inhibited at various points during this thesis the inhibitor U-73122
has since been demonstrated to have questionable inhibitory properties and thus a more efficient
method would need to be sought out in future (Klein et al., 2011).
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6.7 Clinical Implications of these Observations
The observations detailed in this thesis may have profound implications, particulary when trying
to understand the homeostatic control mechanisms of systemic pH and inorganic carbon in the
context of metabolic acidosis and hypercapnia. This is particularly important as hypercapnia can
occur as a complication of numerous disease states, with elevated CO2 often associated with a
worse prognosis and elevated morbidity. The effects of CO2 on both the cAMP and Ca
2+ signalling
pathways presented may potentially provide a key mechanism by which the toxic effects of CO2 are
manifested. For example, there is growing evidence that chronic daytime hypercapnia associated
with obstructive sleep disorders pre-disposes individuals to cardiovascular disease (Gopalakrishnan &
Tak, 2011). Furthermore, the leading cause of hospitalisation and morbidity among COPD patients,
who commonly experience hypercapnia, is cardiovascular events (Sin & Man, 2005). Azzam et
al. suggests that as chronic hypercapnia is known to cause permanent damage to muscle cells
in C.elegans (Sharabi et al., 2009), a similar mechanism might explain the observed cardiovascular
complications (Sin & Man, 2005) and reductions in muscle mass noted with COPD patients (Maltais
& Debigare´, 2003). As Ca2+ is paramount in maintaining muscle, cardiac and circulatory physiology
the signalling events presented in this thesis may provide a key route to understanding pathophysiology
of hypercapnia and suggest possibilities for therapeutic intervention.
Inconsistent with the detrimental effects of CO2, permissive hypercapnia is often used as a treatment,
particularly when mechanical ventilation is required to support patients suffering with respiratory
complications, and this use of CO2 is related to an improved outcome. This protective effect has been
largely attributed to the anti-infammatory influence of CO2, however, further understanding into
the mechanisms involved in these hypercapnic effects is required. These anti-inflammatory effects
stem from the pH independent attenuation of the NF-κB pathway with elevated CO2 (Cummins
et al., 2010). As cAMP is known to potently regulate the NF-κB pathway (Satriano & Schlondorff,
1994; Minguet et al., 2005) it is possible that these signalling events initiate a negative control
feedback loop. The benefits of therapeutically administed permissive hypercapnia have also, in part,
been attributed to an inhibition of alveolar fluid reabsorption via cAMP mediated endocytosis of
Na,K-ATPase (Vada´sz et al., 2008a). Both cAMP and Ca2+ signalling are also known to affect fluid
reabsorption in the lung through other mechanisms, through the regulation of the cystic fibrosis
transmembrane conductance regulator, CFTR (Cheng et al., 1991), and calcium-activated chloride
channels, CaCC (Fischer et al., 2010), respectively. Thus, the signalling event demonstrated in this
thesis could provide a link to the physiological effects observed with elevated CO2.
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7 Appendix I: Extended Methodology
7.1 Nigericin Calibration and Compensation of Drift
In order to convert data recorded at 440 nm and 490 nm from excitation of BCECF-AM loaded
cells into a measurement of the intracellular pH, a nigericin calibration was carried out according
to the methods outlined by Thomas et al. and Hegyi et al. (Thomas et al., 1979; Hegyi et al.,
2004). Briefly, cells are exposed to 10 µg mL−1 of the K+/H+ antiporter nigericin in high potassium
solutions (Section 2.4.1) at a pH range of physiologically relevant values. Most commonly these pH
values were 6.8, 7.0 and 7.4. Due to the action of the nigericin, pH equilibrates across the plasma
membrane through an exchange of internal K+ for external H+, resulting in a pH equilibration better
than 90% (Thomas et al., 1979). It can then be assumed that the intracellular pH is equivalent to
the known extracellular pH of the perfused solution, thus enabling calibration from the 490/440 nm
ratio. By using buffers with high potassium concentrations of 130 mM, similar to the intracellular
concentration, nigericin induced K+/H+ exchange is not limited by internal K+. The resultant K+
gradient will therefore not drive the formation of any pH gradients across the plasma membrane
(Thomas et al., 1979). Calibration by this method provides accurate estimation of pHi as small
as 0.01 pH units (Thomas et al., 1979). A visual representation of the effect of nigericin on the
cells is presented in Figure 58, which displays example raw 490/440 ratio data generated with each
consecutive nigericin solution compared to the same data after pH calibration.
Due to the effects of dye loading, dye leakage, and photomultiplier aperture size, one calibration
curve is not sufficient for accurate determination of pHi, and an appropriate calibration curve must
therefore be selected for each individual experiment (Hegyi et al., 2004). Calibration is only linear
over a narrow range of pHi values with calibration curves often divergent, particularly at higher
pHi values (Boyarsky et al., 1996; Hegyi et al., 2004). Using the method described by Hegyi et al.,
a graph can be generated from which a calibration curve can be created specific to every data set
recorded, based on the assumption that the resting pH of cells in each experiment should be similar
provided that the experimental conditions are identical (Hegyi et al., 2004). With this method,
the use of nigericin in each experiment is unecessary. Representative graphs from this calibration
process are shown in Figure 59.
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Figure 58: Effect of nigericin on intracellular pH in OK cells. Values presented above the trace
refers to the pH of the nigericin containing high potassium solution solution being perfused over
cells. A: 490/440 nm fluoresence ratio. B: Data from A calibrated for pHi.
Figure 59: Explanation of pHi calibration. Calibration used the method outlined by Hegyi et
al., graphs provided from OK cell data. A: Graph of BCECF 490/440 nm emission ratio for
nigericin calibration values (each known pHi linked by diagonal linear regression lines) against the
490/440 nm emission ratio at known pHi 7.4. Vertical lines used to construst calibration curves in
C and arbitrarily numbered 1-6 from left to right. B: BCECF calibration curves. Each line was
constructed from the vertical lines in B and their intercepts with diagonal lines of known pHi so
that 490/440 nm ratio could be plotted against pHi. From this graph calibration raw data could be
calculated individually for each experimental data set.
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In addition to nigericin calibrations, raw data was also adjusted to compensate for drift. Drift
refers to the continuous and unavoidable leakage of the BCECF-AM dye from the cells and can
be seen clearly on the raw data example (Figure 60) as a decrease in emission intensity with 440
nm (Hegyi et al., 2004), therefore potentially leading to a loss of pHi accuracy (Weiner & Hamm,
1989). To compensate for this, data can be adjusted using the method outlined by Hegyi et al.
(Hegyi et al., 2004) whereby a resting pHi for cells under each experimental condition is calculated
and an imaginary line can be drawn across the data set linking all the time points where the cells
are expected to be at this resting pHi. Using this method a correction can be made based on the
assumption that the drift is linear, which is generally the case (Hegyi et al., 2004). To compensate
for this drift, the product of the following equation is subtracted from the pHi value calculated
through nigericin calibration:
pHi change = pHi start - pHi end /total number of data sample points within this range
Illustration of this principle is shown in Figure 60 which shows a raw data set with obvious drift (A),
the affect on the ratio (B) and an example of the same data set once this drift has been compensated
for (C).
It is important to note that in addition to all of the above corrections to the data sets, intital
background counts were also removed from raw data, using values measured from the microspectro-
fluorometer before the shutter to the photomultiplier had been opened.
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Figure 60: Compensation for drift A: Graphical representation of raw fluoresence data displaying
obvious drift in the 490 nm values. B: Graph of the 490/440 nm ratio for this same data set.
Horizontal lines approximately contecting same pHi values. C: Data set adjusted for drift and
calibrated to show intracellular pH. Horizontal lines approximately connecting same pHi values.
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7.2 DT40 Bradford Assay
DT40 cells were grown as a suspension culture. This presented problems when measuring intracellular
cAMP levels due to the large amount of insoluble material in lysed cell samples clogging the
chromatography columns used to measure cAMP with adherant cells (Section 2.4.6). Instead a cAMP
ELISA (GE Healthcare R©, RPN2251) was utilised. To account for the possible variations in cell
number between samples, ELISA generated cAMP concentrations were normalised for sample protein
content. Protein concentration was determined through Bradford assay (Section 2.6.2) where optical
density at 595 nm is compared to a standard curve generated using known concentrations of BSA
(Figure 61). This value could then be used to generate cAMP concentrations normalised to sample
protein content, enabling comparision between assays. Data provided in Table 17 demonstates this
method providing a clear increase in normalised cAMP values in cells exposed to forskolin compared
to a DMSO control.
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Figure 61: Bradford standard curve example. Experimentally determined standard curve generated
using standard protein bovine serum albumin (BSA) at known concentrations.
Sample
Bradford Protein ELISA Generated Normalised
Mean S.E.M.Assay Conc. cAMP Conc. cAMP Content
OD595 (µg/ml) (fmol/ml) (fmol/µg protein)
DMSO 1 0.637 1.419 45.11 31.79
84.57 25.10
DMSO 2 0.625 1.225 94.38 77.02
DMSO 3 0.63 1.306 199.56 152.80
DMSO 4 0.605 0.902 69.20 76.69
FSK 1 0.658 1.758 2179.97 1239.95
929.03 122.34
FSK 2 0.642 1.500 1354.27 902.97
FSK 3 0.632 1.338 859.51 642.22
FSK 4 0.651 1.645 1531.56 930.99
Table 17: Normalising DT40 ELISA sample cAMP content to protein content: table to illustrate
calculations. Sample protein concentration calculated via Bradford assay and comparison of the
optical density at 595 nm to a BSA generated standard curve (Figure 61). Concentration of cAMP
generated using cAMP ELISA (GE Healthcare R©, RPN2251). S.E.M. refers to the standard error of
the mean.
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7.3 Fura 2 Calcium Calibration
To convert data recorded at 340 nm and 380 nm from excitation of Fura 2-AM loaded cells into
the correct measurement of the intracellular [Ca2+], calibration was carried out according to the
methods outlined by Grynkiewicz et al. and Bouyer et al. (Grynkiewicz et al., 1985; Bouyer et al.,
2003). Cells were loaded with Fura 2-AM (Section 2.4.2) with the inclusion of 5 µM ionomycin
during the second incubation step. Ionomycin is a calcium ionophore which transports ions across
the lipid bilayer of the cell membrane allowing for the assumption that the cytoplasmic [Ca2+] is
equal to that of the surrounding medium. The cells were then incubated in Krebs-Ringer-HEPES
solutions containing 0 mM (130 mM NaCl, 25 mM Glucose, 20 mM HEPES, 14 mM NaHCO3, 5
mM KCl, 1 mM MgSO4, 5 mM EGTA, pH 7.4) and dye saturating 5 mM (130 mM NaCl, 25 mM
Glucose, 20 mM HEPES, 14 mM NaHCO3, 5 mM KCl, 1 mM MgSO4, 5 mM CaCl2, pH 7.4) free
Ca2+ ions and their fluorescence levels at 340 and 380 nm measured (Figure 62).
From these values intracellular [Ca2+] could be calculated using the method outlined by Grynkiewicz
et al. in which the equation shown below was employed (Grynkiewicz et al., 1985). Here Kd
refers to the dissociation constant, R340/380 the experimental 340/380 nm ratio, Rmin the minimum
340/380 nm ratio at 0 mM Ca2+, Rmax the maximum 340/380 nm ratio at dye saturating 5 mM
Ca2+, Sf2 the fluorescence measurement at 380 nm with 0 mM Ca
2+ and Sb2 380 nm fluorescence
with dye saturating 5 mM [Ca2+].
[Ca2+]i = Kd (
R340/380−Rmin
Rmax−R340/380 ) x
Sf2
Sb2
To ensure that the light beam used to excite the dye for fluoresence measurements was not causing
autofluorescence from another cellular constituent, cells were exposed to the beam in the absence
of Fura 2. This test gave fluorescence values of ∼2.50 at 340 nm, ∼3.00 at 380 nm and 340/380
ratios ∼0.85. While small, these values could lead to the generation of potentially misleading Ca2+
concentrations. To eliminate this possibilty at the end of every experiment cells were quenched using
5 mM MnCl2, as suggested by Bouyer et al. (Bouyer et al., 2003). Quenched fluoresence values for
each wavelength were then treated as background and removed from the experimental values prior
to ratio generation and calculation of Ca2+ concentration.
The dissociation constant (Kd) was calculated for the equipment employed, allowing for potential
variations in instrument sensitivity and optical path length. To do this, the commercially avaliable
Molecular Probes R© ‘Fura-2 Calcium Imaging Calibration Kit’ was utilised. In this kit free-Fura 2
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Figure 62: Ionomycin calibration example. 0 mM Ca2+ solution refers to a Krebs-Ringer-HEPES
solution containing 5 mM EGTA, 5 mM Ca2+ solution with 5 mM CaCl2 and 5 mM Mn
2+ with 5
mM MnCl2
Figure 63: Fura 2-AM dissociation constant calculation. Experimentally determined calibration
curve generated using Molecular Probes R© ‘Fura-2 Calcium Imaging Calibration Kit’. Log of the
dissociation constant provided by the y-axis intercept of the best-fit line provided. R340/380 refers
to the the experimental 340/380 nm ratio, Rmin the minimum 340/380 nm ratio at zero Ca
2+,
Rmax the maximum 340/380 nm ratio at dye saturating Ca
2+, Sf2 the fluorescence measurement at
380 nm with zero Ca2+ and Sb2 380 nm fluorescence with dye saturating Ca
2+
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acid is provided in a range of free Ca2+ ion/EGTA mixtures providing a range of free calcium from
0 µM through to dye saturating concentrations of 39 µM. These solutions were measured for their
340 and 380 nm fluorescence values under similar conditions to the in cellulo experimental conditions
at pH 7.2 and 37◦C. Data generated from these measurements can then be used to draw a calibration
graph Figure (63) where the y-axis intercept forms the log of this empirically determined dissociation
constant. Using this method, the dissociation constant was calculated as 182.43 nM.
An example of this calibration process including removal of background quench values and application
of the Grynkiewicz et al. equation to generate Ca2+ concentrations is provided as Figure 64.
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Figure 64: Example of experimental Fura 2 data calibrated for [Ca2+] A: Graphical representation
of raw fluorescence data (left panel) with 340/380 nm ratio (right) B: Graphical representation of
fluorescence data with quench values removed, raw data on left and 340/380 nm ratio on right. C:
Final graph for Ca2+ ion concentration.
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7.4 Measuring pHi Recovery After Ammonium Chloride Pulse
In order to monitor the activity of sodium-hydrogen exchanger 3 (NHE3), OK cells were exposed to
ammonium chloride pulses under different conditions and NHE3 dependent pHi recovery measured
using the cell-permeable dye BCECF-AM. Once pHi values had been calculated using the methods
provided in Appendix 7.1, recovery was then measured by two methods: linear regression and ∆pHi.
These methods were chosen as a combination of methodology from the literature (Preisig et al., 1987;
Alpern, 1985). As displayed in Figure 65, recovery rate slows as pHi approaches its resting level,
thus initial recovery rates were measured for comparision between samples. This intial rate provides
the best representation of NHE3 activity prior to any buffering of protons by cellular constituents
(Preisig et al., 1987). With both methods recovery was calculated from an initial starting point
(time zero) set as the lowest pHi measurement following pHi decline. Linear regression values were
calculated using GraphPad Prism 4 R© using pHi values from the first 45 seconds of recovery (Figure
65).
The pHi recovery rate was also measured as a change in pHi (∆pHi) from the ‘time zero’ (see above)
starting point. Subsequent data points were calculated as positive or negative changes in pHi from
this initial starting value, allowing for rate to be estimated as ∆pHi sec−1. This method was of most
value when creating graphical comparisons of recovery rates (Figure 66).
197
Figure 65: Example of NH4Cl pulse pHi recovery measurements. Initial recovery rate measured over
first 45 seconds of recovery using lowest recorded pHi as time zero. Insert provides magnification of
this period with linear regression best fit line illustrated for this data set.
Figure 66: Example of ∆pHi method of measuring pHi recovery following NH4Cl pulse. Comparision
period similar to that shown in Figure 65 with the lowest recorded pHi following NH4Cl pulse set
as time zero (t = 0). Data points from this pHi value at t = 0 were then be measured as change
in pHi (∆pHi). Graphical representations were extended to a 100 second period for better visual
comparison.
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8 Appendix II: Proteomics
8.1 Introduction
Chapters 3, 4 and 5 focused on the effects of elevated CO2 on a specific intracellular signalling
pathway and its physiological outcome. In contrast, this appendix is concerned with the global
effects of CO2 on protein expression. Using quantitative proteomic analysis of whole cell lysates
using iTRAQ reagents and LC/MS/MS, proteins could be identified and their relative abundances
calculated between samples. This method was used to identify proteins affected by elevation of CO2.
Evidence for global effects of CO2 in the literature have previously focused on transcriptomics
(Sheth et al., 2008; Sharabi et al., 2009). An abundance of mRNA, however, is not necessarily
indicative of the resultant protein concentration, which depends on its translation and degradation
rates. In fact, analyses indicate that differences in protein concentrations are only 20% - 40%
attributable to variable mRNA levels, underlining the importance of post-transcriptional regulation
(Brockmann et al., 2007). Additionally, the function of many proteins is further governed by a range
of post-translational modifications such as phosphorylation and glycosylation indistinguishable by
transcriptomic analysis methods.
8.1.1 iTRAQ Reagents
Proteomic analysis utilised the iTRAQ reagent system. These reagents, introduced by Darrly Pappin
and colleagues at Applied Biosystems in 2004 (Ross et al., 2004), refer to a set of amine specific
isobaric reagents. These reagents, when fragmented in the mass spectrometer, yield unique reporter
ions with the same mass but different charges, allowing identification of the iTRAQ label employed.
This means that labelled peptides are indistinguishable in MS but exhibit intense signatures with
MS/MS supporting quantitation (Ross et al., 2004). In addition to their isobaric nature, these
reagents are designed to react with all primary amines, including the N-terminus and the -amino
group of any of the lysine side-chains (Ross et al., 2004). They can, therefore, be used with all
protein mixtures with samples typically reduced, alkylated and enzymatically digested with typsin
prior to labelling (Section 2.6.5). Labelling with iTRAQ reagents enhances MS/MS fragmentation,
improving the confidence of the results (Zieske, 2006). Through use of this method up to eight
different samples (using the eight available reagents) can be analysed simultaneously, allowing for
quantitative comparison of the labelled peptide peaks.
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8.2 Optimisation of Sample Generation Method
As covered in Chapters 3, 4 and 5, elevation of pCO2 from 5% (v/v) to 10% (v/v) resulted in changes
in intracellular pH and calcium in addition to alterations in agonist induced cAMP. To establish
whether any protein expression levels altered under elevated CO2 was due to a combination of
these variables opposed to CO2 itself, various control experiments were simultaneously carried out,
varying CO2, mimicking the CO2 mediated pHi change with 2 mM propanoic acid, and by chelating
intracellular calcium using BAPTA-AM. The 8 conditions chosen for experimentation are detailed in
Table 18. As both BAPTA-AM and FSK were added as solutions in a DMSO solvent, where these
additions were absent the requisite volume of DMSO was added to eliminate this as a potential
variable. HEK-293t cells were used as these cells had the advantage of being both similar to those
used in previous chapters, thus yielding potentially comparable results, in addition to being of
human origin and, therefore, iTRAQ labelled peptides could be identified with appropriate levels of
confidence using the extensive human NCBI library. Each condition was carried out simultaneously
and repeated three times to produce independent replicates of samples.
Preparation of samples (Section 2.6.1) required an 8 hour incubation step at the appropriate pCO2
and agonist/chelator concentration. This step was required to allow cells to respond and where
appropriate alter their levels of protein expression. As CO2 decreases the pH of solutions, preliminary
experiments were carried out to monitor the pH over the whole 8 hour period in an attempt to control
medium pH between experiments requiring different CO2 concentrations, to help eliminate pH as
a determining factor. Similar to results displayed in Section 5.2.1, optimal experimental conditions
were chosen where the media pH was maintained at similar levels between samples for the longest
duration. This was achieved by including 100 mM HEPES in the incubating media in addition to
a starting pH of 7.50 for 5% (v/v) CO2 samples and pH 7.65 for 10% (v/v) CO2 . As displayed in
Figure 67, under these conditions the pH was equilibrated by 1 hour, with a difference in pH of only
0.01 ± 4.08 x 10−3 between samples at this time and 0.02 ± 9.57 x 10−3 after the full 8 hours.
In order to perform quantitative proteomic comparisons prior to trypsin digest and labelling with
the isobaric tags, each sample was analysed by Bradford assay (Section 6) to calculate protein
concentration. Using this value, 50 µg of each sample could be measured and treated further. To
test visually that these protein concentrations were correct an SDS-PAGE gel was run using 10 µg of
sample protein as calculated by this method. These gels (Figure 68), show that each sample within
the three replicates gave similar intensity bands, implying equal loading of protein as desired.
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Sample Number [CO2] (v/v) Additional Conditions
1 5% DMSO
2 5% 10 µM FSK
3 5% 2 mM PA (DMSO)
4 5% 10 µM FSK, 2 mM PA
5 10% DMSO
6 10% 10 µM FSK
7 10% 1 mM BAPTA-AM
8 10% 10 µM FSK, 1 mM BAPTA-AM
Table 18: Experimental conditions for iTRAQ samples.
Figure 67: Optimisation of pH for iTRAQ sample preparation. pH changes with each pCO2 and
different starting pH values of pH 7.50 for 5% CO2 (v/v) and pH 7.65 for 10% (v/v) CO2, 100mM
HEPES. Legend refers to CO2 concentrations as v/v in air.
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Figure 68: 1D SDS-PAGE gels of samples for iTRAQ labelling. Gels labelled A, B and C representing
10 µg of HEK-293t whole cell lysate samples from each independent experiment run on 12%
acrylamide gels. Wells left to right on all gels displaying samples for: [1] 5% (v/v) CO2 DMSO
control, [2] 5% (v/v) CO2 with 10 µM FSK, [3] 5% (v/v) CO2 with 2 mM PA, [4] 5% (v/v) CO2
with 10 µM FSK and 2 mM PA, [5] 10% (v/v) CO2 DMSO control, [6] 10% (v/v) CO2 with 10 µM
FSK, [7] 10% (v/v) CO2 with 1mM BAPTA-AM, [8] 10% (v/v) CO2 with 10 µM FSK and 1 mM
BAPTA-AM and where relevant a standard protein ladder.
202
8.3 Comparision of iTRAQ Proteomic Data
Use of the iTRAQ LC/MS/MS method generated data for 1502, 2116 and 1965 individual proteins
for each replicate respectively, thus giving an average estimated coverage of 9.31% of the typical
protein content of a human cell (Uhlen, 2005; Bodzon-Kulakowska et al., 2007). This value is low
compared to similar procedures from the literature which report proteome coverage of 20-30% (Ross
et al., 2004), but still usable. The partial peptide sequences were compared through the program
ProteinPilotTMl 2.0.1, against the NCBI library for Homo sapiens for identification where possible
to enable further comparison between samples.
ProteinPilotTM generates a Microsoft ExcelTM spreadsheet (example displayed as Table 19) displaying
the quantitative amount of each protein as a ratio compared to the control experiment (5% [v/v] CO2
with no FSK or BAPTA-AM) value. Associated with each ratio are two significance measurements:
a p-value and error factor. Briefly, the p-value refers to the probability that the observed ratio
was different from unity by chance with values closer to zero indicating greater significance. The
error factor is concerned with reporting errors in the ratio with the true ratio expected to be found
between the ‘ratio x error factor’ and the ‘ratio / error factor’. Therefore, in this case the closer the
number is to 1, the better the confidence of the result.
Accession Protein Name Ratio P-value Error Factor
gi—4503483 Translation elongation factor 2 1.02188611 0.399478436 1.051439881
gi—4885431 Heat shock 70kDa protein 1B 1.009026885 0.713204145 1.049557567
Table 19: Sample of ProteinPilotTM generated data.
Due to the large quantity of data generated, it was unfeasible to manually identify proteins with
altered expression levels. Therefore, a program was written using the programming language
PythonTM. This program (Section 8.3.1) was designed to search through the proteomic data sets
and select ratios of up or down-regulated proteins, chosen to have ratios either above 1.1 or below
0.9. From these values only those with appropriate levels of significance (with p-values below 0.05)
were then allowed for further selection. The identified peptides with significantly altered expression
levels were then compared across all three replicate data sets from each independent experiment to
produce the results presented in Section 8.4.
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8.3.1 Program Written to Analyse Proteomic Data
The program written to analyse the proteomics data is provided in the boxes below with explanation
provided in red following a hash (#).
from __future__ import division
# Divides numbers properly instead of treating all numbers as intergers
import csv
import string
# Imports csv and string modules for use later on
# The ‘def read_data’ routine below defines how to read in the data as a csv
# (comma-separated values) file
def read_data(filename,spacing=0):
f=open(filename,’U’)
fid=[]
for line in f:
fid.append(line)
f.close()
fid = fid[spacing:]
inData=csv.reader(fid,delimiter=’,’)
data=[]
# Square brackets instruct the program to read the data as a list rather than
# an array
for row in inData:
data.append(row)
# Reads data in rows not columns
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return data
# Once data has been read in it is returned to its previous location
# The ‘def anyabove’ and ‘def anybelow’ routines below define how to create
# cut-off values for analysing quantitative ratios of protein concentrations
# between samples. Values of 1.1 for up-regulation and 0.9 for down-regulation
# were chosen arbitrarily (see below) with ratio values above or below these
# values respectively highlighted as of interest
def anyabove(list,value):
for element in list:
if element > value:
return True
return False
def anybelow(list,value):
for element in list:
if element < value:
return True
return False
# The ‘def reg’ routine then defines how to apply these cut-off values
def reg(filename):
data = read_data(filename) # Reads in data in rows
print ’Length of file:’, filename, len(data)
# Generates a read-out of the file length (number of rows) and the associated
# file name
above = 1.1
below = 0.9
# Defines the cut-off values
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cols = [6,9,12,15,18,21,24]
# Defines which columns to apply this command to, those chosen contain the
# ratios of protein content between samples
printout=False
# The program had some difficulty reading some parts of the data due to absent
# and blank cells in the original csv/excel file. The following lines of code
# deal with this problem
for i in range(2,len(data)): # Adds any missing columns
try:
dummy = data[i][25] # Looks at all columns to number 25
except:
data[i].append(’’) # Adds blank cells at the end of rows if
data[i].append(’’) # cells are absent
for c in cols:
if data[i][c]==’’:
data[i][c] = data[i-1][c]
data[i][c+1] = data[i-1][c+1]
data[i][c+2] = data[i-1][c+2]
# Where empty cells are present this command instructs the program to read in
# the value from the previous row in a repetitive loop and is repeated for
# ratios, p-values and error factors. This is important in sections of the data
# where the peptide sequence had numerous potential identities when searching
# the human NCBI database
# The section below then acts as a filter, telling the program to apply the
# previously defined routines and create a list of protein IDs (unique
# identifiers for each protein, using the ‘GenInfo Identifier’ from the NCBI
# Genbank database located in the data set as column 3) for those proteins which
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# fit the stipulated criteria of having one or more ratios above or below the
# previously defined cut-off values
j=0
i_out = []
ID_out = []
for i in range(1,len(data)):
values=[]
for c in cols:
values.append(float(data[i][c]))
if anyabove(values,above) or anybelow(values,below):
i_out.append(i)
ID_out.append(data[i][3])
data_out=[0]*len(i_out)
a=0
for i in i_out:
data_out[a] = data[i]
a+=1
return data_out,ID_out
# The routine below, ‘def pv’ acts as another filter taking the data which
# fulfils the above criteria and then tests for the significance of the data,
# only selecting ratios with an associated p-value below a defined cut-off value,
# set below as 0.05
def pv(data,below=0.2):
p_cols = [7,10,13,16,19,22,25] # These columns contain p-values
i_out = []
ID_out = []
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for i in range(0,len(data)):
values=[]
for c in p_cols:
try:
values.append(float(data[i][c]))
except:
pass
if anybelow(values,below):
i_out.append(i)
ID_out.append(data[i][3])
data_out=[0]*len(i_out)
a=0
for i in i_out:
data_out[a] = data[i]
a+=1
print ’Number of significant rows:’, len(ID_out)
return data_out,ID_out
# The ‘def pvalues()’ tells the program which files to apply these filters on
# with File-1.csv containing the data for the first replicate of experiments
# etc. By including all three files the filters can be applied to all three
# data sets at the same time
def pvalues():
filename1 = ’./File-1.csv’
data1,ID1 = reg(filename1)
filename2 = ’./File-2.csv’
data2,ID2 = reg(filename2)
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filename3 = ’./File-3.csv’
data3,ID3 = reg(filename3)
cutoff = 0.05 # Defines the p-value cut-off
d1_sig,ID1_sig = pv(data1,below=cutoff) # Selects rows which have any
d2_sig,ID2_sig = pv(data2,below=cutoff) # p-values below the prescribed
d3_sig,ID3_sig = pv(data3,below=cutoff) # cut-off
# The following ‘fileout’ routines print the rows from each file containing
# data that meets the prescribed criteria as three separate csv files entitled
# ‘significant1.csv’ for data set 1 etc.
fileout=open(’./significant1.csv’,’a’)
for i in range(0,len(d1_sig)):
print >>fileout, d1_sig[i]
fileout.close()
fileout=open(’./significant2.csv’,’a’)
for i in range(0,len(d2_sig)):
print >>fileout, d2_sig[i]
fileout.close()
fileout=open(’./significant3.csv’,’a’)
for i in range(0,len(d3_sig)):
print >>fileout, d3_sig[i]
fileout.close()
# The rest of the code then compares the unique protein IDs (using the NCBI
# ‘GenInfo Identifier’ numbers) for the data which fits the above criteria and
# searches through the three lists generated from each data set to identify
# which proteins appear in all three. It then produces a file containing these
# protein IDs and their associated data, bringing together the values from each
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# independent experimental replicate
ID_common = []
for ID in ID1_sig:
if ID in ID2_sig and ID in ID3_sig:
ID_common.append(ID)
print ’Amount of cross matches:’, len(ID_common)
ind1=[]
row_number1=[]
for i in range(0,len(d1_sig)):
ind1.append(d1_sig[i][3])
for ID in ID_common:
row_number1.append(ind1.index(ID))
ind2=[]
row_number2=[]
for i in range(0,len(d2_sig)):
ind2.append(d2_sig[i][3])
for ID in ID_common:
row_number2.append(ind2.index(ID))
ind3=[]
row_number3=[]
for i in range(0,len(d3_sig)):
ind3.append(d3_sig[i][3])
for ID in ID_common:
row_number3.append(ind3.index(ID))
fileout=open(’./significant.csv’,’a’)
for i in range(0,len(row_number1)):
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ia = row_number1[i]; ib = row_number2[i]; ic = row_number3[i]
print >>fileout, d1_sig[ia][3],’,’,d1_sig[ia][4],’,’,
string.join(d1_sig[ia][6:],’,’)
print >>fileout, d2_sig[ib][3],’,’,d2_sig[ib][4],’,’,
string.join(d2_sig[ib][6:],’,’)
print >>fileout, d3_sig[ic][3],’,’,d3_sig[ic][4],’,’,
string.join(d3_sig[ic][6:],’,’)
fileout.close()
if __name__ == ’__main__’:
pvalues()
This program generated a file containing 108 NCBI ‘GenInfo Identifiers’ for proteins which could
then be searched manually for any trends, the results from which are provided in Section 8.4.
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8.4 Proteins Identified to have Altered Expression
Whilst the analysis program displayed in Section 8.3.1 generated 108 proteins of interest, when
looking at the data very few of these proteins showed any consistant trends across the experimental
conditions. Those with such trends are displayed in Table 20. Only two proteins exhibited altered
expression with CO2: carbonic anhydrase II which was upregulated and methylenetetra- hydrofolate
dehydrogenase I which was downregulated. Results from FSK activated samples were more promising
with proteins histone H3 and KIA0098 upregulated and chaperonin containing TCP1 and solute
carrier family 16 downregulated.
Multiple papers have looked at the effect of elevated CO2 on the cell although, as mentioned, most
of these have looked at the gene expression level rather than the downstream protein production.
Tomanek et al. focuses on the effect of elevated CO2 on estuarine eastern oyster Crassostrea
virginica protein expression; however hypercapnia in this context (∼357 Pa PCO2 ) is a lot lower
than in humans (∼6 kPa). Here the authors observe differential expression of 12% of proteins
(54 of 456) with 17 identified (Tomanek et al., 2011). In this study elements of the cytoskeleton
were found to be upregulated including actin, actin-polymerisation factor and calponin 2 and in
addition a host of proteins involved in cellular response to oxidative stress such as superoxide
dismutase (catalyses superoxide generation), peroxiredoxins 2, 4 and 5 (antioxidants involved in
detoxification of organic peroxides and H2O2), thioredoxin-related nucleoredoxin, mitochondrial
malate dehydrogenase (Tomanek et al., 2011). Furthermore, there was an observed upregulation
of certain regulators of protein synthesis and degradation, including the 40S ribsomal protein and
proteosome alpha type 3 protein (Tomanek et al., 2011). Taken as a whole, these changes to the
proteome indicate that elevated CO2 is causing significant oxidative stress by producing reactive
oxygen species (ROS) either directly or indirectly, with the concomitant lowered pH effecting electron
transport chain efficiency. The results from the study presented in this report do not support any
of these findings, although due to the poor peptide identification this is not surprising.
From transcriptomics there is evidence in the literature that elevated CO2 levels lead to increased
expression of apoptotic proteins in the cortical neurons of newborn piglets (Fritz et al., 2005),
cell adhesion molecules procollagen and fibulin, surfactant proteins A and D and chloride channel-
activated 3 in neonate mice (Li et al., 2006a), innate immune and inflammatory response genes
downstream of the NF-κB pathway in human alveolar adenocarcinomic cells (Cummins et al., 2010)
and sGC, ubiquitin ligase and elements of the innate immune system in Caenorhabditis elegans
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(Sharabi et al., 2009). There is also evidence for decreased gene expression of immune response
genes and elements of the WNT1-inducible signalling pathway in neonate mice (Li et al., 2006a) and
heat shock proteins in Candida albicans (Sheth et al., 2008) and Caenorhabditis elegans (Sharabi
et al., 2009). Interestingly Sharabi et al. reported downregulation of carbonic anhydrase genes in
Caenorhabditis elegans after 6 and 72 hours of elevated CO2 (Sharabi et al., 2009) whilst this report
showed upregulated protein expression at 8 hours. Repetition of this experiment would be needed
to confirm this result.
As noted, unfortunately this experiment returned very little useful data. Whilst the experimental
method for cell treatment has been optimised throughout this report and the lysis method is near
identical to that which is recommended in the literature (Witzmann et al., 2002; Bodzon-Kulakowska
et al., 2007), there are numerous options for the cell lysate sample preparations and LC/MS/MS
separation. It may be possible that the conditions used were not optimum for the complexity of the
samples due to the facilities available. Further experimentation would be required to improve the
quality of the data returned.
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